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There is a need to increase awareness among African American men regarding 
their potential risk of prostate cancer and inform them of screening and treatment 
options, given the health disparities that affect their group. To do so, an innovative 
e-health video was developed, using an animated avatar video to educate African 
American males about prostate cancer and potential screening methods in a way that is 
culturally appropriate. Effectiveness of this e-health intervention was tested on a 
sample of 41 African American males. Efficacy was measured using a repeated 
measures design that used pre- and post-measures of four target behaviors regarding 
prostate cancer screening. These four target behaviors include: (1) getting an annual 
physical exam, (2) discussing the possibility of getting a digital rectal exam to screen 
for prostate cancer with a doctor, (3) discussing the possibility of getting a PSA exam 
to screen for prostate cancer with a doctor, and (4) spreading awareness about prostate 
cancer among other African American men. The stage of change, which is a theoretical 
framework adapted from Prochaska and DiClemente (1983), measures changes in 
human behavior from precontemplation and contemplation on the low end to action 
and maintenance on the high end. Self-efficacy was also measured before and after the 
intervention for each of the four target behaviors. Paired t-tests show that the stage of 
change for the third and fourth target behaviors and self-efficacy for the second, third, 
and fourth target behaviors were significantly increased by the e-health intervention, 
indicating that the intervention was successful. Additionally, participant ratings about 
the intervention were largely positive. In effect, this study finds that the e-health 
intervention developed in this study not only works, but is an affordable, scalable, and 
practical tool that can educate African American males about prostate cancer screening 
practices. 
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Mullins, Onukwugha, Bikov, Seal, and Hussain (2010) explained how health 
disparities, which are “defined as differences in disease incidence, morbidity, and 
mortality that exist between specific populations, are more commonly seen in African 
American populations” (p. 572). According to Hoffman et al. (2001), prostate cancer “is 
the most frequently diagnosed visceral cancer and the second leading cause of cancer 
death in men” (p. 388). 
Wu and Modlin (2012) reviewed disparities in prostate cancer that involved 
African American men. They discussed how “African American men are 
disproportionately affected, with a prostate cancer incidence two-thirds higher than 
whites and a mortality rate twice as high” (p. 313). 
Mullins et al. (2010) examined the influence of race and age disparities and the 
impact these factors have had on staging prostate cancer in the African American (AA) 
population; and the increased metastasis that occurs as a result of inaccurate staging. 
Mullins et al. reported that “African American (AA) men with prostate cancer (PC) have 
more advanced disease and poorer prognosis than their White counterparts” (p. 566). 
Mullins et al. (2010) observed further that “AA patients with localized PC 
experience shorter disease-free survival than other racial groups” in addition to “multiple 
factors including socioeconomic status and behaviors contribute to higher PC incidence 
and mortality among AA men” (p. 566). Mullins et al. reported that “ racial disparities 
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persist even after controlling for socioeconomic status” and although “AA men not only 
have higher PC incidence and mortality but also PC may be more aggressive in AA men 
than European American men, particularly at younger ages” (p. 566). Mullins et al. also 
noted research findings where “AA men were less likely to receive relatively more 
expensive or innovative treatments” (p. 566). They noted how a lack “of awareness of 
treatment options and lack of patient education by physicians can affect access to health 
care” (p. 566). 
Hoffman et al. (2001) focused on African American men and the risk factors for 
prostate cancer—whether demographic, socioeconomic, health insurance, educational, or 
marital status—drawing upon data from the Prostate Cancer Outcomes Study (PCOS). 
Hoffman et al. utilized data from the Prostate Cancer Outcomes Study (PCOS), which 
“was initiated in 1994 to collect individual-level data from a population based cohort of 
men with newly diagnosed prostate cancer to assess the effects of cancer treatments” 
(p. 388). Using these data, Hoffman et al. explained how the objective of their analysis 
“was to use this data to determine the association, if any, between race/ethnicity and 
prostate cancer clinical stage after adjusting for demographic, socioeconomic, clinical, 
and pathologic factors” (p. 388). 
Hoffman et al. (2001) noted that there are “important racial and ethnic differences” 
that “exist in prostate cancer epidemiology” (p. 388). More specifically, “African-
Americans have the world’s highest incidence of prostate cancer and a more than twofold 
higher mortality rate compared with whites” (p. 388). They suggested that the “excess 
mortality for African-Americans apparently results from an increased risk for presenting 
with advanced-stage disease” (p. 388). Hoffman et al. found that African-Americans were 
“more than twice as likely as whites to present with advanced disease” (p. 393). 
Mullins et al. (2010) also discussed how “AA and older men are more likely to be 
diagnosed with advanced-staged PC, [and] we find that there also is a higher probability 
that AA and older men with PC will not be staged” (p.572). Mullins et al. concluded that 
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“based on historical SEER-Medicare data and document that there are disparities among 
diagnosed PC patients in the probability of being staged,” while demonstrating “PC 
staging did not improve from the years 1998 to 2002 for AA men and older men” 
(p. 572). 
Mullins et al. (2010) discussed how “AA men and also men aged 80 years and 
older with prostate cancer were less likely to have had their prostate cancer staged 
compared with non-Hispanic whites and men aged 65-69 years” (p. 572). Hoffman et al. 
(2001) found that “African-Americans had the highest proportion of advanced disease 
(12.3%), followed by Hispanics (10.5%) and non-Hispanic whites (6.3%)” (p. 389). Also, 
“African-Americans and Hispanics were generally younger, less educated, poorer, and 
less likely to have had a previous PSA test than non-Hispanic whites” (p. 389). Hoffman 
et al. also found that “African-Americans had the most comorbidity and the highest PSA 
levels;” and overall “African-Americans (16.8%) and Hispanics (12.9%) had a higher 
proportion than non-Hispanic whites (10.5%) of poorly differentiated cancers” (p. 389). 
Mullins et al. (2010) observed how “when staging did take place, the probability of 
having distant metastatic disease was higher for AA men and also for all men as they 
aged, compared with the reference group of 65-69 year olds” (p. 572). Mullins et al. 
noted that, in part, “the observed disparities in staging may reflect informed patient 
decision-making, but continued monitoring and education regarding new treatment 
options should continue for all men with PC” (p. 572). 
Hoffman et al. (2001) explained how the racial/ ethnic disparity “in the stage at 
diagnosis is clinically important because stage strongly predicts survival” (p. 391). 
Unfortunately, they also reported that the “prostate cancer mortality rate is substantially 
higher for African-Americans than for non-Hispanic whites” (p. 391). 
Hoffman et al. (2001) explained that “African-Americans appeared to have more 
aggressive cancers because they had the highest overall proportion of poorly 
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differentiated cancers (16.8%) and were more likely than non-Hispanic whites to have 
poorly differentiated cancers within all clinical stages” (p. 393). 
Wu and Modlin (2012) discussed data indicating that “African American men 
generally present with disease that is more advanced than in white men” (p. 314). “This 
historically has been attributed to the fact that African Americans have been less likely to 
be screened for prostate cancer” (p. 314). 
According to Wu and Modlin (2012), “African American men tend to have a 
higher incidence of prostate cancer, they also tend to have more-aggressive disease (i.e., a 
higher pathologic grade) at the time of diagnosis, which may contribute to the disparity in 
mortality rates” (p. 314). They reviewed “a body of evidence supports the contention that 
prostate cancer is more aggressive in African American men” (p. 314). Other noteworthy 
findings revealed how “men in Nigeria and Ghana also have a high incidence of prostate 
cancer, as do men of African descent in the Caribbean islands and in the United 
Kingdom” (p. 314). 
Wu and Modlin (2012) further explained that “potential metastatic disease may be 
identified in a less timely and accurate manner, as African American men are less likely 
to undergo pelvic lymph node dissection” (p. 316). They discussed how “even after 
adjusting for treatment, African Americans continue to have worse survival rates” 
(p. 316). Also, “African American and Hispanic race were associated with higher all-
cause mortality rates” (p. 316). 
According to Wu and Modlin (2012), “it is important to understand what 
mechanisms may underlie these differences and what can be done to narrow the gap” 
(p. 313). “The disparity may be due to a variety of factors, some socioeconomic and some 




Wu and Modlin (2012) discussed how evidence of a “genetic component to the 
high incidence and mortality rate in African American men comes from epidemiologic 
studies of men with similar genetic backgrounds” (p. 314). “Chromosome 8q24 variants 
have been shown in several studies to be associated with prostate cancer risk and are 
more common in African American men” (p. 314). Wu and Modlin also pointed to “a 
higher rate of variations in cell apoptosis genes such as BCL211 and tumor suppression 
genes such as EphB2 in African American men” (p. 314). Wu and Modlin discussed how 
these findings “suggest that genetic differences may contribute to the higher prostate 
cancer incidence and mortality rate seen in African American men” (p. 314). 
A Historical Perspective on Screening and Disparities 
Fowke, Schlundt, Signorello, Ukoli, and Blot (2005) noted that the “prostate 
specific antigen (PSA) test and digital rectal examination (DRE) enable the detection of 
early-stage and organ-confined disease among otherwise asymptomatic men” (p. 333). 
Wu and Modlin (2012) also recognized that the “American Urological Association 
now recognizes that the normal PSA range, in addition to varying along racial lines, also 
is age-dependent” (p. 315). More specifically, the age range recommendations and 
suggested normal PSA levels for African American men were provided by Wu and 
Modlin, while following the work of the Cleveland Clinic Minority Men’s Health Center, 
as shown below: 
 Age 40–49: ≤ 2.5 ng/mL 
 Age 50–59: ≤ 3.0 ng/mL 
 Age 60–69: ≤ 3.5 ng/mL 
 Age 70–79: ≤ 4.5 ng/mL 
 Age > 80: ≤ 5.0 ng/mL 
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Wu and Modlin (2012) suggested that medical doctors “must also be aware of 
racial differences in PSA levels and realize that the predictive value of PSA in the 
diagnosis of prostate cancer may differ between African Americans and whites” (p. 315). 
As it turns out, Black men “with or without prostate cancer, have been found to have 
higher PSA levels” when compared to White men “across all age groups” (p. 315). And, 
other researchers have found that “African Americans with newly diagnosed localized 
prostate cancer had higher serum PSA levels than whites” (p. 315). 
Wu and Modlin (2012) highlighted important recommendations offered by the 
American Cancer Society, which recommends that “African American men who have a 
father or brother who had prostate cancer before age 65 should begin having discussions 
with their physician on this topic”—and, should provide informed consent to their 
physicians so as to begin “screening at age 45” (p. 315). According to Wu and Modlin, 
the National Comprehensive Cancer Network (NCCN) has indicated that the “frequency 
of PSA screening depends on the individual’s PSA level” (p. 315). Further, the National 
Comprehensive Cancer Network has recommended that “men at high risk be offered a 
baseline PSA measurement and digital rectal examination at age 40” (p. 315). 
Fowke et al. (2005) reported that the American Cancer Society (ACA), “the 
American Urological Association (AUA), and the American College of Radiology (ACR) 
have recommended that counseling and annual PSA/DRE screening be offered to men 
starting at 50 years” (p. 339). 
According to Hoffman et al. (2001), both the “American Urological Association 
and the American Cancer Society” had identified “African-Americans as a high-risk 
group” and had recommended “annual screening with digital–rectal examination and 
PSA beginning at age 40 years” (p. 394). 
Fowke et al. (2005) also discussed screening recommendations offered by “the 
American Cancer Society (ACS)” as well as “other groups”—including how they have 
“created age and race-specific guidelines”; for example, there was the recommendation 
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for engagement in “annual consultation and screening,” which should begin at age 50 for 
Caucasian men and at age 45 for African American men and “high-risk men” (p. 334). 
Fowke et al. (2005) examined the differences between the African American 
population and the Caucasian population, while investigating differences in prostate 
cancer screening by age, socioeconomics, and demographic indices. According to Fowke 
et al., race “remains a consistent risk factor for prostate cancer incidence and mortality 
among U.S. men” (p. 333). Also, African-American (AA) men “have a higher incidence 
and are diagnosed with more advanced cancer compared to Caucasian (CA) men” 
(p. 333). 
Fowke et al. (2005) also reported their own findings, which were consistent “with 
prior research” (p. 339). More specifically, they found that Caucasian men “older than 
age 65 were significantly more likely to report a recent PSA test or DRE” (p. 339). 
Fowke et al. indicated how African American men “were less knowledgeable about 
prostate cancer screening tests” (p. 333). 
Hoffman et al. (2001) highlighted how “African-Americans, particularly in lower 
socioeconomic groups, are often poorly informed about prostate cancer and are less 
willing than non-Hispanic whites to participate in screening programs” (p. 393). 
Wu and Modlin (2012) also discussed how it may be the case that “African 
Americans are unaware of early detection methods for prostate cancer (e.g., PSA 
testing),” and experience “other barriers such as cost and transportation” as factors that 
may prevent African American men from being screened” (p. 315). 
Role of Potential Factors 
Mahal et al. (2014) discussed some of the multifactorial causes for the excess 
mortality among AA men; for example, AA men may have “a biologic predisposition for 
aggressive disease, have poorer access to care, experience treatment delays, and/or 
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receive care from lower volume and quality centers, all of which could lead to worse 
survival after a median follow-up of only 39 months” (p. 388). 
Wu and Modlin (2012) cited potential contributory factors, such as the possibility 
that “African Americans receive less screening,” experience “poor communication” with 
physicians, and are impacted by a “lack of cultural competency among physicians” 
(p. 315). They also cited a “lack of health insurance (and poor access to quality care as a 
result), and deficiency of knowledge about screening” (p. 315). 
Hoffman et al. (2001) noted that socioeconomic “factors have been hypothesized to 
explain the racial and ethnic differences in the stage of prostate cancer at diagnosis” 
(p. 391). According to Hoffman et al., “African-Americans, who are disproportionately 
represented in the lower socioeconomic levels, are believed to have less access to health 
care and preventive services than non-Hispanic whites” (p. 391). They also reported how 
“insurance status and employment status were associated with the risk for presenting with 
advanced disease” (p. 391). Also mentioned was the reality that “socioeconomic factors 
alone cannot adequately explain the higher percentage of advanced disease in African-
Americans” (p. 391). 
Fowke et al. (2005) also discussed risk factors for being diagnosed with advanced 
prostate cancer. These factors included men “living in low-income and low-education 
census tracts, men without health insurance, or men with publicly funded insurance” 
(p. 334). 
Hoffman et al. (2001) also noted many factors. These included the role of potential 
“racial differences in tumor biology, possibly attributable to differences in dietary, 
hormonal, or molecular factors,” which may “lead to more aggressive tumors” (p. 388). 
Wu and Modlin (2012) also discussed the potential role of “nutritional factors” that 
may “also contribute partly to prostate carcinogenesis” (p. 317). There are also potential 
culture-specific and “race-specific differences in diet” that may “play an important role in 
prostate cancer risk” (p.317). For example, obesity “has been shown to increase the risk 
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of more-aggressive prostate cancer, but not of less-aggressive tumors” (p. 317). Also, for 
African American men, obesity appear to be a significant risk factor, given that obesity 
“was found to be associated with shorter biochemical relapse-free survival” in African 
American men; yet, on the other hand, obesity “was not an independent risk factor in 
white men” (p. 317). This suggests how “healthy lifestyles” can play a role in the 
“reduction in risk for prostate cancer”; they also suggested relevant benefits from “a low-
fat diet, a healthy body mass index, and daily exercise” (p. 318). 
Health Care Disparities and Treatment Factors 
Wu and Modlin (2012) noted how “the 2002 Institute of Medicine report, Unequal 
Treatment: Confronting Racial and Ethnic Disparities in Health Care, found evidence that 
racial and ethnic minorities tend to receive lower-quality health care than whites” 
(pp. 313-314). Wu and Modlin found more “favorable survival outcomes for African 
Americans with localized disease may be achieved with uniform assignment of 
treatment” (p. 316). Wu and Modlin reported how “survival outcomes were equivalent 
between whites and blacks when treatment was assigned in a uniform manner without 
regard to race” (p. 315). They discussed the manner in which “data suggest that if 
localized prostate cancer is treated adequately and appropriately, African American 
patients may have improved survival rates” (p. 317). 
Wu and Modlin (2012) also noted how there are research studies that “have also 
determined that there “are apparent differences “in the treatments offered to patients, 
which in turn negatively affect survival” (p. 316). The treatments highlighted were 
“potentially curative local therapies (including radical surgery or radiation)” that “may be 
recommended less often to black men because of major comorbidities or socioeconomic 
considerations” (p. 316). 
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Mahal et al. (2014) examined trends in disparate treatment of African American 
(AA) men with localized prostate cancer (PCa) across National Comprehensive Center 
Network (NCCN) risk groups in the United States. According to Mahal et al., it has been 
reported that “African American (AA) men have a significantly higher risk of dying from 
PCa than white men” (p. 386). In addition, it is generally “unknown how much of this is 
due to differences in biology vs disparities in treatment patterns and access to care” 
(p. 386). 
Regarding prostate cancer (PCa) and guidelines established by the National 
Comprehensive Cancer Network (NCCN), Mahal et al. (2014) further reported that “there 
is a paucity of literature that examines racial disparities in PCa by NCCN risk groups, and 
evidence is conflicting as to whether racial disparities in the use of definitive treatment 
change with more advanced disease” (p. 386). Mahal et al. also indicated that “AA 
patients were significantly less likely to receive curative-intent treatment” relative to 
“white men among patients with intermediate- to high-risk PCa” (p. 387). 
Mahal et al. (2014) investigated prostate cancer-specific mortality (PCSM). They 
found “after a median follow-up of 39 months, cumulative incidence estimates of PCSM 
were significantly higher for AA men compared with white men among patients with 
intermediate- to high-risk disease, with 5-year PCSM rates of 4.5% (95% CI, 4.1%-4.9%) 
for AA men” (p. 388). Mahal et al. indicated that statically “multivariate competing-risks 
regression analysis revealed an increased risk” for prostate cancer specific mortality 
(PCSM) “among AA men compared with white men, with a hazard ratio of 1.12 
(95% CI, 1.01-125; p=.03)” (p. 388). Mahal et al. also reported that “men with 
intermediate- to high-risk PCa are at a 12% increased relative risk for PCSM compared 
with white men” (p. 388). Yet, “AA men receive curative-intent treatment 18% less often 
relative to white men” (p. 388). Mahal et al. further indicated that this “disparity is even 
greater among high-risk patients as AA men with high-risk disease were 40% less likely 
to receive curative treatment compared with white patients” (p. 388). 
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Mullins et al. (2010) also indicated that “AA men tend to be less informed of their 
options compared with Whites, and therefore may not seek aggressive treatment options 
for clinically localized PC” (p. 566). Furthermore, Mullins et al. reported how “AA men 
with locally advanced PC are less likely to undergo radical prostatectomy than their 
White counter-parts” (p. 566). 
As per Mullins et al. (2010), “potential causes of the observed disparities in 
staging” may “include physician bias against staging” the prostate cancer of African 
American men, as well as the elderly—whether “intentional or unintentional” (p. 572). 
Further, additional potential causes may include “health system factors or a lack of 
staging facilities at hospitals where many AA or elderly seek care, a lack of effective 
communication (lack of cultural competency)” (p. 572). Also, additional causes may 
include a “lack of delivery of informed consent provided to AA and elderly males by 
physicians to explain the importance and rationale for staging, lack of patient education 
about prostate cancer by physicians” (p. 572). In addition, other causes may involve a 
“lack of health literacy on the part of AA or elderly patients, leading to lack in 
understanding the importance of staging, socioeconomic determinant factors (i.e., lack of 
transportation, difficulty getting off work, etc.), or patient behavioral factors” (p. 572). 
Underwood et al. (2004) evaluated data (N=142,340) from 1992 and 1999 with 
White, Black, and Hispanic men and identified racial/ethical disparities in the treatment 
of localized/regional prostate cancer. Underwood et al. found that compared “to white 
American men black American men are at greater risk for this cancer and they experience 
greater mortality” (p. 1504). Underwood et al. offered the following: 
Although the higher mortality in black men may be secondary to 
inherent genetic differences, as demonstrated by higher tumor grade and 
stage at presentation, disparities in the use of definitive therapy may also 
contribute to the observed disparity in mortality. (p. 1504) 
Underwood et al. (2004) further explained how Black men “were most likely to 
receive definitive therapy (radical prostatectomy or external beam radiation) when 
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diagnosed with localized prostate cancer” (p. 1505). They also went on to report on the 
“most rapidly growing ethnic group in the United States” (p. 1506), i.e., Hispanics. For 
this group of Hispanic men, Underwood et al. reported a “75% increase in incident 
prostate cancer cases between 1969 and 1991” (p. 1504). Furthermore, “more disturbing 
was the observation that while age adjusted mortality between 1983 and 1991 decreased 
in non-Hispanic men, it remained stable in Hispanic men” (p. 1504). They noted how 
“treatment patterns in the Hispanic American population have been less well 
characterized” (p. 1504). 
Underwood et al. (2004) continued to explain that Black men as compared to 
Hispanic men experienced the “lowest odds of receiving definitive therapy” (p. 1506). 
This is noteworthy since “higher grade prostate cancers results in greater cancer specific 
mortality in a 10 to 15-year period in men who do not receive definitive treatment” 
(p. 1506). 
Underwood et al. (2004) emphasized that “a combination of biological and 
sociological factors contribute to the racial/ethnic disparity in prostate cancer mortality 
and our finding is just one of many potential nonbiological mechanisms” (p. 1506). 
Underwood et al. emphasized how “racial/ethnic disparities in the use of definitive 
treatment were observed” for African American and Hispanic men when compared to 
“white men throughout the 1990s” (p. 1507). 
The Contemporary PSA Controversy 
There has also been controversy around the PSA test. For example, Barry (2009) 
has noted that there are high risks of overdiagnosis and overtreatment associated with 
PSA screening. Barry reported on the “first reports from two large, randomized trials that 
many observers hoped would settle the controversy” (p. 1351). More specifically, the 
U.S. Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial reported no 
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mortality benefit from combined screening with PSA testing and digital rectal 
examination “during a median follow-up of 11 years” (p. 1352). On the other hand, the 
European Randomized Study of Screening for Prostate Cancer (ERSPC) trial reported 
that “PSA screening without digital rectal examination was associated with a 20% 
relative reduction in the death rate from prostate cancer as a median follow-up of 9 years, 
with an absolute reduction of about 7 prostate cancer deaths per 10,000 men screened” 
(p. 1352). Further, “ongoing results from both of these trials may necessitate rethinking 
the role of digital rectal examination in cancer screening”(p. 1353). Meanwhile, Barry 
has emphasized that there are high risks of overdiagnosis and overtreatment associated 
with PSA screening. Barry elaborated: 
After digesting these reports, where do we stand regarding the PSA 
controversy? Serial PSA screening has at best a modest effect on prostate-
cancer mortality during the first decade of follow-up. This benefit comes at 
the cost of substantial overdiagnosis and overtreatment. It is important to 
remember that the key question is not whether PSA screening is effective but 
whether it does more good than harm. (p. 1353) 
Similarly, McNaughton-Collins and Barry (2011) posed a key question: “Who 
should decide about screening for prostate cancer: expert panels of clinicians and 
methodologists, primary care clinicians, specialists, or fully informed patients 
themselves?” (p. 1951). 
The Controversy and Resultant Varied Recommendations to Date 
The U.S. Preventive Services Task Force 
Further, the U.S. Preventive Services Task Force (Moyer, 2012) provided 
recommendations, as an independent panel of experts in primary care and prevention. 
The  USPSTF (Moyer, 2012) reported as follows: 
The USPSTF recommends against prostate-specific antigen (PSA)–
based screening for prostate cancer (grade D recommendation)…. 
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Contemporary recommendations for prostate cancer screening all 
incorporate the measurement of serum PSA levels; other methods of 
detection, such as digital rectal examination or ultrasonography, may be 
included. There is convincing evidence that PSA-based screening programs 
result in the detection of many cases of asymptomatic prostate cancer. There 
is also convincing evidence that a substantial percentage of men who have 
asymptomatic cancer detected by PSA screening have a tumor that either 
will not progress or will progress so slowly that it would have remained 
asymptomatic for the man’s lifetime. The terms “overdiagnosis” or “pseudo-
disease” are used to describe both situations…. (p. 12) 
The USPSTF further elaborated on their recommendation: 
Although the USPSTF discourages the use of screening tests for which 
the benefits do not outweigh the harms in the target population, it recognizes 
the common use of PSA screening in practice today and understands that 
some men will continue to request screening and some physicians will 
continue to offer it. The decision to initiate or continue PSA screening 
should reflect an explicit understanding of the possible benefits and harms 
and respect the patients’ preferences. Physicians should not offer or order 
PSA screening unless they are prepared to engage in shared decision making 
that enables an informed choice by the patients. Similarly, patients 
requesting PSA screening should be provided with the opportunity to make 
in- formed choices to be screened that reflect their values about specific 
benefits and harms. Community- and employer-based screening should be 
discontinued. (p. 122) 
Also acknowledged by Moyer (2012) were the recommendations of other major 
groups, as follows: 
The American Urological Association recommends that PSA screening, 
in conjunction with a digital rectal examination, should be offered to 
asymptomatic men aged 40 years or older who wish to be screened, if 
estimated life expectancy is greater than 10 years…. It is currently updating 
this guideline…. The American Cancer Society emphasizes informed 
decision making for prostate cancer screening: Men at average risk should 
receive information beginning at age 50 years, and black men or men with a 
family history of prostate cancer should receive information at age 45 
years…. The American College of Preventive Medicine recommends that 
clinicians discuss the potential benefits and harms of PSA screening with 
men aged 50 years or older, consider their patients’ preferences, and 
individualize screening decisions…. The American Academy of Family 
Physicians is in the process of updating its guideline, and the American 
College of Physicians is currently developing a guidance statement on this 
topic. (p. 132) 
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American Urological Association 
On the other hand, guidelines approved by the American Urology Association 
(AUA) board of directors in April of 2013 were published by Carter et al. (2013). This 
involved the AUA commissioning an independent group to conduct a systematic review 
and meta-analysis of the available published literature, covering prostate cancer detection 
and screening. The guidelines appear below, as per Carter et al.: 
GUIDELINE STATEMENTS 
1. The Panel recommends against PSA screening in men under age 40 years. 
(Recommendation; Evidence Strength Grade C) 
In this age group there is a low prevalence of clinically detectable 
prostate cancer, no evidence demonstrating benefit of screening and likely 
the same harms of screening as in other age groups. 
2. The Panel does not recommend routine screening in men between ages 40 
to 54 years at average risk. (Recommendation; Evidence Strength Grade C) 
For men younger than age 55 years at higher risk (e.g. positive family 
history or African American race), decisions regarding prostate cancer 
screening should be individualized. 
3. For men ages 55 to 69 years the Panel recognizes that the decision to 
undergo PSA screening involves weighing the benefits of preventing 
prostate cancer mortality in 1 man for every 1,000 men screened over a 
decade against the known potential harms associated with screening and 
treatment. For this reason, the Panel strongly recommends shared decision-
making for men age 55 to 69 years that are considering PSA screening, and 
proceeding based on a man’s values and preferences. (Standard; Evidence 
Strength Grade B) 
The greatest benefit of screening appears to be in men ages 55 to 69 
years. 
4. To reduce the harms of screening, a routine screening interval of two 
years or more may be preferred over annual screening in those men who 
have participated in shared decision-making and decided on screening. As 
compared to annual screening, it is expected that screening intervals of two 
years preserve the majority of the benefits and reduce overdiagnosis and 
false positives. (Option; Evidence Strength Grade C) 
Additionally, intervals for rescreening can be individualized by a 
baseline PSA level. 
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5. The Panel does not recommend routine PSA screening in men age 70+ 
years or any man with less than a 10 to 15 year life expectancy. 
(Recommendation; Evidence Strength Grade C) 
Some men age 70+ years who are in excellent health may benefit from 
prostate cancer screening. (pp. 1-2) 
The American Cancer Society 
The American Cancer Society (2014) has offered the following recommendations 
for the early detection of prostate cancer: 
The American Cancer Society (ACS) recommends that men have a 
chance to make an informed decision with their health care provider about 
whether to be screened for prostate cancer. The decision should be made 
after getting information about the uncertainties, risks, and potential benefits 
of prostate cancer screening. Men should not be screened unless they have 
received this information. 
The discussion about screening should take place at age 50 for men who 
are at average risk of prostate cancer and are expected to live at least 10 
more years. 
This discussion should take place starting at age 45 for men at high risk 
of developing prostate cancer. This includes African Americans and men 
who have a first-degree relative (father, brother, or son) diagnosed with 
prostate cancer at an early age (younger than age 65). 
This discussion should take place at age 40 for men at even higher risk 
(those with more than one first-degree relative who had prostate cancer at an 
early age). 
After this discussion, those men who want to be screened should be 
tested with the prostate-specific antigen (PSA) blood test. The digital rectal 
exam (DRE) may also be done as a part of screening. 
If, after this discussion, a man is unable to decide if testing is right for 
him, the screening decision can be made by the health care provider, who 
should take into account the patient’s general health preferences and values. 
Assuming no prostate cancer is found as a result of screening, the time 
between future screenings depends on the results of the PSA blood test: 
-Men who choose to be tested who have a PSA of less than 2.5 ng/ml, 
may only need to be retested every 2 years. 
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-Screening should be done yearly for men whose PSA level is 2.5 ng/ml 
or higher. 
Because prostate cancer often grows slowly, men without symptoms of 
prostate cancer who do not have a 10-year life expectancy should not be 
offered testing since they are not likely to benefit. Overall health status, and 
not age alone, is important when making decisions about screening. 
Even after a decision about testing has been made, the discussion about 
the pros and cons of testing should be repeated as new information about the 
benefits and risks of testing becomes available. Further discussions are also 
needed to take into account changes in the patient’s health, values, and 
preferences. (paras. 1-9) 
Memorial Sloan Kettering Cancer Center 
The Memorial Sloan Kettering Cancer Center (2014) has offered the following 
recommendations, in contrast, while recognizing a role for both the PSA and digital rectal 
examination (DRE): 
Prostate-Specific Antigen (PSA) Test 
This blood test measures levels of prostate-specific antigen, a protein 
made by cells of the prostate gland. Although it is normal for men to have 
low levels of PSA in their blood, prostate cancer can increase a man’s PSA 
levels. Men with an elevated PSA level (greater than or equal to 3 ng/mL) or 
a rising value over time may be referred for a biopsy. 
However, an elevated or rising PSA level alone does not always mean 
that a man has prostate cancer. PSA levels also increase with age, and may 
be higher in men with a common, noncancerous condition called benign 
prostatic hyperplasia (BPH), or with a condition called prostatitis, an 
inflammation of the gland. 
Digital Rectal Examination (DRE) 
In this detection test, the doctor inserts a gloved finger into the rectum to 
feel for swelling or inflammation of the prostate or other abnormalities such 
a hardness or nodule that might suggest the presence of cancer. 
Prostate Cancer Screening Guidelines at Memorial Sloan Kettering 
Doctors at Memorial Sloan Kettering recommend that all men get their 
first PSA test at age 45. For those with a family history of the disease, and 
for African American men — who are at a significantly higher risk of 
developing prostate cancer than are Caucasian men — our recommendation 
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is to have your first PSA test at age 40. The frequency of follow-up PSA 
testing and whether to have additional testing depend on the results of this 
test, as well as other factors including your age, whether there is a history of 
prostate cancer in your family, any future changes in PSA level, and your 
general health… 
Getting the Right Diagnosis 
A prostate that feels abnormal and an elevated PSA level are both 
possible indicators of prostate cancer, but neither test — alone or in 
combination — can provide a definitive diagnosis, which can only be 
established with a prostate biopsy…. (paras 2-5, 7) 
Recommendations for Future Research 
Hoffman et al. (2001) recommended that future research “be directed at the 
identification of biologic markers and genetic susceptibility factors, as well as additional 
socioeconomic factors, including use of health-care systems, distance from health care, 
diet, literacy, and health beliefs” (p. 394). On the other hand, Fowke et al. (2005) 
suggested that the assessment “of relationships between prostate cancer screening and 
social support structures, self-efficacy to make health care decisions, and individual 
perceptions of health and disease might help address these issues” (p. 339). 
Statement of the Problem 
The problem that this study addresses is the need to increase awareness among 
African American men regarding their potential risk of prostate cancer (Hoffman et al., 
2001) and the health disparities (Mullins et al., 2010; Wu & Modlin, 2012) characterizing 
their group, as well as foster discussion with doctors about their family history of prostate 
cancer and whether they should pursue prostate cancer screening—meaning involvement 
in the “prostate specific antigen (PSA) test and digital rectal examination (DRE),” which 
“enable the detection of early-stage and organ-confined disease among otherwise 
asymptomatic men” (Fowke et al., 2005, p. 333). There is also a need to increase 
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awareness of treatment options to compensate for a lack of physician education on the 
topic (Mullins et al., 2010). Further, there is a need for innovative approaches to health 
education. For example, there is the need to evaluate the feasibility of positively 
impacting decisions to discuss prostate cancer screening with one’s physician through the 
use of e-health tailored to be culturally appropriate; and, also positively impact 
knowledge of prostate cancer treatment options (Misra & Wallace, 2012)—i.e., using 
avatar videos (cartoon-like). In addition, it is important to asses the extent to which those 
exposed to the avatar videos intend to recommend them to other African American men, 
as they may engage in the diffusion of the innovation (Rogers, 1962, 1995) of e-health on 
prostate cancer. African American men so informed via e-health may be able to share the 
video with any men in their social networks regarding prostate cancer. 
Purpose of the Study and Objectives 
The purpose of this study is to develop and evaluate an innovative online e-health 
avatar video (cartoon-like) tailored to be culturally appropriate for African American 
men—as a potentially viable approach to fostering patient discussions with their 
physicians about prostate cancer screening. In addition, the main purpose of the study is 
to identify significant predictors of African American men recommending the e-health 
video to other men. 
Research Questions, Survey Parts, and Data Analysis Plan 
Given a sample of African American men (N=41) who respond to a social 
marketing campaign (i.e., using e-mails, text messages, twitter, Facebook, flyers posted 
in community venues) and complete a survey, including watching an avatar video, this 
study answers the following research questions: 
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Quantitative Portion of Study 
1. What are their demographic and background characteristics (e.g., age, 
socioeconomic status, level of education)? 
PART I: BASIC DEMOGRAPHICS (BD-9) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
2. What is their health status (e.g., Body Mass Index) and how do they rate their 
healthcare? 
PART II: BRIEF HEALTH SURVEY (BHS-8) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
3. What is the prevalence of diagnoses of prostate cancer, history of screening 
for prostate cancer, as well as the prevalence of prostate cancer in their family 
and in their social network—including deaths from prostate cancer and the 
metastasis of cancer? 
PART II: PROSTATE CANCER SCALE (PCS-10) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
4. What is their health literacy, as measured in terms of relevant skills and self-
efficacy to perform them? 
PART III: SCALE MEASURING HEALTH LITERACY VIA SKILLS AND 
SELF-EFFICACY (SM-HL-V-S-SE-16) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
5. What is their stage of change and self-efficacy for (1) going to see a medical 
provider and getting a physical examination at least once a year, 
(2) discussing with their medical provider whether they should receive a 
digital rectal examination to screen for prostate cancer, and (3) discussing 
with their medical provider whether they should receive a PSA test to screen 
for prostate cancer? 
PART V: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—PRE-VIDEO (PCS-ES-M-SOC-SE-PRE-V-4) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
6. After watching an avatar (cartoon-like) video, what do they report as their 
dose of exposure to the video (i.e., watched none, some, most, or all of the 
video)? 
PART VI: DOSE OF EXPOSURE TO VIDEO (DOE-TV-1) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
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7. How do they evaluate or rate the video in terms of the information shared? 
PART VII: RATE THE VIDEO (RTV-1) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
8. After watching the video, what is their stage of change and self-efficacy for 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
PART VIII: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—POST-VIDEO (PCS-ES-M-SOC-SE-POST-V-4) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
9. Did they move across stages of change from precontemplation or 
contemplation to preparation for any of the four target behaviors (i.e., 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 
comparing their pre-video viewing (PART V) to post-video viewing scores 
(PART VIII) 
10. Did they experience an increase in self-efficacy or confidence to perform the 
four target behaviors from (i.e., (1) going to see a medical provider and 
getting a physical examination at least once a year, (2) discussing with their 
medical provider whether they should receive a digital rectal examination to 
screen for prostate cancer, (3) discussing with their medical provider whether 
they should receive a PSA test to screen for prostate cancer, and (4) spreading 
awareness among other African American men about the need for prostate 
cancer screening) from before to after watching the videos? 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 
comparing their pre-video viewing (PART V) to post-video viewing scores 
(PART VIII) 
11. Is there a significant relationship between selected demographics and other 
study scales with the study outcome variable/dependent variable of being in 
an action or maintenance stage for [# (3)] making sure they receive a PSA test 
to screen for prostate cancer—as measured before watching the video? 
Data Analysis Plan: Inferential statistics, specifically Spearman correlations 
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12. What are the significant predictors of being in an action or maintenance stage 
for [# (3)] making sure they receive a PSA test to screen for prostate cancer—
as measured before watching the video? 
Data Analysis Plan: Multiple regression and backward stepwise regression 
analyses. 
Mixed Methods Portion of Study 
13. To what extent do they intend to diffuse the innovation of providing health 
education on prostate cancer via e-health in the form of an avatar video by 
either recommending or not recommending the video? And, what are their 
reasons for recommending or not recommending the avatar video, including 
any other comments they might have? 
PART IX: INTENTION TO ENGAGE IN DIFFUSION OF THE 
INNOVATION OF WATCHING THE AVATAR VIDEO (DIWV-2) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages; and, the identification of emergent 
themes for the qualitative data 
Anticipated Findings from Data Analysis 
It was anticipated that the significant predictors of being in an action or 
maintenance stage for [# (3)] making sure they receive a PSA test to screen for prostate 
cancer—as measured before watching the video—would be the following independent 
variables: 
 Higher level of education 
 Higher socioeconomic status 
 Lower Body Mass Index (BMI) 
 Higher health literacy skills and self-efficacy 
 Higher pre-video viewing self-efficacy for (1) going to see a medical provider 
and getting a physical examination at least once a year, (2) making sure they 
receive a digital rectal examination to screen for prostate cancer, (3) making 
sure they receive a PSA test to screen for prostate cancer, and (4) spreading 




Rationale for the Study 
Regarding prostate cancer, Mullins et al. (2010) identified a lack “of awareness of 
treatment options and lack of patient education by physicians” (p. 566). Thus, there is a 
rationale for increasing awareness around prostate cancer. 
Also, there is a rationale for investigating the prevalence of diagnoses of prostate 
cancer, history of screening for prostate cancer, as well as the prevalence of prostate 
cancer in their family and in their social network—including deaths from prostate cancer 
and the metastasis of cancer. Indeed, the rationale for this investigation is multifaceted, 
involving how African American/Black men have the following, with regard to prostate 
cancer (PC): 
 the world’s highest incidence of PC (Hoffman et al., 2001); 
 been reported to experience a PC incidence two-thirds higher than Whites (Wu 
& Modlin, 2012); 
 been found to possess a lack of awareness of treatment options and suffer from 
a lack of education by physicians, resulting in lack of access to health care, as 
well as lower likelihood of seeking aggressive treatment options for localized 
PC (Mullins et al., 2010); 
 higher incidence of PC, and a higher mortality from PC, and present with a 
more aggressive PC—relative to European American men (Mullins et al., 
2010); 
 a lower likelihood of receiving more expensive or innovative treatment 
(Mullins et al., 2010); 
 the lowest odds of receiving definitive therapy for prostate cancer—including 
the risk of developing higher grade prostate cancers and greater cancer specific 
mortality (Underwood et al., 2004); 
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 a pattern of being less likely to undergo radical prostatectomy compared to 
their White counterparts (Mullins et al., 2010); 
 a risk of increased metastasis as a result of inaccurate staging, or a tendency for 
the PC not to be staged, or suffer from physicians failing to provide education 
on the importance of staging PC (Mullins et al., 2010); 
 a pattern of presenting with more advanced prostate cancer disease with a 
poorer prognosis (Mullins et al., 2010); 
 a shorter disease-free survival period relative to other racial groups (Mullins 
et al., 2010); 
 suffer racial/ethnic disparities in prostate cancer mortality (Underwood et al., 
2004)—specifically, a mortality rate twice as high as that of White men (Wu & 
Modlin, 2012). 
Also noteworthy is how equivalent survival outcomes have been realized when 
Black and Whites had treatment assigned “in a uniform manner without regard to race” 
(Wu & Modlin, 2012, p. 315). This further underscores the likely role of disparities in 
health care service delivery. 
One way to address disparities in health care service delivery is to empower 
African American men so they have a sufficiently high level of self-efficacy to be able to 
perform the four target behaviors: (1) going to see a medical provider and getting a 
physical examination at least once a year; (2) making sure they receive a digital rectal 
examination to screen for prostate cancer; (3) making sure they receive a PSA test to 
screen for prostate cancer; and, (4) spreading awareness among other African American 
men about the need for prostate cancer screening—so they, too, can seek out prostate 
cancer screening. Thus, there is a rationale for this study investigating men’s stage of 
change (i.e., theory of Prochaska & DiClemente, 1983) and self-efficacy (i.e., theory of 
Bandura, 1977, 1997) for performing these four target behaviors—first, before watching 
an online e-health avatar (cartoon-like) video, and, second, after watching the video. 
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The rationale for developing and evaluating the online e-health avatar video on 
prostate cancer follows from numerous previous studies conducted by fellows of the 
Research Group on Disparities in Health (RGDH) of Teachers College, Columbia 
University that have found that such a video can serve as a brief intervention (Aiyedun, 
2014; Chung, 2013; Garcia, 2013; Renne, 2013). Such studies have typically found 
evidence that an online avatar video can foster significant movement across stages of 
change (e.g., precontemplation to contemplation stage), as well as increases in self-
efficacy for performing behaviors of focus in the video. These studies have all followed 
the work of Misra and Wallace (2012) in seeking to create e-health that is tailored to be 
culturally appropriate for the category of consumers of focus. The present study 
continues in that tradition of research conducted by fellows of the RGDH through the 
sponsorship of Professor Barbara Wallace, Director of the RGDH, while specifically 
tailoring e-health for African American men considered at high risk for prostate cancer—
as indicated by Hoffman et al. (2001). 
It also follows, logically, that there is value in determining dose of exposure to the 
video (i.e., watched none, some, most, or all of the video). Dose of exposure may be a 
factor related to how the participants evaluate and rate the videos. Further, of interest is 
whether the participants’ intend to recommend the video to others, or engage in diffusion 
of the innovation (Rogers, 1962, 1995) of e-health on prostate cancer. Reasons for either 
recommending or not recommending the e-health avatar video, as well as other 
comments offered, also allowed the study men to express themselves freely, while 
qualitative data analysis will identified emergent themes. 
At the same time, there is a rationale for investigating potential underlying causal 
mechanisms or varied factors potentially operating. More specifically, there is a rationale 
for investigating demographic and background characteristics, including age, 
socioeconomic status, level of education, Body Mass Index (BMI)—as well as health 
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insurance and ratings of their health status and health care; and, ratings of their health 
care providers for their cultural sensitivity and cultural competence. 
Research has shown that potential factors are numerous. For example, they may be 
socioeconomic, biological, receipt of lower quality health care, a lack of cultural 
competency among physicians, deficiencies in nutritional intake—which can contribute 
to prostate carcinogenesis, as well as obesity and a lack of a healthy lifestyle (Wu & 
Modlin, 2012). 
There is also a rationale for investigating level of health literacy, while 
operationalizing this as per the definition provided by the CDC (2014a). The CDC has 
defined health literacy, as follows: “The Patient Protection and Affordable Care Act of 
2010, Title V, defines health literacy as the degree to which an individual has the 
capacity to obtain, communicate, process, and understand basic health information and 
services to make appropriate health decisions” (para. 1). Also, Mullins et al. (2010) 
identified a lack of health literacy as a potential factor in prostate cancer health 
disparities. 
Other studies have selected as the study outcome variable/dependent variable being 
in an action or maintenance stage for the target behavior of interest (e.g. Garcia, 2013). 
Thus, there is a rationale for this study selecting the study outcome variable/dependent 
variable of being in an action or maintenance stage for [# (3)] making sure they receive a 
PSA test to screen for prostate cancer—as measured before watching the video. This 
study outcome variable/dependent variable permits the investigation of whether selected 
demographic and other study scales are significantly related, and exploring independent 
variables that may significantly predict it. 
Finally, there is a rationale for the study’s theoretical framework, given prior 
similar research studies (e.g., Aiyedun, 2014; Chung, 2013; Garcia, 2013; Renne, 2013). 
This framework includes the following: the stages of change from the transtheoretical 
model brought forth by Prochaska and DiClemente (1983); the self-efficacy theory 
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advanced by Bandura (1977, 1997); and, the diffusion of innovation theory as per the 
work of Rogers (1962, 1995). 
Definition of Terms and Abbreviations 
The following terms and abbreviations have definitions, as follows: 
 BCL2 Gene: “A protein that helps control whether a cell lives or dies by 
blocking a type of cell death called apoptosis” (National Institute of Health 
(NIH), 2017a). 
 Biological Predisposition: “Also known as genetic predisposition, is an 
increased likelihood of developing a particular disease based on a person’s 
genetic makeup” (NIH, 2017b). 
 Cause-specific: “Death rate are deaths assigned to a specific cause during a 
given time interval” (CDC, 2014b). 
 Chromosome 8: “Humans normally have 46 chromosomes in each cell, divided 
into 23 pairs. Chromosome 8 spans more than 146 million DNA building 
blocks (base pairs) and represents between 4.5 and 5 percent of the total DNA 
in cells” (NIH, 2017c). 
 Chromosome 8q24: “Chromosome 8q24 is associated with increase cancer 
incidence. See definitions chromosome 8 and q24” (NIH, 2017c). 
 EphB2 Gene: “This gene encodes a member of the Eph receptor family of 
receptor tyrosine kinase transmembrane glycoproteins” (NIH, 2017d). 
 Genetic variants: “An alteration in the most common DNA nucleotide 
sequence. The term variant can be used to describe an alteration that may be 
benign, pathogenic, or of unknown significance. The term variant is 
increasingly being used in place of the term mutation” (NIH, 2017e). 
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 Gleason score: “A system of grading prostate cancer tissue based on how it 
looks under a microscope. Gleason scores range from 2 to 10 and indicate how 
likely it is that a tumor will spread. A low Gleason score means the cancer 
tissue is similar to normal prostate tissue and the tumor is less likely to spread; 
a high Gleason score means the cancer tissue is very different from normal and 
the tumor is more likely to spread” (NIH, 2017f). 
 Health Disparities: “The Department of Health and Human Services (HHS) 
defines health disparities as differences in health outcomes that are closely 
linked with social, economic, and environmental disadvantage and are often 
driven by the social conditions in which individuals live, learn, work, and play” 
(NIH, 2017g). 
 Intermediate to high risk cancer: “In terms of being at risk for prostate cancer, 
intermediate risk can be viewed as having a PSA test result between 10 and 20, 
a Gleason score of 7, or a clinical stage that is T2b. High risk can be viewed as 
having a PSA test result greater than 20, a Gleason score of 8 to 10, or a 
clinical stage that is T2c to T3c” (Prostate Cancer Risk Group, 2014).       
 Prostate cancer (PCa or PC): “Cancer that forms in tissues of the prostate (a 
gland in the male reproductive system found below the bladder and in front of 
the rectum). Prostate cancer usually occurs in older men” (NIH, 2017h). 
 Prostate Cancer Specific Mortality (PCSM): This is the cause-specific mortality 
rate measurement of a prostate cancer population; see mortality rate and cause 
specific mortality. 
 Mortality rate: “A mortality rate is a measure of the frequency of occurrence of 
death in a defined population during a specified interval” (CDC, 2012b). 
 Prostate Summary Analysis (PSA): “A protein made by the prostate gland and 
found in the blood. PSA blood levels may be higher than normal in men who 
have prostate cancer, benign prostatic hyperplasia (BPH), or infection or 
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inflammation of the prostate gland. Also called prostate-specific antigen” (NIH, 
2017i).  
 q24: “Translocations between chromosome 8 and other chromosomes have 
been associated with other types of cancer. This translocation leads to 
continuous cell division without control or order, which likely contributes to 
the development of Burkitt lymphoma” (NIH, 2017c). 
 Tumor suppression genes: “A type of gene that makes a protein called a tumor 
suppressor protein that helps control cell growth. Mutations (changes in DNA) 
in tumor suppressor genes may lead to cancer. Also called antioncogene” (NIH, 
2017j). 
Delimitations 
The study was delimited to AA men ages 18 and above who complete the study 
survey, including reporting watching and rating the avatar video. 
Limitations 
Limitations for this study include the following: the use of self-report data that are 
not validated, including the risk of participants providing potentially socially desirable 
responses—as no measure of social desirability is being used in this study; the manner in 
which study subjects need to have access to computers and the internet to complete the 
study; the potential burden of time on study participants’ given study task—even as the 
Principal Investigator has attempted to limit the length of study participation; and the 
difficulty of engaging a stigmatized, hard-to-reach population of African American men 
at risk for prostate cancer, which may potentially limit the sample size. Finally, the study 
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used a sample of convenience that limits generalizability, as well as volunteers who may 
have certain characteristics (e.g., greater interest in prostate cancer). 
Conclusion 
This chapter has served to introduce the study. Subsequent chapters of the 
dissertation provides a literature review (Chapter II), study methods (Chapter III), results 






This chapter reviews literature relevant to the dissertation topic. The chapter covers 
the following issues: (1) epidemiology of prostate cancer in the United States, with 
emphasis on health disparity issues among African Americans; (2) factors related to 
prostate cancer’s prevalence, morbidity, and mortality; (3) research on the symptoms of 
prostate cancer; (4) research on screening methods; (5) treatment of prostate cancer; 
(6) interventions to increase awareness, screening, and adherence to treatment 
recommendations; (7) research on e-health; and (8) theories guiding this study. 
Epidemiology of Prostate Cancer in the United States and Health Disparities 
in Prevalence, Morbidity, and Mortality Suffered by African Americans 
African American men suffer the highest prostate cancer incidence and 
mortality rates among men of all racial and ethnic backgrounds in the United 
States [1]. This racial disparity is the largest for any major cancer and all 
African American men are deemed to be at high-risk for prostate cancer. The 
United States Senate passed a resolution in 2012 recognizing prostate cancer 
among African American men to be of epidemic proportions [2]. (Jarrett, 
2013) 
Researchers concur, as Holmes et al. (2012) wrote: “Prostate cancer (PC) is the 
most common malignancy in men and the second leading cause of cancer death” (p. 883). 
“In 2011,” they reported, “more than 240,000 men were diagnosed with prostate cancer 
in the United States, of whom 33,000 died of the disease” (p. 883). Likewise, Crawford 
et al. (2014) stated that “prostate cancer is the most frequently diagnosed cancer and the 
  
32 
second leading cause of cancer related death in men, with an estimated 238,590 new 
cases and 29,720 deaths in the United States during 2013” (p. 664). Similarly, Myers 
et al. (2010) wrote: “In 2010, there were an estimated 217,730 new cases of prostate 
cancer in the United States, and 32,050 deaths from the disease, making it the second 
leading cause of cancer-related death among men” (p. 240). 
Holmes at al. (2010) further noted that “black men are more likely to be diagnosed 
with advanced prostate cancer (high risk, locally advanced or metastatic disease) and 
more likely to die of this disease” (p. 884), and that “racial disparities in prostate cancer 
diagnosis and survival are well documented” (p. 883). Black patients in the U.S., they 
emphasized, are diagnosed with prostate cancer at a higher incidence and a younger age 
and with more advanced disease. In the same regard, Powell et al. (2010) reported the 
results of large Detroit study in which, they stated, “the age specific incidence rate of 
distant PCa/100,000 men was approximately 4 times greater in AAM [African American 
men] than in EAM [European American men] for all age groups” (p. 1794). 
Earlier researchers, too, noted the same basic findings in relation to overall prostate 
cancer incidence and mortality in the U.S., as well as its relatively higher incidence 
among African American men. For example, Freedman et al. (2006) reported that 
“prostate cancer is the most common noncutaneous malignancy among U.S. men, with an 
estimated 234,460 new cases and 27,350 deaths in 2006” (p. 14068), and the highlighted 
the fact that “African Americans have the highest incidence of prostate cancer in the 
United States” (p. 14068). Likewise, Salami, Etukakpan, and Olapade-Olaopa (2007) 
observed: “The highest incidence of CaP worldwide has been recorded in black men and 
African-American men (AAM) are twice as likely as Caucasian Americans to die from 
the disease” (p. 456). Salami et al. also reported that AAMs “are also more likely to 
present at a younger age with more advanced disease and have historically had a poorer 
prognosis” (p. 456). Moreover, Salami et al. noted that “AAM with newly diagnosed CaP 
have higher PSA values than white men at initial diagnosis and in all stages, grades, and 
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age categories of the study population” (p. 458), and added: “Black men throughout the 
world have a higher rate of the disease than other ethnic groups” (p. 456). 
As a consequence of this well-known and well-documented disparity, Knight 
(2014) reported that the American Cancer Society suggests “testing at younger ages for 
men at higher than average risk, including African American men” (p. 258). Myers 
(2011) noted that: “A recent report using data from the National Cancer Institute’s 
Surveillance, Epidemiology, and End Results program is consistent with this view” 
(p. 240). 
Factors Related to Prostate Cancer’s Prevalence, Morbidity, and Mortality 
Why do African American men experience a higher rate of prostate cancer, greater 
morbidity, and increased mortality from the disease than do White men? Existing 
research offers a range of answers. 
For example, Heidenreich et al. (2011) reported: “The factors that determine the 
risk of developing clinical PCa are not well known, although three well-established risk 
factors have been identified: increasing age, ethnicity, and heredity” (p. 62). They also 
reported: “If one first-line relative has the disease, the risk is at least doubled” (p. 62), 
and that, “if two or more first-line relatives are affected, the risk increases 5- to 11-
fold.… About 9% of individuals with PCa have true hereditary PCa, defined as three or 
more relatives affected or at least two who have developed early onset disease” (p. 62). 
Freedman et al. (2006) conducted a study to “explore how much of the increased 
incidence of prostate cancer in African-American men might be explained by African (as 
compared with European) ancestry at 8q24” (p. 14070). To determine this, they studied 
1,597 prostate cancer cases and 873 controls, and “evaluated the risk for individuals 
carrying zero, one, and two chromosomes with African ancestry” at the 8q24 locus. 
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(p. 14070). They concluded that “8q24 explains a large proportion of prostate cancer in 
younger African Americans” (p. 14071). Therefore, they stated: 
If it were possible to develop a treatment that reduced prostate cancer 
risk in the African-American population to the level that is seen in men who 
carry two copies of 8q24 inherited from recent European ancestors, the rate 
of prostate cancer would decrease by 49%. (p. 14070) 
In addition, Freedman et al. (2006) noted that 8q24 increases significantly as men 
grow older. They wrote that this finding was “intriguing because it is known 
epidemiologically that the differential incidence of prostate cancer in African versus 
European Americans is greater at younger ages and is attenuated with older age” 
(p. 14071), and noted that “the specific variants causing increased risk for prostate cancer 
in African American because of 8q24 … remain to be identified” (p. 14071). Despite the 
fact that these variants remain to be identified, however, Freedman et al. were clear that 
the “results indicate … a formally significant association of prostate cancer to ordering 
by age” (p. 14069). 
In a Detroit study they conducted, Powell et al. (2010) “found a highly significant 
association between CYP3A43 and high grade PCa in men younger than 60 years old” 
(p. 1795). “PCa volume in our patients with RP [radical prostatectomy] was greater in 
AAM than in EAM and the disease became distant disease at a ratio of 4 AAM to 1 EAM 
in the Detroit SEER population” (p. 1795). Powell et al. highlighted that “these findings 
support the concept that PCa grows more rapidly in AAM than in EAM and/or earlier 
transformation from latent to aggressive PCa occurs in AAM than in EAM” (p. 1795). In 
short, these authors concluded, “Multiple genetic and biological pathways contribute to 
more aggressive PCa, and increased cell proliferation and metastasis in AAM than in 
EAM” (p. 1794), which implies “a strong association between race and genotype” 
(p. 1795). 
In 2007, Salami et al. wrote: “Many studies on molecular and cellular mechanisms 
suggest that black men have a genetic predisposition to the development and/or 
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progression of CaP” (p. 457), and reported that “abnormalities in enzymes regulating 
testosterone metabolism have also been implicated in increased CaP risk in black men” 
(p. 458). They elaborated: “Other molecular differences found in black men with CaP 
include a common mutation in EphB2, a gene on chromosome 1p, that has been 
associated with CaP risk in AAM with a family history of CaP” (p. 458), adding that 
“most clinical studies have shown that CaP is more aggressive in black than in white or 
Asian men leading to calls for efforts to detect the disease early in that sub-population” 
(p. 459). Heidenreich et al. (2011) underscored the importance of PSA, writing that “the 
level of PSA is a continuous parameter: The higher the value, the more likely the 
existence of PCa” (p. 63). Heidenreich et al. noted that “the finding that many men may 
harbour PCa, despite low levels of serum PSA, has been underscored by recent results 
from a US prevention study” (p. 63). 
Salami et al. (2007) reported that “epidermal growth factor receptor (EGFR) gene 
and higher levels of expression of the wild-type EGFR protein have been detected in 
malignant prostatic tissues from black men” (p. 458), and noted that “[its most common 
mutant has] been shown to play a role in the initiation and progression of CaP, and both 
are now targets for specific anti-CaP strategies” (p. 458). In a study of prostate cancer in 
African American and Nigerian men, Salami et al. found that “invasive cancers were 
significantly higher in AAM than in Nigerian cases” (p. 458). Salami et al. also noted that 
“Jamaicans have an even higher incidence of CaP,” and reported that a “recent study of 
CaP risk amongst men in the United Kingdom found that black men were three times 
more likely to be diagnosed with the disease than Caucasians” (p. 457). Moreover, 
Salami et al. noted: “Other studies have also found a higher prevalence of CaP in black 
men than in Caucasians (8.5% vs. 3.7%) in South Africa” (p. 457). 
Salami et al. (2007) concluded: “The incidence figures above suggest that genetic 
factors play a major role in the observed racial differences in CaP phenotype” (p. 457), 
and added that “similar rates of CaP observed in black Caribbean and black African men 
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in the UK PROCESS Cohort study supports this assertion” (p. 457). Similarly, Powell 
et al. (2010) wrote: “We propose that a more rapid PCa growth rate and/or earlier 
transformation from latent to aggressive PCa in AAM than in EAM contribute 
significantly to the racial disparity of advanced disease at diagnosis and to the 2 to 3 
times greater mortality rate in AAM than in EAM” (p. 1973). 
Salami et al. (2007) also noted that the postoperative outcomes of Black men are 
less favorable, “as they have a higher rate of positive surgical margins, more instances of 
locally advanced CaP, and a greater percentage of cancers with a Gleason score of 8 or 
higher. Black ethnicity also appears to be an independent predictor of disease recurrence 
after adjusting for pretreatment indices of disease extent” (p. 457). 
Although evidence of a genetic predisposition is widely accepted, non-genetic 
factors may also contribute to the higher incidence of prostate cancer, morbidity, and 
mortality among Black men, as Salami et al. (2007) noted: 
It is also of significance that, despite recent reports that black race is a 
predictor of detecting CaP at biopsy [50], both black native African men and 
AAM perceive ‘barriers’ to attending prostate-cancer screening clinics, 
particularly if this involves taking biopsy samples even when they are found 
to have elevated PSA levels. (p. 458) 
On the other hand, Salami et al. (2007) considered it noteworthy that “these studies 
also found that black men had higher grade cancers, consumed a diet high in fat content, 
and had significantly higher Body Mass Indices (BMIs) than whites” (p. 459). As a 
result, they said that researchers “concluded that a high-fat diet and obesity are associated 
with progression of latent to clinically significant prostate cancer and suggested that these 
factors may contribute to the differences in prostate cancer risk and biology between 
blacks and whites” (p. 459). It should be noted that there is a considerable gap in our 
understanding regarding the biological determinants of prostate cancer. To date, scientists 
have been unable to precisely determine how biology interacts with behavior to affect 
how susceptible one is to getting prostate cancer. 
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Salami et al. (2007) noted that “despite the acceptance of the observation that CaP 
is more aggressive in black men, differential clinical management resulting in less 
aggressive investigation and/or treatment has been suggested as a factor in the poorer 
outcomes seen in this sub-population” (p. 459), adding, “This postulation has been 
supported by data that suggest that race/ethnicity as an independent predictor of CaP is 
conditional and dependent on age, stage and year of diagnosis, and that if diagnosed and 
treated early enough, the role of race as a factor in CaP outcome is significantly 
decreased” (p. 459). 
Salami et al. (2007) also described what they termed a “disproportionate frequency 
of watchful waiting among AAM and Hispanics that was not completely explained by 
racial/ethnic variation in clinical characteristics or life expectancy” (p. 459). They 
concluded that there is “considerable evidence that there are racial/ethnic differences in 
the incidence and prognosis of CaP” (p. 461), and stressed the importance of continued 
research: 
The effect of black race and the environment on the molecular and 
clinical characteristics of CaP would be best investigated by looking at these 
indices in native black Africans and comparing them with findings in 
Africans in the Diaspora (USA, UK and the Caribbean) and whites…. Such 
studies would shed more light on the factors that determine the biology of 
CaP and may lead to a better understanding of the disease and improved 
treatment strategies, ultimately improving the health of men in this sub 
population specifically and in all men in general. (p. 461) 
Similarly, Powell et al. (2010) noted that “nonfinancial barriers such as poor health 
seeking behavior were reported to delay PCa diagnosis in AAM” (p. 1793), and added 
that “fear of the PCa diagnosis and distrust of the health care system appear to be the 
most dominant factors” (p. 1793). Moreover, they remarked that “factors such as diet, 
obesity and hypertension impact PCa by association and some mechanistic processes 
were noted” (pp. 1794-1795), and specifically referred to the following findings: 
AAM have a higher fat content diet,18 are more obese with a higher 
body mass index19 and have a higher rate of hypertension than EAM.20 The 
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latter 2 factors are components of metabolic syndrome. The mechanism 
associated with obesity and hypertension includes the release of 
inflammatory cytokines and reactive oxides and, thus, oxidative stress, DNA 
damage and NFkB activation. NFkB causes PCa cell proliferation. (p. 1795) 
Further, Powell et al. (2010) reported that “a high fat content diet is associated with 
glucose-like growth factor 1 up-regulation” (p. 1795), adding that “the protein NFkB 
activates or up-regulates androgen receptor protein expression” (p. 1795). Powell et al. 
also noted the  role of “autocrine motility factor receptor, CXC chemokine receptor R4 
and matrix metalloproteinase 9, and found that these genes were more highly expressed 
in tumors from AAM than from EAM” (p. 1795). Further, Powell et al. reported that 
“these genes may be impacted by environmental factors, including diet, obesity and 
inflammation” (p. 1795). 
Powell et al. (2010) also reported that the “incidence of PCa is approximately 60% 
higher and the mortality rate is 2 to 3 times greater in AAM than in EAM” (p. 1792). 
They noted that these “findings [had] been consistent for more than 20 years, before and 
after the PSA era” (p. 1792), and that men “of West African ancestry from the Caribbean 
and South America share incidence and mortality similar to those of AAM, suggesting a 
possible genetic basis of these outcomes” (p. 1792). 
On the other hand, Powell et al. (2010) contended that “multiple factors probably 
contribute to these disparities” (p. 1792), and suggested that lack of access to care might 
be “responsible for disproportionate advanced disease and mortality in AAM compared 
to EAM” (p. 1792). In addition, these authors noted that “AAM continue to present with 
more advanced disease and a higher mortality rate” (p. 1793), and added that “financial 
barriers or the lack of insurance were also suggested as potential causes of the disparity” 
(p. 1793). Although Powell et al. reported on the Behavioral Risk Factor Surveillance 
Study, which showed insurance rates for AAM and EAM older than 50 years to be “81% 
and 89%, respectively” (p. 1793)—a statistically significant difference—this finding did 
not, in their opinion, “account for the entire disparity” (p. 1793). 
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Powell et al. (2010) noted that “PCa starts at the same time in AAM and EAM but 
becomes distant metastatic disease at a disproportionate rate of 4:1 in AAM to EAM 
beginning at ages 40 to 49 years” (p. 1794), and wrote: 
A recent report concluded that extensive HGPIN is associated with an 
increased risk of clinically significant PCa. Data suggest that at ages 40 to 49 
years conversion to clinically significant PCa at disproportionate rates in 
AAM vs EAM may be the beginning of the PCa racial disparity. (p. 1794) 
Powell et al. (2010) reported that “support for these observations and conclusion 
are based on volume and Gleason grade analysis from the RP database revealing higher 
Gleason grade PCa in AAM than in EAM at early ages (40 to 49 years). They noted that 
“volume and grade reflect PCa biology, [so] the analysis implies that PCa in AAM is 
biologically and genetically more aggressive than in EAM” (p. 1794). Finally, the authors 
stressed the idea that “Cancer is a genetic disease, and the explanation of and answer to 
differences in incidence and disease progression should begin there” (italics added, 
p. 1794). 
To determine risks more clearly, Freedman et al. (2006) recommended “admixture 
mapping to identify a locus at 8q24 that substantially affects risk for prostate cancer” 
(p. 14071), noting that “African ancestry has not had much time to break up because of 
recombination and typically extend millions of base pairs” (p. 14068). “Although 
admixture mapping,” the authors elaborated, “was first proposed >50 years ago and has 
good power to detect risk variants that are strikingly different in frequency across 
populations, it has not been practical until recently” (p. 14068). The process involves 
screening “through the genome of populations of mixed ancestry such as African 
Americans (5), searching for regions where the proportion of DNA inherited from either 
the ancestral European or African population is unusual compared with the genome-wide 
average” (p. 14068). Their study, they stated, 
shows that admixture mapping can be a powerful and practical way to map 
genetic variants for complex disease. The results motivate the application of 
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admixture mapping to other disorders, especially those like prostate cancer 
in which incidence varies across populations. These results also highlight the 
scientific value of studies to find disease genes in specific ethnic groups, 
such as African Americans. (p. 14071) 
While Freedman et al. (2010) focused on the idea of genome mapping, Holmes 
et al. (2012) concluded, from a study of 2,251 patients, that “obstacles to health care 
access rather than lack of awareness were the likely causes of the racial disparities” 
(p. 884), and “hypothesized that longer travel distance represents a barrier to biopsy and 
is associated with later stage at diagnosis” (p. 884). Holmes et al. “further hypothesized 
that long travel distance may disproportionally impact black patients compared to white 
patients” (p. 884), and reported that a “total of 6,490 patients 65 years old or older were 
diagnosed in 2004 to 2005” (p. 884), excluding patients that were “of nonwhite or 
nonblack race (41), had missing data on residence (49) or distance to a urologist (8), had 
a history of cancer (718) or a coding error in gender (44), or were diagnosed at autopsy or 
on the day of death (12)” (p. 884). Using “descriptive statistics … to examine the 
proportion of patients by key variables and stratified by distance group (0 to 10, 11 to 20 
and greater than 20 miles from a urologist) and race” (p. 884), Holmes et al. found that 
“longer distance to a urologist was significantly associated with a diagnosis of higher risk 
prostate cancer,” and that “distance to care disproportionally affects black patients” 
(p. 887). 
Holmes et al. (2012) added that “a delay in care due to barriers such as distance to 
a urologist may be more likely to manifest clinically in black men, for example as high 
risk disease” (p. 887). Since distance, they noted, is “a potentially modifiable obstacle to 
care and may affect black patients more than white patients, intervention to decrease this 
barrier could lead to decreased racial disparities” (p. 887). 
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Research on Symptoms 
According to Alcena (2013), symptoms of prostate cancer are divided into early 
symptoms and late symptoms. Early symptoms of prostate cancer include: (1) frequent 
urge to urinate, (2) difficulty passing urine, and (3) pain on urination. The symptoms of 
advanced prostate cancer include all of these symptoms listed above, as well as (1) blood 
in the urine, (2), urinary retention, (3) pain in the lower abdomen, and (4) urinary tract 
infections (p. 51). 
Alcena (2013) also summarized the ways to diagnose prostate cancer, which 
include (1) a complete history, (2) a complete physical exam, (3) a digital rectal 
examination, (4) a count of the prostatic specific antigen (PSA), (5) an ultrasound of the 
prostate, and (6) a biopsy of the prostate (p. 52). 
In addition, Alcena (2013) emphasized the importance of PSA testing, stating that 
the “PSA is crucial in establishing the diagnosis of prostate cancer” (p. 52), and that, in 
prostate cancer, “the PSA may be abnormally lower because of the higher blood volume 
the obesity creates” (p. 51). “This is particularly important in evaluating African 
American men,” she wrote, “because of the high percentage of obesity that exists in 
African American men” (p. 52). In addition, Salami et al. (2007) noted that African 
American men “with metastatic CaP are also more likely than their white counterparts to 
have extensive disease and bone pain and poorer performance status, younger age at 
study entry, higher Gleason score, and higher PSA levels” (p. 459). 
Alcena (2013) also emphasized the importance of the digital rectal examination, 
during which “the physician can tell if the prostate gland is enlarged, and if so, how 
enlarged,” and noted that there “have been times … when the PSA was normal and a 
cancerous nodule was palpated” (p. 52). However, there is disagreement in the medical 
community about the use and validity of screening methods, as the next section describes. 
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Research on Screening Methods 
Controversy surrounds what the appropriate guidelines for prostate cancer 
screening should be. Myers et al. (2010) described the screening process: “Prostate 
cancer is often diagnosed through prostate cancer screening, which includes digital rectal 
examination (DRE) and prostate specific antigen (PSA) testing” (p. 240). Because of 
some harmful consequences related to screening, guidelines have shifted over time. 
For example, Knight (2014) reported, “False-positive prostate cancer screening 
results have been associated with persistent psychological distress, even with a negative 
biopsy” (p. 258). Moreover, Knight reported that there was “the potential for 
overtreatment of indolent prostate cancer that would be unlikely to progress during a 
man’s lifetime” (p. 257), and noted that “adverse consequences of surgical and radiation 
treatment for prostate cancer have been well documented, including pain, incontinence, 
sexual dysfunction, and bowel problems” (p. 257). As a consequence, Knight stated, the 
process is “surrounded by more controversy than many other health decisions” (p. 257), 
and is also “emotionally and cognitively complicated” (p. 259). In particular, Knight said 
that the benefits of prostate cancer screening have been questioned “for men older than 
74, especially in those who have comorbidities and life expectancy less than 10 years” 
(p. 257). 
Therefore, Knight (2010) wrote, the guidelines for prostate cancer screening during 
the past decade “have been revised to reflect evidence that PSA testing for prostate 
cancer is associated with significant harms related to overtesting and overtreatment of 
low-risk disease” (p. 258). Based on the evidence, he noted, “the US Preventive Services 
Task Force (USPSTF) does not recommend routine prostate cancer screening using PSA 
testing in men of any age” (p. 258). 
However, Knight (2010) also noted that criticism has been raised about how the 
USPSTF interpreted the evidence: “The USPSTF presents the most limited use of 
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screening, discouraging PSA screening for men of any age and suggests that informed 
decision making be used only when men request a PSA test” (p. 258). Knight pointed out 
that “other professional and scientific organizations have developed alternate guidelines” 
(p. 258), and that these “offer patients and health professionals clear pathways for care 
that are based on evidence, consensus of experts, or best practices” (p. 258). Moreover, 
he emphasized: “Shared decision making is considered as an approach to helping men 
make these choices, and resources, such as patient decision aids, are discussed” (p. 258). 
He also contrasted USPSTF’s guidelines with those of the American Cancer Society 
(ACS), which recommend that “average-risk men be screened for prostate cancer using 
PSA testing starting at age 50 if the man is informed about the alternatives to testing, the 
potential benefits, and the risk of harms” (p. 258). 
Myers et al. (2011) reported that “prostate cancer screening is likely to remain 
controversial in the immediate future,” and noted, “In this climate, it is imperative to 
identify effective methods for engaging adult male patients in shared decision about 
screening” (p. 245). 
In their 2011 article, “A community-based intervention to promote informed 
decision making for prostate cancer screening among Hispanic American men changed 
knowledge and role preferences: A cluster RCT,” Chan et al. (2011) concurred on the 
view that controversy surrounds PSA testing: “Although screening for prostate cancer 
with prostate specific antigen (PSA) is widespread, PSA testing remains controversial” 
(p. e44), and cited the following evidence as reason: 
Interim results from two large, randomized trials to determine the 
efficacy of PSA testing, the U.S. Prostate, Lung, Colorectal, and Ovarian 
(PLCO) Cancer Screening Trial and the European Randomized Study of 
Screening for Prostate Cancer (ERSPC), revealed at best, a modest reduction 
in prostate cancer mortality with regular PSA testing in the first decade of 




As a result, Chan et al. (2011) concluded, “promoting informed decision making 
for prostate cancer screening with PSA, as recommended by many professional 
guidelines, seems more appropriate than ever” (p. e44), and noted: 
Professional organizations recommend informing men of the potential 
risks and benefits of prostate cancer screening so that men age 50 and older 
(or age 40 if they are at high risk for prostate cancer, e.g., positive family 
history), can make an informed decision about whether to undergo screening. 
(pp. e44-e45) 
Chan et al. (2011) also reported that: “Previous studies to promote informed 
decision making (IDM) for prostate cancer screening with PSA have focused on 
evaluating interventions, particularly decision aids, in various media (e.g., videotape, 
booklet, internet) delivered predominantly in clinical settings” (p. e45). In light of this, 
Chan et al. highlighted the “need for a community-based intervention to promote IDM for 
PSA testing arises from the limitations and barriers to promoting IDM in clinical settings, 
including “patient, physician, and system barriers: patient comorbidity, limited 
education/health literacy, physician forgetfulness, and lack of time in a clinical visit” 
(p. e45). 
Like others, Knight (2014) stressed the importance of “shared decision-making” in 
the approach of contemporary guidelines to the question of prostrate screening (p. 258), 
and defined this as: 
typically involving communication between patient and health professional, 
where information is shared about the options in the choice (e.g., to screen or 
not) and the expected outcomes of each option (e.g., survival, side effects 
with treatment, anxiety, late detection of prostate cancer), including the 
scientific uncertainty surrounding the expected benefits and harms. (p. 258) 
This process, according to Knight et al. (2014), often involves having the 
professional develop “an understanding of the man’s values, goals, and preferences 
relevant to the options and where the trade-offs between the benefits and harms are 
considered from the patient’s perspective” (p. 259). However, Knight et al. noted that 
existing guidelines do not equally stress this point. Some guidelines, they wrote, 
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“emphasize an informed decision-making approach in which the emphasis is placed on 
providing information and less on understanding the patient’s values, goals, and 
preferences relevant to the choice” (p. 259). 
Differences in screening guidelines and in emphasis on the nature of patient 
involvement persist. For example, Knight et al. (2014) reported that “the American 
College of Preventive Medicine recommends no routine screening at any age, but 
suggests that all men be informed about the potential risks and benefits of prostate cancer 
screening and that the man’s preferences be considered in the final choice” (p. 259). 
“The American Society of Clinical Oncology (ASCO) guidelines, and those of the 
ACS and the American Urology Association (AUA), also recommend that men be 
informed about the risks and benefits of screening,” according to Knight et al. (2014), 
“and explicitly recommend a shared decision-making approach in which the information 
exchange occurs in the context of a discussion between a man and his health 
professionals” (p. 259). 
Knight et al. (2014) further noted that screening for prostate cancer has come to be 
considered “a preference-sensitive decision in which several reasonable choice 
alternatives are available (e.g., screening vs no screening) that differ in terms of their 
characteristics and outcomes” (p. 259). They also referred to “effective decisions,” the 
goal of which, in the case of prostate cancer screening, would be “implementation of 
smarter screening based on prostate cancer risk characteristics” (p. 259). 
It is particularly relevant to this current study that Knight et al. (2014) mentioned 
the public’s response to the revised guidelines, which “suggests that many men do not 
embrace recommendations to limit PSA testing and screening for prostate cancer” 
(p. 259). The authors stated that “Caire and colleagues found that most of those men seen 
in a screening clinic disagreed with the earlier USPSTF recommendations to discontinue 
screening at age 75” (p. 259). Knight also noted that “a survey of a national online panel 
found that 62% agreed with USPSTF recommendations against prostate cancer screening 
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with PSA, but only 13% intended to follow the guidelines and forego PSA testing” 
(p. 259). 
Moreover, adoption of the revised guidelines has not created much change in the 
practices of healthcare providers. Knight (2014) wrote that adoption of the USPSTF 
recommendations among primary care providers has been modest: “Among 89 primary 
care providers responding to a national Internet survey in 2010, 51% and 64% indicated 
that they discuss and order PSA testing for men between 50 and 74, respectively” 
(p. 261). Further, Knight highlighted: “28% indicated that their screening practices had 
been influenced by the 2009 publications of the European Randomized Screening for 
Prostate Cancer and the Prostate, Lung, Colorectal and Ovarian trials, respectively” 
(p. 261); and listed the following reasons for the lack of significant change in providers’ 
practices: 
Providers cited several barriers to stopping PSA testing in their patients 
who had previously participated in prostate cancer screening, including 
patient expectations of screening, lack of time to discuss changes in 
recommendations, worry about malpractice litigation, and discomfort with 
uncertainty. (p. 261) 
Knight (2014) also noted, however, that some USPSTF guidelines recommended 
shared decision making and stated that “the choice of screening be based on the man’s 
preferences” (p. 262). He elaborated: 
The types of shared decision making suggested by the guidelines 
include (1) providing information on the alternatives for prostate cancer 
screening, potential benefits and harms, and uncertainties associated with the 
various outcomes, and (2) assessing the man’s preferences for screening 
alternatives (e.g., PSA testing vs no PSA testing) or for the potential 
outcomes and downstream impacts of screening (e.g., survival, false-positive 
rate, anxiety associated with prostate cancer, treatment and its associated 
impacts on urinary and sexual function). (p. 262) 
Despite this growing focus on shared discussion, Knight (2014) emphasized that 
little of such interaction has actually taken place between physicians and their patients: 
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A recent nationally representative sample of men between ages 49 and 
75 responding to the National Health Interview Survey reported that most 
(64.3%) had not had any previous discussions with their physicians about 
PSA screening and its benefits and harms and associated uncertainties, and 
only 8% of the respondents reported discussion of 3 key elements of shared 
decision making (i.e., advantages, disadvantages, and scientific 
uncertainties). (p. 262) 
Knight (2014) also concluded: “The absence of shared decision making was 
associated with no screening rather than with screening” (p. 262). Moreover, Knight 
reported: “Current guidelines are in agreement … on the importance of taking an 
informed decision-making or a shared decision-making approach to prostate cancer 
screening” (p. 264); and elaborated: “Informed or shared decision making endorses 
providing patients with information on the potential benefits and harms associated with 
screening and considering what is important to a patient in evaluating the benefits and 
harms” (p. 264). Knight concluded that it was important to include “improved 
knowledge, realistic perceptions of the benefits and harms, lower decision conflict, and 
improved agreement between the man’s values and his choices about screening” (p. 264). 
While Chan et al. (2011) found that Hispanic men were at lower risk for prostate 
cancer than non-Hispanic Whites, he also found that “they are more likely to die from 
prostate cancer,” and wrote that “this may reflect a lower likelihood of timely, high 
quality treatment. Hispanic men are less likely to have heard of the PSA test or to have 
used it, and Hispanic men who have had this test are less likely to report discussing pros 
and cons of the test with their physician” (p. e45). As a result, Chan et al. emphasized 
“the need for a culturally appropriate intervention to promote IDM for prostate cancer 
screening with PSA among Hispanic men in El Paso, TX” (p. e45). 
Knight (2014) noted that “shared decision making is a central principle embodied 
in the Institute of Medicine concept of patient-centered care, including decisions about 
screening” (p. 262). He also weighed in on the value of patient decision aids, stating that: 
Patient decision aids are decision support technologies that have been 
developed to support shared decision making, to improve the quality of the 
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decision, and to reduce variation in care and unnecessary tests and 
treatment.… Distinct from patient education materials, patient decision aids 
aim to provide information that is based on the considerations and concerns 
that patients have in making the decision and that is balanced and free from 
bias. (p. 262) 
Knight (2014) reported that “prostate cancer screening decisions are significant to 
men and their families, considering the potential for benefits, including survival and the 
possibility of harms from overtesting and overtreatment” (p. 264). Knight added that 
“these decisions are challenging because of emotions associated with prostate cancer, as 
well as common cognitive tendencies” (p. 264). 
Myers et al. (2011) reported that “a recent report using data from the National 
Cancer Institute’s Surveillance, Epidemiology, and End Results program is consistent 
with this view” (p. 240). They also reported that “current prostate cancer screening 
guidelines recommend that informed, shared decision making should be part of routine 
primary care for older adult men” (p. 240). However, like Knight (2014), they noted that, 
“in practice … most men have little or no discussion about prostate cancer screening with 
a primary care provider” (p. 240), and they concluded that “there is a pressing need for 
methods to facilitate informed and shared decision making about prostate cancer 
screening use” (p. 240). 
Heidenreich et al. (2011) also stated that “the decision to undergo early PSA testing 
should be a shared decision between the patient and his physician based on information 
balancing its advantages and disadvantages” (p. 63), and noted that “the main diagnostic 
tools to diagnose PCa include DRE, serum concentration of PSA, and transrectal 
ultrasound (TRUS)–guided biopsies” (p. 63). Heidenreich et al. reported: “In about18% 
of all patients, PCa is detected by a suspect DRE alone, irrespective of the PSA level [14] 
(LE: 2a)” (p. 63). The authors added that “a suspect DRE in patients with a PSA level of 
up to 2ng/ml has a positive predictive value of 5-30%” (p. 62). 
Costanza et al. (2011) reported that “considerable controversy exists about the 
effectiveness of prostate specific antigen (PSA) screening in reducing mortality from 
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prostate cancer (PCa), although there is good evidence that the PSA test can detect early 
stage prostate cancer” (p. 193). Most organizations, they stated, “recommend that men 
should be given the opportunity to discuss the benefits and risks of PSA testing with their 
primary care providers (PCPs) before making a screening decision” (p. 193). However, 
they noted: 
Two recent reports of randomized trials of PSA screening have done 
little to resolve the screening controversy. One study showed no mortality 
benefit. The other identified a small impact of PSA testing on PCa mortality 
but was associated with considerable human and financial cost due to 
overtreatment. (p. 193) 
Costanza et al. (2011) reported: “Whether PSA testing can significantly reduce 
PCa-specific mortality has resulted in some PCPs who strongly recommend PSA testing, 
some who strongly recommend against, and few who inform men about the pros and cons 
and share in the decision-making process” (p. 193). They continued: 
To make an informed decision, the US Preventive Services Task Force 
suggests that one should understand the risk or seriousness of the disease and 
the preventive service offered, one should understand its risks, benefits, 
alternatives, and uncertainties and one should weigh his values regarding 
potential harms and benefits before engaging in decision making. Decision 
making may be shared with one’s provider and sharing may range from no 
sharing at all to ceding the decision making to the PCP. (p. 193) 
Myers et al. (2011) noted that “decision aids (e.g., print materials, telephone 
contacts, videos, and Internet tools for providing information), have been investigated as 
a means to increase patient prostate cancer screening knowledge and involvement in 
decision making about screening” (p. 240). Myers et al. found: “The studies have sought 
to assess decision aid impact on patient knowledge, decisional conflict, and screening 
use” (p. 240), and reported the “findings from a randomized controlled trial, referred to as 
the Decision Counseling Trial (DCT) (p. 240), which was “designed to test the impact of 
nurse-mediated decision support on patient prostate cancer screening knowledge and 
decisional conflict (primary outcomes) and on informed decision making and actual 
screening use (secondary outcomes) (pp. 240-241). On their endpoint survey, Myers et al. 
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reported that “97% of the EI [Enhanced Intervention] Group respondents reported that 
they remembered discussing prostate cancer screening with the nurse educator and 87% 
said that they would recommend such a discussion to other men” (p. 242). 
Costanza et al. (2011) concluded that “most aids increase knowledge and help 
subjects feel more confident about their decision” (p. 194), and added that a PCa 
screening decision aid “should … not promote screening but rather promote informed 
decision making that is congruent with a man’s values and understanding” (p. 194). They 
further stated that a good decision aid: 
should (1) improve knowledge of the problem, options, and outcomes, 
(2) create realistic expectations of outcomes, (3) clarify personal values for 
outcomes, (4) promote congruence between values and choice, (5) reduce 
decisional conflict, (6) promote implementation of choices and (7) improve 
satisfaction with decision making. These standards seem to us and others to 
apply to decision making around cancer control issues in general and PSA 
screening, in particular. (p. 194) 
Treatment of Prostate Cancer 
Heidenreich et al. (2011) claimed that “it is usually impossible to state that one 
therapy is clearly superior over another because of the lack of randomized controlled 
trials in this field… however, based on the available literature, some recommendations 
can be made” (p. 64). Accordingly, Heidenreich et al. offered “a summary, subdivided by 
stage at diagnosis,”  and “proposed a few suggestions to follow regarding the different 
treatment options available” (p. 64). To begin with, they stated: 
Active surveillance (AS) must be differentiated from WW. The latter is 
based on a delayed symptomatic noncurative treatment in patients who are 
not candidates for an aggressive local therapy, whereas the former must be 
seen as suitable therapy for those who might also be offered a curative 
approach. Such patients with very low-risk PCa are initially not treated but 
are followed and treated with a curative intent if progression or the threat of 
progression occurs during follow-up. (p. 64) 
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Heidenreich et al. (2011) reported, “AS was conceived with the aim of reducing the 
ratio of overtreatment in patients with clinically confined low-risk PCa based on early 
data demonstrating that men with well-differentiated PCa have a 20-yr PCa-specific 
survival rate of 80-90%” (p. 64). They also noted that “three prospective randomised 
trials [had] assessed the role of immediate postoperative radiotherapy” (p. 66). “Although 
different in inclusion criteria, “ Heidenreich et al. added, “all trials concluded that 
immediate postoperative radiotherapy significantly improves 5-yr clinical or biologic 
survival by about 20% (p < 0.0001)” (p. 66). They further reported that “three-
dimensional conformal radiotherapy (3D-CRT) is the gold standard, and intensity-
modulated radiotherapy (IMRT), an optimised form of 3D-CRT, is becoming more 
widely used as is image-guided radiotherapy” (p. 66), adding: “In radical prostatectomy 
(RP) specimens, both the primary and the secondary Gleason grade should be reported” 
(p. 62), as well as the “presence of the tertiary grade and its approximate proportion of 
the cancer volume” (p. 62). 
“For external radiotherapy, a dose of at least 74 Gy is recommended for the 
management of low-risk PCa,” Heidenreich et al (2011) wrote, “because biochemical 
disease-free survival is significantly higher when compared with a dose <72 Gy (69% vs 
63%; p = 0.046)” (p. 66); while “for intermediate-risk PCa, many series have shown a 
significant impact of dose escalation on 5-yr progression free survival in cT1c–T3 PCa, 
with a dose ranging from 76 to 81 Gy” (p. 66). They also reported that “transperineal 
brachytherapy is a safe and effective technique for low-risk PCa” (p. 67). In patients with 
high-risk disease, they said that 
external irradiation with dose escalation improves 5-yr biochemical disease 
free survival but seems insufficient to cover the risk of systemic relapse. For 
intermediate and highly localised PCa, a combination of external irradiation 
with 6 mo of ADT resulted in a 13% improvement in the 8-yr OS rate 
(p < 0.001). For locally advanced PCa, the data of the EORTC-22961 trial 
demonstrated a 4.7% benefit in OS after a median follow-up of 5.2 yr in 
favour of 3-yr ADT when compared with short-term ADT. (p. 66) 
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Heidenreich et al. (2011) elaborated on follow-up care, reporting that “patients 
diagnosed with PCa who underwent local treatment with curative intent are usually 
followed for at least 10 yr or until advanced age makes follow-up superfluous” (p. 68). 
Heidenreich et al. added that “determination of serum PSA together with a disease-
specific history can be supplemented by DRE if locally recurrent disease is suspected” 
(p. 67). However, they noted that “long-term results are lacking, and 5-yr biochemical 
progression-free rates are inferior to those achieved by RP in low-risk patients” (p. 68). 
Therefore, Heidenreich et al. stated, “patients must be informed accordingly” (p. 68). 
They also noted that “the results of a randomised trial of EBRT versus CSAP in patients 
with clinically localised PCa [had been] published recently and presented promising 
results” (p. 68). 
Crawford et al. (2014) conducted a literature search “using the following terms: 
prostate cancer, guidelines, metastasis, and imaging. Relevant US and European clinical 
practice guidelines were reviewed, and recommendations of scanning for metastatic 
disease in patients with prostate cancer” (p. 665). They found “no consensus on optimal 
indications or methods for imaging” (p. 665), also noting “a lack of consensus on when to 
initiate imaging for metastases and frequency of testing in clinical practice” (p. 665), and 
concluded that “evidence-based recommendations focus mainly on primary prostate 
cancer staging and not on follow-up after biochemical recurrence or hormonally 
refractive disease” (p. 665). 
Crawford et al. (2014) further noted a “disparity and a lack of agreement in the 
current clinical practice guidelines and available literature on patient selection, imaging 
modality, and timing of scanning for metastatic disease, which represents a key transition 
that influences the treatment decision-making process” (p. 665). They also noted that 
“false positives occur from trauma and various other noncancerous sources (p. 667),” and 
added that “microscopic infiltrations are not detected, and osteolytic lesions are poorly 
detected, limiting sensitivity and specificity” (p. 667). In addition, they noted that “other 
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imaging modalities, such as plain radiography, computed tomography (CT), magnetic 
resonance imaging (MRI), and positron emission tomography/computed tomography 
(PET/CT), might be needed to clarify equivocal lesions” (p. 667). 
Investigating further, Crawford et al. (2014) noted that “approximately 10%-20% 
develop castration-resistant prostate cancer (CRPC) within approximately 5 years of 
follow-up” (p. 664), and stated that “50% of patients will have evidence of biochemical 
prostate specific antigen (PSA) disease recurrence at 10 years after treatment with radical 
prostatectomy or radiation therapy” (p. 664). Moreover, Crawford et al. elaborated that: 
“ninety percent of men with metastatic CRPC (mCRPC) have a rising PSA with more 
than 80% having bone metastases and more than 20% having soft tissue metastases, 
mainly in the lymph node” (p. 664). Crawford et al. discussed that “the median survival 
from CRPC diagnosis varied from 9 to 30 months in different studies” (p. 664). The 
authors also noted that a recent study “showed reasonably low incidences of bone 
metastases in newly diagnosed asymptomatic patients with a PSA level < 20 ng/mL and 
Gleason score < 6, suggesting a bone scan is not necessary as a routine examination at the 
initial staging of prostate cancer” (p. 665). Further, they stated that “other studies found 
that approximately 25% of patients with bone metastasis had a PSA level < 20 ng/mL and 
Gleason score < 7, and bone scans might be necessary in patients with a PSA level 
between 10 and 20 ng/mL” (p. 665). On the basis of these studies, Crawford et al. 
concluded: “Because metastasis occurred at a low PSA level before symptoms, it was 
suggested that patients with biochemical progression need to be managed with regular 
bone scans to detect metastasis even if PSA is low” (p. 665). 
Crawford et al. (2014) reported: “Frequent post-treatment PSA surveillance has 
resulted in earlier detection of progression and metastases and has influenced treatment 
trends” (p. 664), and added that “the presence or absence of metastases is one of the most 
important factors influencing the selection of therapy in prostate cancer” (p. 664). “In 
each disease state,” they noted, 
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there are important therapeutic implications when metastases are found 
radiographically. With initial prostate cancer staging, definitive local therapy 
with surgery or radiation might not be pursued in patients found to have 
metastatic disease. After local therapy, biochemically recurrent prostate 
cancer is often treated with intermittent androgen deprivation therapy 
(ADT). (pp. 664-665) 
Crawford et al. (2014) concluded that “different approaches to ADT should be 
pursued in these distinct clinical states” (p. 665), noting that “there is no U.S. Food and 
Drug Administration approved therapy for M0 CRPC, yet recent advances in mCRPC 
have led to regulatory approval of multiple agents carrying low toxicity, yet significant 
survival or supportive care benefits” (p. 665). They also highlighted the fact that “the 
most recent published American Urological Association guidelines for early detection of 
prostate cancer and the management of CRPC made no recommendations on appropriate 
timing of imaging in M0 patients to monitor disease progression” (p. 665), and noted that 
“findings from clinical validation studies demonstrate a lack of consensus on the standard 
of care for detection of metastatic disease in prostate cancer” (p. 665). However, 
Crawford et al. stated, 
A study conducted by Even-Sapir et al37 demonstrated that NaF 
PET/CT is a highly accurate modality (100% for sensitivity, specificity, 
positive predictive value, and negative predictive value) for the detection of 
bone metastases in patients with prostate cancer. It can detect many 
metastatic lesions overlooked by bone scan. A prospective study in patients 
with biochemical relapse of prostate cancer showed that NaF PET/CT is 
useful in the detection of occult osseous metastases and that its positivity 
tends to associate with increasing PSA level and might occur in lower PSA 
ranges than conventionally recognized. (p. 665) 
Crawford et al. (2014) also stated that “pelvic lymph node dissection is currently 
the gold standard for evaluating the presence of nodal involvement in men undergoing a 
radical prostatectomy deemed at risk” (p. 667), and added that “there are limited imaging 
methods for detecting nodal involvement in patients with prostate cancer” (p. 667). 
According to Crawford et al., “reliable and optimal detection rates have not been 
achieved by CT or MRI or even with PET/CT using 18F-fluoromethylcholine or 18F-
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fluorodeoxyglucose” (p. 667). They further discussed the use of “PET/CT scan with new 
tracer 11C-choline,” and said it “has been demonstrated to be highly specific and more 
sensitive than PET alone or MRI as a noninvasive means of staging pelvic lymph nodes 
in prostate cancer” (p. 667). “Taken together,” they concluded, “modern imaging 
modalities have improved accuracy but have major limitations, including variations in 
accuracy, high cost, and lack of availability” (p. 667). They also noted that questions still 
surround the issue of imaging: “What is the preferred imaging modality? At what time 
point and frequency should imaging be done? They also recognized that there are distinct 
patient groups to be used in the evaluation of metastatic disease in prostate cancer” 
(p. 668). 
Crawford et al. (2014) suggested that “prospective, rigorously controlled, clinical 
imaging trials are needed to establish the optimal role of new imaging strategies in 
prostate cancer, so appropriate patient management decisions can be made early in this 
disease stage” (p. 667); and also stated: “Initiating proper clinical strategies for the 
detection of metastases in advanced prostate cancer is important for optimal patient 
management” (p. 668). Noting that “recommendations to promote early identification of 
metastatic disease were developed during the workshop with the objective of improving 
clinical patient management and facilitating appropriate treatment practices” (p. 668), 
they stressed the need for further research: “To definitively conclude that refinements in 
imaging could improve survival for patients with prostate cancer, prospective, rigorously 
controlled, clinical imaging trials will be needed” (p. 668). 
While studies about their efficacy and suitability need to catch up, options for 
treatment of prostate cancer are constantly changing and expanding, as the Interactive 
Treatment Chart, created by the Dattoli Cancer Treatment Centers (1993, 2015), 
indicates. In its entirety, the chart includes the risks associated with each methodology, 
the pros and cons, any long-term studies that have been published, and medical indicators 
for each type of treatment. But it will suffice here to list the types and a brief description: 
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(1) Calypso®—a new radiation program that uses GPS technology to focus the radiation 
beam; (2) Cryotherapy Cryosurgery Cryoablation—freezes and thaws cancer cells to 
destroy them; (3) Focal Cryotherapy—a salvage treatment for recurrent disease; 
(4) Cyberknife®—a form of external radiation therapy; (5)  HIFU (High Intensity 
Focused Ultrasound)—utilizes focused sound waves to ablate cancer cells; 
(6) Hormonal Therapy-Androgen Deprivation Therapy (ADT)—utilizes hormones 
to decrease testosterone production and inhibit production and growth of cancer 
cells; (7) Radiation—of different types targets and destroys cancer cells; 
(8) Brachytherapy—implantation of radioactive sources (e.g., seeds or pellets) directly 
into the prostate and the tumor; (8) Palladium103—a radioactive isotope with a short 
half-life that spares surrounding tissue; (9) Iodine125—a longer half-life than Palladium, 
which exposes more of the surrounding tissue; (10) High Dose Rate (HDR) —temporary 
brachytherapy implants using Iridium 192; (11) Combination Therapy—two or more 
types of radiation, sometimes with the addition of hormones; (12) EBRT-External Beam 
Radiation Therapy—fractionated photon doses; (13) IMRT-Intensity Modulated 
Radiation—uses protons; (14) DART-True Dynamic Adaptive Radiation—uses 
components of 4G image-guided, intensity-modulated radiotherapy (4D IGIMRT), 
enabling state-of-the-art control of photon beams; (15) Adaptive Radiation Therapy—
uses neutrons to kills cancer cells; (16) Proton Therapy—uses proton beams, often 
combined with photons; (17) RapidArc®—a new product that uses single radiation 
rotation; (18) Tomotherapy—computed tomography-guided IMRT; (19) surgery—the 
former gold standard of treatment; (20) Radical Prostatectomy—surgical removal of 
most of the gland; (21) Robotic “da Vinci” Laparoscopic—robotic equipment removes 
the gland through small abdominal openings; (22) Watchful Waiting—no treatment, just 
periodic retesting; (23) Expectant Surveillance—similar to watchful waiting but also 
includes ingesting complementary medicines and homeopathic substances. 
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Interventions Designed to Increase Awareness, Screening, 
and Adherence to Treatment Recommendations 
The research that Chan et al. (2011) conducted among Hispanic men in Texas led 
them to the conclusion that a “culturally appropriate intervention to promote IDM for 
prostate cancer screening with PSA” was needed in this group (p. e45). They “developed 
a community-based intervention guided by formative research to assure that the 
intervention would be grounded in the men’s social experience” (p. e45) and “involved 
community partners in the development and implementation of the intervention and 
several aspects of the evaluation process” (p. e45). Further, as they noted, 
Because the intervention was implemented in natural non-clinical 
settings we used a cluster randomized design to assess the short-term impact 
of our intervention on men’s knowledge about prostate cancer screening, 
their preferred role in decision making about screening with PSA, beliefs 
related to informed decision-making, and screening intentions. (p. e45) 
Chan et al. (2011) administered surveys “before and after the intervention or for 
controls, after the discussion of the diabetes video, by the protomores who read the 
questions to the group” (p. e46); the questions included “age, race/ethnicity, country of 
birth, education, health insurance, whether they had a partner, and self-reported health” 
(p. e46). In addition, they asked whether subjects had ever heard of a PSA test or digital 
rectal exam (DRE), or had had experience with PSA or DRE. 
“A major theme in our focus groups,” Chan et al. (2011) reported, “was that the 
men had difficulty understanding that anyone would think there is a decision to be made 
about prostate cancer screening” (p. e46). To address this issue, the researchers 
developed new items to assess this “normative belief and how it might have changed after 
the intervention to an understanding that there is a decision to be made about prostate 
cancer screening” (p. e47). They described these changes as follows: 
We assessed this change with questions: “It is important for a man to 
think about what he would do if he has an abnormal test result before getting 
tested for prostate cancer;” “It is important for a man to weigh the potential 
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pros and cons of getting tested for prostate cancer before deciding whether or 
not to be tested.” (pp. e46-e47) 
Chan et al. (2011) “asked five questions adapted from the Speilberger State 
Anxiety Scale” (p. e47), noting that the items “asked whether the program made the 
participant have various feelings about making the decision” (p. e47). In addition, “Five 
items from the Ottawa acceptability compendium asked about general aspects of the 
program, clarity of explanations, balance of the program, amount of time for discussion, 
quantity of information, and total length of the program” (p. e47). 
Chan et al. (2011) reported: “Our study demonstrates the feasibility of developing 
and implementing a community-based intervention to promote informed decision making 
(IDM) for prostate cancer screening with PSA” (p. e49). Chan et al. noted, “Although 
there have been many studies involving decision aids delivered in clinical settings to 
patients, our study shows that informed decision making can be promoted in community 
settings to community residents” (p. e49). 
Chan et al. (2011) highlighted: “We engaged community members in the formative 
work leading up to the development of our intervention” (p. e49). Chan et al. noted: 
“Interventions to promote IDM for PSA testing have been delivered through the Internet 
or postal mail” (p. e49). Chan et al. concluded that “delivering the decision aid in small 
group settings by trusted lay health workers as we did in our study, we demonstrated the 
feasibility of delivering an IDM intervention outside of clinical settings to underserved 
Hispanic men” (p. e49). 
Chan et al. (2011) stated, “This finding may be related to low income and/or to low 
health literacy” (p. e49). Chan et al. reported, “In the 2000 National Health Interview 
Survey, approximately 34% of Hispanic men who had taken a screening PSA test did not 
report a discussion with their physician about the advantages and disadvantages of 
screening” (p. e49). “Taken together,” Chan et al. stated, “these findings suggest that a 
sizable number of Hispanic men are undergoing PSA testing with little knowledge about 
  
59 
it, little discussion about it, and without participating in this decision with their 
physician” (p. e49). 
Interestingly, however, Chan et al. (2011) noted that: 
The complexity of promoting the idea of ‘‘informed decision making’’ 
for a screening test was highlighted by our findings that 44% of men in the 
intervention group believed that the program was trying to encourage men to 
get tested and that 51% of men thought that the program was trying to 
encourage men not to get tested. (p. e50) 
“Consistent with studies evaluating decision aids for prostate cancer screening,” 
Chan et al. (2011) wrote, “we found that intervention participants moved toward a more 
active role in decision making, compared with the control group” (p. e50). “After the 
intervention,” they said, “intervention participants moved to more active role preferences 
for both the prostate cancer screening decision and general health care decisions, relative 
to the control participants” (p. e48). This difference, they found, “was statistically 
significant for prostate cancer screening and close to the p < 0.05 criterion for general 
health decisions” (p. e48). In addition, they evaluated a number of other responses on the 
part of the participants: 
A minority of intervention participants reported any stress following the 
session. The most common feelings were being tense (34%) and/or worried 
(24%). Participants said that the program showed why there is a decision to 
be made about testing (97%), that the decision depends on what matters most 
(values) (99%), helped them think about how much say they wanted in 
making the decision (97%), and showed all sides of the decision (98%). 
(p. e49) 
In discussing the limitations of their findings, Chan et al. (2011) noted that they 
had “assessed men immediately after they had completed the program, rather than over a 
longer follow-up period because of budgetary constraints” (p. e50). Because of this 
constraint, they stated, it was possible that their findings “reflected the short-term impact 
of our intervention which may diminish with time” (p. e50). They also reported that their 
study was “the first to show that underserved Hispanic men lack knowledge about 
prostate cancer screening and can become more informed about the facts about screening 
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through a community based intervention program delivered in small group settings” 
(p. e50). It could, they added, “encourage underserved Hispanic men to take a more 
active role in their decision making process, make them more aware of weighing the pros 
and cons of screening, and imbue them with greater awareness of the downstream 
consequences of screening” (p. e50). 
Myers et al. (2011) found that “endpoint decisional conflict was equally low 
among men in both study groups” (p. 243). Myers et al. reported that “this finding differs 
from earlier studies that have reported increased and reduced decisional conflict in 
response to the use of decision aids” (p. 243). As Myers et al. suggested, “differences in 
study design and intervention methods may help to explain such variation in decision aid 
impact on decisional conflict” (p. 243). Myers et al. added that:  
The approach tested in this study involved training primary care practice 
nurses to prepare patients for a discussion of screening with their physician. 
Our findings suggest that nurse-led decision counseling may help to increase 
patient knowledge and influence IDM without increasing decisional conflict. 
(p. 245) 
Myers et al. (2011) reported: “It has been proposed that decision counseling should 
be part of routine primary care” (p. 245), and said that a move toward implementing this 
recommendation … policymakers should acknowledge the time and effort involved in 
delivering well-documented, effective decision support services, and provide adequate 
compensation for improving this aspect of medical care. Providing effective mediated 
decision support on a large scale may have salutary effects on patient adherence and 
satisfaction (p. 456). 
In 2007-2008, Costanza et al. (2011) conducted a pilot study: to “(1) evaluate the 
effectiveness of computer-assisted telephone counseling (CATC) as a decision aid for 
men considering PSA testing and (2) to present a testable surrogate for discussion and 
decision sharing with one’s PCP (p. 194). They noted: “The more common model of 
informed decision making includes a decision aid (print, video, etc.) with no or limited 
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live interaction between decision aid and subject, sometimes followed by discussion 
and/or shared decision making between patient and PCP” (p. 194). Their eligibility 
criteria for the study were: “being male, ability to speak English, age 50-70 years (45-70 
for African Americans), no history of PCa and no PSA test in the last 12 months” 
(p. 194). 
For their study, Costanza et al. (2011) sent a booklet to their participants, followed 
by a call from a telephone counselor. They followed CATC protocol, and noted that “the 
booklet was patterned after the PROCASE booklet of Partin et al. who had included 
concepts that patients, urologists and oncologists consider key to understanding PCa and 
the PSA test” (p. 194). Further, they noted that the booklet was later revised “with the 
help of a low literacy consultant … to accommodate low literacy participants at a 5th 
grade reading level” (p. 194), and said it “ultimately included findings from focus groups 
and key informant interviews with African-American and non African-American and 
low-literate men” (p. 194). They reported: 
Overall, the intervention was well received by the men. Almost all 
considered the booklet and the counseling improved their knowledge of PCa 
and PSA. We believe the booklet and counseling presented a balanced 
picture, neither for nor against testing. This contention is supported by two 
facts: (a) men in two focus groups reviewed the booklet and informed us that 
the booklet was not biased but balanced regarding PSA testing and (b) men 
who had not made a decision prior to the intervention were equally apt to 
make a pro or a con testing decision following the intervention. (p. 198) 
Although Costanza et al. (2011) cautioned against generalizing their findings 
because most of their participants were “white, middle class and well educated” (p. 198), 
they stated that: “Our pilot study was successful in significantly improving knowledge, 
decreasing decisional conflict, increasing decisional satisfaction and increasing the 
number of men making a decision about PSA testing” (p. 198); and concluded that: 
We believe the intervention, combining print material with a CATC 
system provides realistic and effective decision support for men facing a 
difficult decision and could potentially substitute for discussion of PSA 
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testing with their PCPs. However, in the absence of a controlled trial, this is 
speculation. (p. 199) 
Heidenreich et al. (2011) reported, “There is currently no evidence for introducing 
widespread population-based screening programmes for early PCa detection in all men” 
(p. 62), and cited the following results of a major cancer screening trial, in which 
randomly assigned 76,693 men were randomly assigned “to receive either annual 
screening with prostate-specific antigen (PSA) or digital rectal examination (DRE) or 
standard care as the control” (p. 62): 
After a follow-up of 7 yr, the incidence of PCa per 10 000 person-years 
was 116 (2820 cancers) in the screening group and 95 (2322 cancers) in the 
control group (rate ratio: 1.22). The incidence of death per 10 000 person-
years was 2.0 (50 deaths) in the screened group and 1.7 (44 deaths) in the 
control group (rate ratio: 1.13). The PLCO project team concluded that PCa-
related mortality in screen-detected individuals was very low and not 
significantly different between the two study groups. (p. 62) 
The absolute risk difference revealed by this trial, according to Heidenreich et al. 
(2001), “was 0.71 deaths per 1000 men” (p. 62), which means, the authors concluded, 
“that 1410 men would need to be screened and 48 additional cases of PCa would need to 
be treated to prevent 1 death from PCa” (p. 62). Based on these data, Heidenreich et al. 
noted that “the real benefit of the ESRPC trial will only be evident after 10–15 yr of 
follow-up…. Furthermore, we have to wait for the results of the economic burden and the 
side effects resulting from more intensive screening” (p. 62). 
Research on E-Health 
In addition to the initiatives noted above, which were undertaken to determine 
whether patient education and information—via a variety of delivery options—influence 
patient decision-making about care, e-options are also being tried. “Recently,” Misra and 
Wallace (2012) noted, “both Google (Google Health) and Microsoft (HealthVault) 
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introduced publicly available, Internet-based PHRs at no cost” (p. 220). The authors also 
cited the fact that: 
Other relevant research was conducted with a sample (n=220) of 
primarily young African American and Hispanic women with a mean age of 
32 years (Bacon, 2007). Data showed that the vast majority (72.5%) had 
been using the computer and Internet to access healthcare information for a 
period greater than 6 months—as a well-maintained behavior. In addition, 
the women reported high levels of self-efficacy or confidence in using the 
computer and Internet to access websites providing healthcare information. 
(p. 219) 
According to Misra and Wallace (2012), “Accessing such online health 
information gives individuals privacy, and helps people to make important decisions—
whether for themselves or others” (p. 220). The authors consider it 
important to explore how design and presentation modalities incorporating 
user-centered design can contribute to the efficacy of health communication 
across health literacy levels—whether presenting health information via 
various large or small computer devices such as personal computers, mobile 
iPhones, interactive television. (p. 216) 
But how exactly are these e-options defined? According to Misra and Wallace 
(2012), “There is evidence that e-health should be defined ever so broadly.” To support 
this, they cite Eysenbach’s (2001) definition of e-health, noting the importance of his 
description of e-health as: 
an emerging field … referring to health services and information delivered 
or enhanced through the Internet and related technologies. In a broader 
sense, the term characterizes not only a technical development, but also a … 
commitment for networked, global thinking, to improve health care locally, 
regionally, and worldwide by using information and communication 
technology. (p. 218) 
Citing Fox and Joes (2009), Misra and Wallace (2012) found that 
61% of American adults have looked online for health information and about 
two-thirds talked to someone else about what they found online. In addition, 
about half of the respondents reported having read online other peoples’ 
commentary or about their experiences with health issues. (p. 219) 
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This “tremendous growth in electronic health information technology,” Misra and 
Wallace (2012) state, “necessitates attention being paid to the task of designing the e-
health message, and to evaluating what has been designed” (p. 217). Moreover, they note 
that “one may identify the field of Health Informatics and Information Technology 
(HIIT) as one characterized by new advances that are constantly emerging,” and specify 
that the “available range of effective HIIT tools support … the receipt, processing, 
transmission, retrieval, protection, and analysis of vast amounts of information and data” 
(p. 217). “The breadth and scope of HIIT,” the authors conclude, “encompasses the 
global tracking of diseases, as well as reaching underserved populations, thereby 
impacting health disparities” (p. 217). They went on to cite Adams and Leath (2008), 
who drew “upon information disseminated by the World Health Organization in 
identifying potential outcomes from the use of information and communication 
technology” that includes, among other features, the creation of “national and local 
information systems supporting the development of effective, efficient and equitable 
health systems” (Misra & Wallace, 2012, p. 217). “Clearly,” Misra and Wallace 
concluded, “HIIT can make vital contributions both its nationally and globally” (p. 217), 
through efficiency, enhancing quality of care, being evidence-based and empowering for 
the public, who can access their medical records electronically and select evidence-based 
health care. In addition, Eysenbach (2001) noted that e-options encourage new 
partnerships and the education of medical doctors and consumers/ patients via online 
information, enable the exchange of information and communication across agencies, and 
extend “the conventional geographic and other boundaries of conventional health care via 
access to global providers online.” He also noted that “e-health can either make health 
care more equitable, or widen the gap between those who have versus those who do not 
have access to computers and Internet networks” (p. 219). As Misra and Wallace (2012) 
noted, Prochaska (2008) “pioneered the design of innovative interactive computer-based 
approaches that can enhance health, reduce health care costs, and provide more inclusive 
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care” (p. 227); and added that Prochaska “described the results of interactive computer-
based interventions delivered at home via programmed algorithms; findings on 
interventions for cigarette smoking cessation revealed how interactive computers alone 
produced a 24% abstinence rate” (p. 227). They continued: 
In support of the assertion that Prochaska’s (2008) pioneering  approach 
produces a more inclusive approach to treatment, as social justice, consider 
the following evidence: 
Across our population trials, we found that African American smokers 
and Hispanic-American smokers had somewhat higher quit rates than non-
Hispanic Whites. The oldest smokers had the highest quit rates…. Treatment 
stereotypes have suggested that certain populations, like younger, older, 
minority, or impaired individuals do not have the same ability to change. 
These results indicate that the problem is not inability to change: the problem 
is inaccessibility to quality change programs. (pp. 227-228) 
Misra and Wallace (2102) also said that Prochaska “suggested a viable future … in 
which emerging paradigms ‘need to rely much more on proactive approaches to reaching 
entire populations’ … delivered primarily by patients using technologies at home” 
(p. 228). 
However, and this is essential, Misra and Wallace (2012) cautioned that those who 
manage information in health care “must also be concerned about the process of 
designing the e-health message,” and stressed that the information “to be communicated 
to providers and consumers should reflect the use of designs that permit effective 
engagement and knowledge acquisition” (p. 217). “One of the major challenges in 
consumer health informatics,” they stated, “is to provide consumers with relevant 
information (that is contextualized and personalized), and to ensure that the information 
is presented is such a way that consumers can understand and act upon the information” 
(p. 220). “What emerges as critical in e-health design,” they noted, is paying “sufficient 
attention … to health communication and health literacy” (p. 221). 
To further emphasize the importance of designing appropriate and effective 
e-messaging, the authors cited Woo (2008), who 
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asserted the importance of websites being linguistically and culturally 
appropriate.… In brief, Woo (2008) stressed the importance of the design of 
e-health effectively engaging users, providing information, and having 
interactive components—such as a chat room, question and answer service, 
e-mail service, and videos/films. (p. 218) 
Misra and Wallace (2012) contend that “an effective strategy involves first 
identifying the target audience, then assessing what they want, think, feel, and do when it 
comes to a particular health issue” (p. 220), and point out that “it is important for 
designers to keep in mind social and cultural factors that inform design,” noting that: 
Designers of e-health must strive to identify and consider categories of 
consumers. As technology expands, new categories of consumers may arise. 
This necessitates future research which expands the base of knowledge about 
categories of consumers. This information may then be used in designing 
e-health messages for specific categories of consumers. (p. 232) 
Misra and Wallace (2012) conclude that there is “an imperative to meet the needs 
of the growing number of consumers seeking out and accessing e-health,” and that both 
“research and attention to the design of e-health messages emerge as vitally important” 
(p. 220). E-health, they stress, “should be easy-to-use, entertaining, and exciting” 
(pp. 218-219). 
Theories Guiding the Study: Stages of Change and Self-efficacy 
Two theoretical frameworks guided this study: (1) The “transtheoretical model” 
(TTM) of change developed by Prochaska and DiClemente, (1983), and (2) the self-
efficacy model developed by Bandura (2001). Also included is Rogers’s (1962, 1995) 
model known as the Diffusion of Innovation (DOV).  
According to Prochaska and DiClemente (1983), TTM involves “10 processes of 
change receiving differential application during … five stages of change” (p. 391). These 
processes of change are: “consciousness raising, self-liberation, social liberation, self-
reevaluation, environmental reevaluation, counterconditioning, stimulus control, 
reinforcement management, dramatic relief, and helping relationships” (p. 391). 
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This model, which sets forth the stages of change that human beings go through, 
provides the theoretical framework for the work of this study in changing behavior 
among African American men. The rationale for using Prochaska and DiClemente’s 
model is to move study participants to the stage of action or maintenance by having them 
commit to annual medical exams that provide PSAs and digital rectal evaluations. The 
goal is to effect behavioral change that leads to a reduction in the mortality rates of 
African American men; increase their potential treatment options; encourage them to 
pursue annual medical reviews of their prostate health; and offer them a greater 
awareness, readiness, and utilization of the diagnostic options available to them. This 
should lead to their increased readiness to act on healthier behavior and to maintain the 
changes they make. To be explicit, this study conceptualizes four stages of change of 
behavior: (1) precontemplation, (2) contemplation, (3) action, and (4) maintenance of 
actions.  
According to Prochaska and DiClemente (1983), one of the most important 
findings to emerge from their research “with self-changers and therapy changers” was 
that “particular processes of change tend to be used much more during particular stages 
of change” (p. 285). Their “initial data suggest[ed] that many individuals begin to 
contemplate changing particular aspects of their lives because of developmental 
processes that move them into a new stage in life” (p. 286). Based on the TTM they 
developed, the authors made a number of predictions about individuals in various stages 
of the change process. For example, “precontemplators” (whom the authors defined as 
individuals who are not aware of having problem, though others see them as having one) 
tend to “be defensive and avoid changing their thinking and behavior; while 
“contemplators, who are seriously thinking about changing their behavior … will be 
“most likely to use consciousness raising to gather further information” about the 
behavior they want to change (p. 391). On the other hand, since “subjects in the action 
stage are most committed to making behavioral changes,” they would be likely to “use 
  
68 
self-liberation, counter-conditioning, stimulus control, and reinforcement management 
the most” (p. 391). 
Overall, Prochaska and DiClemente (1983) concluded that their “research and 
model on self-change and therapy change clearly suggests that “both … verbal and 
behavioral … sets of processes appear to be vitally important for individuals to complete 
the course of change” (p. 285). Verbal processes, they concluded, “are most important in 
preparing clients for action, while the behavioral processes become more important once 
clients have committed themselves to act” (p. 285). 
Bandura’s (2001) concept of self-efficacy also guided the present study. “To be an 
agent,” he wrote, “is to intentionally make things happen by one’s actions.… The core 
features of agency enable people to play a part in their self-development, adaptation, and 
self-renewal with changing times” through the strength of belief in one’s own ability” 
(p. 2). In short, according to Bandura (1997), “Self-efficacy determines the beliefs a 
person holds regarding his or her power to affect situations,” and “none [of these 
mechanisms] is more central or pervasive than people’s beliefs in their capability to 
exercise some measure of control over their own functioning and over environmental 
events” (p. 10). 
In addition, Bandura (2001) wrote, “Having adopted an intention and an action 
plan, one cannot simply sit back and wait for the appropriate performances to appear. 
Agency thus involves not only the deliberative ability to make choices and action plans, 
but the ability to give shape to appropriate courses of action and to motivate and regulate 
their execution.” These, he wrote, include the uses of self-monitoring, performance self-
guidance via personal standards, and corrective self-reactions (Bandura 1986, 1991b). 
Because this study utilizes an avatar and social media in its methodology, the work 
of Rogers (2004) is also relevant. Rogers described the diffusion of ideas as “the process 
through which an innovation, defined as an idea perceived as new, spreads via certain 
communication channels over time among the members of social system” (p. 13). 
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Accordingly, such innovations are applicable to “the recent spread of the Internet or to 
any new idea” (p. 13). 
In expanding upon Rogers’s DOV theory, the Boston School of Public Health 
(BSPH) (2013) wrote that it 
originated in communication to explain how, over time, an idea or product 
gains momentum and diffuses (or spreads) through a specific population or 
social system.  
The end result of this diffusion is that people, as part of a social system, 
adopt a new idea, behavior, or product. Adoption means that a person does 
something differently than what they had previously (i.e., purchase or use a 
new product, acquire and perform a new behavior, etc.). The key to adoption 
is that the person must perceive the idea, behavior, or product as new or 
innovative. It is through this that diffusion is possible. (p. 1) 
In addition, BSPH (2013) noted that “it is important to understand the 
characteristics of the target population that will help or hinder adoption of the 
innovation.” This advice was followed in developing the methods used to gather data for 





This chapter outlines the methods and procedures used in this study. This includes 
an overview of the study design and procedures, description of the study participants, and 
description of research instrumentation. The chapter also presents the treatment of data 
and data analysis plan.  
IRB Approval 
This study received approval for all study activities from the Teachers College, 
Columbia University Institutional Review Board (IRB) as Protocol #15-125 (see 
Appendix A for IRB Approval Letter) on December 12, 2014. It was not until IRB 
approval was attained that the study’s data collection began in August/September 2015. 
The Study Participants 
This study recruited 41 African American men between the ages of 20 and 64 who 
were potentially at risk for prostate cancer, a complete description of the individuals who 
participated in this study is provided in chapter IV Part I, basic demographics. 
Participants were recruited to this via using a dual method. Firstly, advertisements were 
placed on various social media platforms, like Facebook and Twitter. The advertisement 
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that was placed on these websites had to be concise; the messages that solicited study 
participants was: 
Go to www.surveymonkey.com/s/AAProstateCancer/ to take a survey & rate 
a video for a chance to win a $300, $200, or $100 prize. 
In addition to searching for study participants through the internet, the principal 
investigator also approached various entities in New York City, mostly within Harlem 
and the Bronx, where African American males frequent to see if these entities would 
assist the research in recruiting individuals into the study. The visited institutions 
included Harlem’s local community board, the Schomburg Center for Research in Black 
Culture, the Congress on Racial Equality’s (CORE) Bronx division, the NCAAP’s 
Manhattan branch, the Bronx Public Library, local barber shops around Harlem and the 
Bronx, and the YMCA in Harlem. In each of these places, the appropriate administrative 
staff/employee/manager was contacted and the purpose of the study was explained as 
well as the need to recruit study participants. 
These entities were asked to help recruit African American males to the study 
using in three different ways: (1) by posting the study flyer physically in their building, 
(2) by distributing the flyer to their clientele (many copies were provided to the solicited 
entity), or (3) by sending an email out on any listserv that they may have had (not all 
entities had listservs). The first two methods made use of the same study flyer, which is 
provided in appendix F. This flyer outlined the tasks involved in the study, including: 
taking a 30-minute online survey, watching the avatar e-health video over the internet, 
and then spending 10 minutes taking exit questionnaires. The flyer incentivized potential 
participants by placing interested parties into a lottery where they had a chance to win a 
$300, $200, or $100 Amazon gift card. Finally, a URL was provided to any interested 
individuals to find all of the study materials.  The email messages that were sent to solicit 
study participants were drafted by the principal investigator; the email messages shares 
the same information as the study flyer and only the formatting is different. The e-mail 
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message that was sent out is included in Appendix E. Finally, the principal investigator 
also used personal connections and texted an invite to potentially interested participants; 
this text message is shown in Appendix G. 
Participants recruited via the internet or through the personal outreach of the 
principal investigator were all directed to the same URL on survey monkey. Upon 
accessing the relevant page, an introduction to the study was provided and the extent of 
their involvement was explained. Everyone who accessed this URL was then prompted to 
complete a screening instrument, all of the study instruments (which are described in 
details below), watch the avatar e-health intervention, and then finish by taking an exit 
survey. Any participant that did not answer yes to all of these questions was excluded 
from participation in the study. 
1) Are you an African American man who is age 18 or older? 
Yes ___ No___ 
 
2) Are you able to read and understand English on a high school level? 
Yes ___ No___ 
 
3) Are you able to devote about 45 minutes to this study at this time—for a 3 in 
200 chance to win a $300, $200, or $100 gift certificate for use on 
www.Amazon.com? 
Yes ___ No___ 
 
6) More specifically, are you willing to spend 30 minutes answering a survey?  
Yes___ No____ 
 
7) Next, are you willing to watch an avatar video (cartoon) for about 5 minutes? 
Yes___ No____ 
 
8) Are you willing to answer another set of questions for about 10 minutes, 
including rating the avatar videos and describing the impact on you? 
Yes ___ No___ 
After a period of six months, 43 individuals had completed all parts of the study; 
two were then excluded for failing to meet the study requirements. Although the intent 
was to collect up to 200 responses, only 41 respondents who met the inclusion criteria 
participated in the study. A lack of response in a reasonable time frame is a common 
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challenge for many researchers. One limitation of the study participants is that New 
Yorkers were heavily over-sampled, thus limiting the ability of this study to generalize 
the results to the wider African American community of men in the United States. 
Development of the E-Health Avatar Videos 
Other study procedures involved the development of the 10-minute e-health avatar 
video (cartoon-like) that was developed using technology available from 
www.goanimate.com. First, scripts for the videos were created based on a review of 
research, literature, and scholarship on prostate cancer. Second, the scripts were reviewed 
and edited by the dissertation sponsor, Dr. Barbara Wallace. Third, the Principal 
Investigator created the avatar video using www.goanimate.com technology. Fourth, the 
dissertation sponsor reviewed and suggested edits. Fifth, after edits to the avatar videos 
were made and approved, an online focus group was held with a diverse group of video 
reviewers who included health educators, nurses, and medical doctors. This focus group 
provided feedback on strengths, weaknesses, and recommended changes to the 10-minute 
video. Sixth, a second online focus group with different people was held to receive a final 
round of additional feedback. Finally, the edited video was used as an e-health 
intervention in this study. One limitation of the intervention video was that it was made to 
be sensitive to African Americans that grew up in the US; thus, there may be other 
Blacks around the world that this e-health video would not connect with on a cultural 
level. One study participant, for example, identified as “Black Haitian.” 
Description of the Study Instrumentation 
This study used a new instrument entitled the Survey for the African American 
Men’s Prostate Cancer Awareness Avatar Video Study, which is based on both new 
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scales and prior scales used by fellows of the Research Group on Disparities in Health 
(RGDH). The new scales were based on a review of research, being created by the 
Principal Investigator and the dissertation sponsor, Dr. Barbara Wallace, Director of the 
RGDH. The prior scales were developed by Dr. Wallace and/or in collaboration with 
prior fellows of the RGDH. All scales composing the study instrument are described 
herein. In the findings section, means and standard deviations were reported for all 
continuous, discrete, and ordinal variables. Note that some of the items included an 
unsure/not available (NA) option. When calculating means and standard deviations of 
these items, these extra categories were omitted from the calculations. 
Part I: Basic Demographics (BD-9) 
The BD-9 is a demographics tool developed by Dr. Wallace and used by prior 
fellows of the RGDH (e.g., Tettey, 2010). However, the BD-9 also includes questions 
from a brief health survey that was also previously used by Tettey; this permits obtaining 
information on age, socioeconomic status, level of education, Body Mass Index (BMI)—
including health insurance. It includes ratings on a 6-point Likert scale (i.e., 1=Excellent, 
2=Very Good, 3=Good, 4=Fair, 5=Poor, 6=Very Poor) for weight, their health status, and 
the quality of their medical care. One note of caution must be made about the 
measurement of race, which is a difficult construct to operationalize given the complex 
ways that different individuals identify. As can be seen in Appendix D, the BD-9 did not 
distinguish between the different ways that Black males may identify in the US since the 
category was labeled simply as “Black / African American.” Thus, if an individual 
identified more narrowly as “Black Haitian,” then this respondent would be forced to 
select from the more general category that was provided. 
Part II: Basic Health Survey (BHS-8) 
The BHS-8 is a new scale based on review of research that was created for this 
study by the Principal Investigator and his dissertation sponsor, Dr. Wallace. The BHS-8 
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includes eight items that ask respondents to self-rate various aspects of their health, 
including the respondent’s level of overall health, their height, weight, weight self-rating, 
overall quality of care received for medical condition, etc. The full scale can be seen in 
Appendix D.  
Part III: Prostate Cancer Scale (PCS-10) 
The PCS-10 is a new scale based on a review of research that was created for this 
study by the Principal Investigator and his dissertation sponsor, Dr. Wallace. The PCS-10 
permits obtaining the prevalence of diagnoses of prostate cancer, history of screening for 
prostate cancer (i.e., with yes, no, or unsure options), as well as the prevalence of prostate 
cancer in their family and in their social network (i.e., check all that apply)—including 
deaths from prostate cancer and the metastasis of cancer in their network (i.e., number 
indicated). 
Part IV: Scale Measuring Health Literacy via Skills and Self-Efficacy 
(SM-HL-V-S-SE-16) 
The SM-HL-V-S-SE-16 is a new scale based on a review of research that was 
created for this study by the Principal Investigator and his dissertation sponsor, 
Dr. Wallace. Most helpful was how the CDC has defined health literacy, as follows: “The 
Patient Protection and Affordable Care Act of 2010, Title V, defines health literacy as the 
degree to which an individual has the capacity to obtain, communicate, process, and 
understand basic health information and services to make appropriate health decisions” 
(para. 1). Thus, items in the new scale reflect the various aspects of this definition. This 
new scale permits obtaining subjects’ level of health literacy, as measured in terms of 
(1) relevant skills (8 self-ratings), and (2) self-efficacy (8 self-ratings) to perform them. A 




For being able to ask questions that will help me to better understand, or 
completely understand what a health professional has explained to me 
13-I would rate my ability as 
Very Poor Poor Fair Good Very Good Excellent 
1 2 3 4 5 6 
re14-And, I would rate my level of confidence for doing this as 
Not 
confident 
    Extremely 
confident 
0% 20% 40% 60% 80% 100% 
Thus, the scale produces an ability/skills score that is based on 8 items, and a self-
efficacy score that is based on 8 items. Internal consistency was obtained using 
Cronbach’s Alpha for the health literacy ability/skills sub-scale, and for the healthy 
literacy self-efficacy sub-scale. Cronbach’s Alpha was estimated to be .905 and .926 for 
the health literacy skills and self-efficacy scales, respectively. 
Part V: Prostate Cancer Screening Empowerment Scale Measuring Stage of Change 
and Self-Efficacy for Four Behaviors—Pre-Video (PCS-ES-M-SOC-SE-PRE-V-4) 
This is a new scale based on a review of research that was created for this study by 
the Principal Investigator and his dissertation sponsor, Dr. Wallace—while following the 
work of Garcia (2013). This new scale permits obtaining the subjects’ stage of change 
and self-efficacy for (1) going to see a medical provider and getting a physical 
examination at least once a year, (2) making sure they receive a digital rectal examination 
to screen for prostate cancer, (3) making sure they receive a PSA test to screen for 
prostate cancer, and (4) spreading awareness among other African American men about 
the need for prostate cancer screening. For each of these four target behaviors of interest, 
subjects provide: (a) a rating for their stage of change (i.e., following the work of 
Prochaska & DiClemente, 1983, and their stages of precontemplation, contemplation, 
preparation, action and maintenance) for each of the four target behaviors; and (b) a 
rating of their self-efficacy (Bandura, 1977, 1997) or level of confidence for performing 
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each of the four target behaviors. A sample question with the (a) stage of change self-
rating scale, and (b) self-efficacy rating scale is provided, below: 
Subscale 3: Screening for Prostate Cancer Via a PSA Test 
1.) When it comes to the behavior of making sure you receive what is called a 
PSA test to screen for prostate cancer, check the following that most applies to 
you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
2.) When it comes to the behavior of making sure you receive what is called a 
PSA test to screen for prostate cancer,, how confident are you in performing this 
behavior: 
____0% confident                ____20% confident                ____40% confident  
____60% confident              ___  80% confident                 ____100% confident  
____NA, I was born HIV positive—already know my status 
____NA, I have prostate cancer—already know my status 
The measure produced sub-scale scores for each of the four target behavior: i.e., a 
stage of change mean score for the sample, and a self-efficacy mean score for the sample. 
Internal consistency was .749 and .852 for the stage of change and self-effiacy pre-
measures for the four target behaviors.  
Part VI: Dose of Exposure to Video (DOE-TV-1) 
This is a standard single-item tool used in prior studies conducted by fellows of the 
RGDH (e.g., Aiyedun, 2014) that was created by Dr. Wallace, Director of the RGDH. It 
permits determining dose of exposure to an avatar video, after respondents have been 
asked to watch it—as a link embedded in the survey for convenience. The question 
follows: 
1) Please select one of the following: 
□ _____I watched none of the video 
□ _____I watched some of the video 
□ _____I watched most of the video 
□ _____I watched all of the video 
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Part VII: Rate the Video (RTV-1) 
This is a standard single item tool used in prior studies conducted by fellows of the 
RGDH (e.g., Aiyedun, 2014) that was created by Dr. Wallace, Director of the RGDH. It 
permits ascertaining on a six-point Likert scale how subjects evaluate or rate the video in 
terms of the information shared. The single question follows: 
1. In terms of the information shared in the video, how do you rate the video: 
 
Very Poor Poor Fair Good Very Good Excellent 
1 2 3 4 5 6 
Part VIII: Prostate Cancer Screening Empowerment Scale Measuring Stage of 
Change and Self-Efficacy for Four Behaviors—Post-Video (PCS-ES-M-SOC-SE-
POST-V-4) 
This is the same scale as described as PART V, with the difference that PART V is 
administered pre-video viewing, while this PART VIII is administered post-video 
viewing. Hence, PART VIII permits determining, after watching the video, what is their 
stage of change and self-efficacy for (1) going to see a medical provider and getting a 
physical examination at least once a year, (2) making sure they receive a digital rectal 
examination to screen for prostate cancer, (3) making sure they receive a PSA test to 
screen for prostate cancer, and (4) spreading awareness among other African American 
men about the need for prostate cancer screening. Cronbach’s Alpha was .852 and .862 
for the stage of change and self-efficacy subscales for the prostate empowerment scale.  
Part IX: Intention to Engage in Diffusion of the Innovation of Watching the Avatar 
Video (DIWV-2) 
This is a standard two -item tool used in prior studies conducted by fellows of the 
RGDH (e.g., Aiyedun, 2014; Garcia, 2013) that was created by Dr. Wallace, Director of 
the RGDH. It permits ascertaining whether subjects intend to recommend the avatar 
video to others, while an answer of “yes” suggests diffusion of the innovation as per the 
theory of Rogers (1962, 1995). In addition, a second open-ended question permits 
obtaining qualitative data for thematic analysis, as follows: Why would you recommend 
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or not recommend the video cartoon to others? Please explain why or why not. What 
other comments do you have? 
Quantitative Portion of Study 
1. What are their demographic and background characteristics (e.g., age, 
socioeconomic status, level of education)? 
PART I: BASIC DEMOGRAPHICS (BD-9) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
2. What is their health status (e.g., Body Mass Index) and how do they rate their 
healthcare? 
PART II: BRIEF HEALTH SURVEY (BHS-8) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
3. What is the prevalence of diagnoses of prostate cancer, history of screening 
for prostate cancer, as well as the prevalence of prostate cancer in their family 
and in their social network—including deaths from prostate cancer and the 
metastasis of cancer? 
PART III: PROSTATE CANCER SCALE (PCS-10) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
4. What is their health literacy, as measured in terms of relevant skills and self-
efficacy to perform them? 
PART IV: SCALE MEASURING HEALTH LITERACY VIA SKILLS AND 
SELF-EFFICACY (SM-HL-V-S-SE-16) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
5. What is their stage of change and self-efficacy for (1) going to see a medical 
provider and getting a physical examination at least once a year, 
(2) discussing with their medical provider whether they should receive a 
digital rectal examination to screen for prostate cancer, and (3) discussing 
with their medical provider whether they should receive a PSA test to screen 
for prostate cancer? 
PART V: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 




Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
6. After watching an avatar (cartoon-like) video, what do they report as their 
dose of exposure to the video (i.e., watched none, some, most, or all of the 
video)? 
PART VI: DOSE OF EXPOSURE TO VIDEO (DOE-TV-1) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
7. How do they evaluate or rate the video in terms of the information shared? 
 
PART VII: RATE THE VIDEO (RTV-1)  
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
8. After watching the video, what is their stage of change and self-efficacy for 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
PART VIII: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—POST-VIDEO (PCS-ES-M-SOC-SE-POST-V-4) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
9. Did they move across stages of change from precontemplation or 
contemplation to preparation for any of the four target behaviors (i.e., 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
PART IX: MOVEMENTS IN STAGES OF CHANGE TO PERFORM THE 
FOUR TARGET BEHAVIORS 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 




10. Did they experience an increase in self-efficacy or confidence to perform the 
four target behaviors from (i.e., (1) going to see a medical provider and 
getting a physical examination at least once a year, (2) discussing with their 
medical provider whether they should receive a digital rectal examination to 
screen for prostate cancer, (3) discussing with their medical provider whether 
they should receive a PSA test to screen for prostate cancer, and (4) spreading 
awareness among other African American men about the need for prostate 
cancer screening) from before to after watching the videos? 
PART X: MOVEMENT IN SELF-EFFICACY TO PERFORM THE FOUR 
TARGET BEHAVIORS 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 
comparing their pre-video viewing (PART V) to post-video viewing scores 
(PART VIII) 
11. Is there a significant relationship between selected demographics and other 
study scales with the study outcome variable/dependent variable of being in 
an action or maintenance stage for [# (3)] making sure they receive a PSA test 
to screen for prostate cancer—as measured before watching the video? 
PART X1: RELATIONSHIP BETWEEN DEOMGRAPHIC VARIABLES AND 
OTHER STUDY SCALES WITH THE TARGET BEHAVIOR OF GOING TO 
GET A PSA TEST TO SCREEN FOR PROSTATE CANCER (PRE-
MEASURE) 
Data Analysis Plan: Inferential statistics, specifically Spearman correlations 
12. What are the significant predictors of being in an action or maintenance stage 
for [# (3)] making sure they receive a PSA test to screen for prostate cancer—
as measured before watching the video? 
PART XI1: PREDICTING THE TARGET BEHAVIOR OF GOING TO GET A 
PSA TEST TO SCREEN FOR PROSTATE CANCER (PRE-MEASURE) 
Data Analysis Plan: Multiple regression and backward stepwise regression 
analyses. 
Mixed Methods Portion of Study 
13.       To what extent do they intend to diffuse the innovation of providing health 
education on prostate cancer via e-health in the form of an avatar video by 
either recommending or not recommending the video? And, what are their 
reasons for recommending or not recommending the avatar video, including 
any other comments they might have? 
PART XIII: INTENTION TO ENGAGE IN DIFFUSION OF THE 
INNOVATION OF WATCHING THE AVATAR VIDEO (DIWV-2) 
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Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages; and, the identification of emergent 
themes for the qualitative data 
Data Analysis Plan 
All data analysis in this study was executed with the use of the latest available 
version of SPSS. Descriptive statistics (mainly the means and standards deviations) and 
frequency tables were used to describe the distribution of the variables collected. 
Spearman’s correlation coefficient was used to check for a significant relationship 
between the behavior of going to get a PSA exam and other variables in this study since 
this behavior was measured on an ordinal scale. For research questions 9 and 10 that 
considered movements in the stages of change for the participants’ behavior and self-
efficacy respectively, paired t-tests were used to test for statistically significant 
differences between the study’s pre- and post-measures of the four target behaviors. 
Pairwise deletion was used and Levene’s test was used to check for the assumption of 
homogeneity of variance; no violations of this assumption were detected. Cohen’s d, 
which is an effect size measure that is also referred to as the standardized mean 
difference, is used in combination with these paired t-tests to measure the magnitude of 
effect. Regression models were used in two parts of this study. The regression analyses 
all tested for normality of errors and homoscedasticity using graphical methods and no 
major violations were detected; listwise deletion was used. The first series of regression 
models was used to answer research question 12, were the dependent variable was the 
behavior of going to get a PSA exam to screen for prostate cancer. This same dependent 
variable was then regressed on different independent variables in simple linear regression 
models to test the hypotheses listed in the anticipated findings from data analysis section. 
In both sets of regression analyses, a backward stepwise regression was also carried that 
included all variables both sets of analyses.  
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Anticipated Findings from Data Analysis 
It is anticipated that the significant predictors of being in an action or maintenance 
stage for [# (3)] making sure they receive a PSA test to screen for prostate cancer—as 
measured before watching the video, are the following independent variables: 
 Higher level of education 
 Higher socioeconomic status 
 Lower Body Mass Index (BMI) 
 Higher health literacy skills and self-efficacy 
 Higher pre-video viewing self-efficacy for (1) going to see a medical provider 
and getting a physical examination at least once a year, (2) making sure they 
receive a digital rectal examination to screen for prostate cancer, (3) making 
sure they receive a PSA test to screen for prostate cancer, and (4) spreading 
awareness among other African American men about the need for prostate 
cancer screening 
Conclusion 
This chapter described in detail the methods used in the present study.  This 
included an overview of the study design, study procedures, recruitment of participants, 
description of the study participants, and description of research instrumentation. The 
chapter concluded with how data were managed and analyzed. 
Chapter IV describes in detail the results of the study and follow the data analysis 





In accordance with the data analysis plan, this chapter presents the results of the 
survey questions that were used to collect data from the 41 participants who comprised 
this convenience sample. Text and tables are organized by the questions asked in each 
part of the survey.  
Part I: Basic Demographics (BD-9) 
As Table 1 shows, Black/African American men, who are the research focus of this 
study, comprised 40 (97.6%) of its 41 African American participants (Q.12). The 
remaining individual identified himself as mixed race. Ages for the entire sample group 
(Q.10) ranged from 20-64; 22% (n=9) were in the 56-65 age range, followed by 19.5% 
(n=8) in both the 51-55 and the 26-30 age categories (M=43.68, SD=13.00). Table 1 also 
presents the relationship status (Q.11) of the survey takers: 31.7% (n=13) were married, 
22.0% (n=9) had never married, 12.2% (n=5) were divorced, 9.8% (n=4) were in a 
committed relationship, 4.9% (n=2) of participants lived with a significant other, 2.4% 
were dating; the remaining five (12.2%) selected Other. Over eighty percent (80.5%, 
n=33) of the participants were born in the U.S.; eight (19.5%) were born elsewhere 
(Q.15). Table 1 also shows (Q.18) that 36.6% (n=15) of the 41 participants had a 
Doctoral degree, and the remaining five (12.5%) had earned a GED or Associate degree 
(M=16.63, Median=16, SD=2.91). Finally, Table 1 shows participants’ household income 
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Table 1. Basic Demographics of Participants (N=41) 
 
 N % 
(Q.12) Race/Ethnicity   
 1. Black/African American 40 97.6 
 2. Mixed 1 2.4 
   
(Q.10) Age   
(M=43.68, SD=13.00)   
 20-25 3 7.3 
 26-30 8 19.5 
 31-35 3 7.3 
 36-40 2 4.9 
 41-45 3 7.3 
 46-50 5 12.2 
 51-55 8 19.5 
 56-65 9 22.0 
   
(Q.11) Relationship Status   
 Married 13 31.7 
 Divorced 5 12.2 
 Separated 1 2.4 
 Never Married 9 22.0 
 Living with Significant Other 2 4.9 
 In a Committed Relationship 4 9.8 
 Currently Dating 2 2.4 
 Other 5 12.2 
   
(Q.15) U.S. Born   
 1. Yes 33 80.5 
 2. No 8 19.5 
   
(Q.17) Income   
(M=$118,048.45, Median=$74,999.50, SD=$152,626.25)   
 1. Less than $10,000 3 7.3 
 2. $10,000-$19,000 2 4.9 
 3. $20,000-$39,000 4 9.8 
 4. $40,000-$49,000 4 9.8 
 5. $50,000-$99,999 14 34.1 
 6. $100,000-$199,999 10 24.4 
 7. $200,000-$299,000 2 4.9 
 8. $300,000-$399,999 0 0.0 
 9. $400,000-$499,999 0 0.0 
 10. $500,000-$799,999 1 2.4 




Table 1 (continued) 
 
 N % 
(Q.18) Highest Level of Education   
(M=16.63, Median=16, SD=2.91)   
 12. 12th Grade/GED 5 12.5 
 14. Associate Degree 5 12.5 
 16. Bachelor’s Degree 15 36.6 
 18. Master’s Degree 10 24.4 
 22. Doctoral Degree 6 14.6 
   
(Q.19) Employment Status   
 Part-time Undergraduate 1 2.4 
 Full-time Undergraduate 1 2.4 
 Part-time Graduate 1 2.4 
 Full-time Graduate 4 9.8 
 Employed Part-time 3 7.3 
 Employed Full-time 24 58.5 
 Unemployed 6 14.6 
 Receiving SSI/SSD 2 4.9 
 Receiving Welfare 0 0.0 
 Other 3 7.3 
 
(Q.17) and employment status (Q.19). Ten (34.1%) of the participants reported that their 
household income was $50,000-$99,000, and another 24.4% (n=10) reported theirs as 
$100,000-$199,999. Two (4.9%) participants selected the $200,000-$299,000 category; a 
total of 13 reported incomes below $50,000, and one reported that his income was over 
$800,000 (M=$118,048.45, Median=$74,999.50, SD=$152,626.25).1 As to their 
employment status, over half (58.5%, n=24) of the participants were employed full-time, 
followed by 14.6% (n=6) who were unemployed, and 9.8% (n=4) who were full-time 
graduate students. None of the study participants were receiving welfare. Note that the 
response options to Q.19 were not mutually exclusive since respondents could select 
                                                 
1 Since participant income was measured using an ordinal scale as shown in Table 1, the 
mean and standard deviation was calculated by using the midpoint of each response option. For 
example, the midpoint of the response option $10,000-$19,000 was $14,500 and for $20,000-
$39,000 was $29,500. 
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multiple options to describe their employment status. As a result, the frequency 
percentages for Q.19 do not sum up to 100%. 
Part II: Brief Health Survey (BHS-8) 
Table 2 presents participants’ responses to the questions in Part II of the survey, 
which addressed their health and provider care. When asked how they rated their overall 
health (Q.20), 39% (n=16) of the respondents rated it as Good, followed closely by 
36.6% (n=15) who rated theirs as Very Good; another 19.5% (n=8) considered theirs 
Excellent, and 4.9% (n=2) described theirs as Fair (M=4.71, SD=.84). Body Mass Index 
(BMI) was calculated from height (Q.21) and weight (Q.22) and ranged between 21.77 
and 39.99. For BMI, the 25-30 range is usually considered overweight while 30+ is 
widely considered indicative of obesity (CDC, 2017). Going off of these cutoffs, there 
were 11 study participants who were in the normal range (26.8%), 15 in the overweight 
category (36.6%), and14 in the obese category (34.1%) (M=28.45, SD=4.72). Asked to 
self-rate their weight (Q.23), 58.5% (n=24) characterized themselves as Normal; another 
36.6% (n=15) considered themselves Overweight, and 4.9% (n=2) considered themselves 
Obese (M=2.46, SD=.60). In response to Question 24, whether/what kind of medical 
insurance they had, 73.2% (n=30) of participants responded that they had a private 
insurance plan, followed by 12.2% (n=5) who had Medicaid, 2.4% (n=1) who had 
Medicare, and 4.9% (n=2) who had an HMO; 12.2% (n=5) responded that this question 




Table 2. Brief Health Survey (N=41)   N      % 
(Q.20) Overall Health 
(M=4.71, SD=.84) 
  
1. Very Poor 0 0 
2. Poor 0 0 
3. Fair 2 4.9 
4. Good 16 39.0 
5. Very Good 15 36.6 
6. Excellent 8 19.5 




20-24.99 11 26.8 
25-29.99 15 36.6 
30-34.99 11 26.8 
 35-39.99 3 7.3 
   
(Q.23) Weight Self-Rating 
(M=2.46, SD=.60) 
  
     1. Underweight 0 0 
2. Normal 24 58.5 
3. Overweight 15 36.6 
4. Obese 2 4.9 
 
(Q.24) Medical Insurance 













  4.9 
12.2 
  2.4 
Not Applicable  5 12.2 
 
(Q.25) Overall Quality of Health Care  
(M=4.78, SD=.83) 
  
1. Very Poor 0 0 
2. Poor 0 0 
3. Fair 3 7.3 
4. Good 10 24.4 
5. Very Good 20 48.8 
6. Excellent 7 17.1 
7. N/A 1 2.4 
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Table 2 (continued)   N              % 
(Q.26) Overall Quality of Care from Primary Provider   
(M=4.68, SD=.86)   
1. Very Poor 0 0 
2. Poor 0 0 
3. Fair 4 9.8 
4. Good 11 26.8 
5. Very Good 19 46.3 
6. Excellent 6 14.6 
7. N/A 1 2.4 
 
(Q.27) Sensitivity / Competence of Primary Provider  
(M=4.55, SD=1.09) 
  
1. Very Poor 0 0 
2. Poor 1 2.4 
3. Fair 7 17.1 
4. Good 9 22.0 
5. Very Good 15 36.6 
6. Excellent 8 19.5 
7. N/A (I do not receive any health care) 1 2.4 
 
Note that respondents were given the chance to select multiple categories in 
response to Q.24, so these responses were not mutually exclusive. In addition, seven 
participants (17.1%) rated the overall quality of the healthcare they receive (Q.25) as 
Excellent, 20 (48.8%) rated theirs as Very Good; ten (24.4%) rated theirs as Good, and 
three (7.3%) characterized their healthcare as Fair (M=4.78, SD=.83). A single 
respondent said the question was not applicable. Table 2 also shows how this sample of 
men rated the overall quality of care they receive from their primary healthcare provider 
(Q.26): Nineteen (46.3%) rated this care as Very Good, followed by 11 (26.8%) who 
rated theirs as Good. Six (14.6%) rated theirs as Excellent, and another four (9.8%) rated 
theirs as only Fair. One participant responded that the question did not apply to him 
(M=4.68, SD=.86). Finally, Table 2 shows how study participants rated the sensitivity 
and competence of their providers in treating them as an African American (Q.27): 
Fifteen (36.6%) participants selected the Very Good category, nine (22.0%) selected 
  
90 
Good, and eight (19.5%) selected Excellent; the remaining seven (17.1%) chose Fair 
(M=4.55, SD=1.09). 
Part III: Prostate Cancer Scale (PCS-10) 
Tables 3 and 4 present more detailed information on the health status of 
participants (Table 3) and their families (Table 4), specifically in relation to PC 
(Q.28-40). Participants were first asked about themselves. In response to Question 28, 
how many had been told by their physician that they had PC, 37 (90.2%) of the 41 
participants responded that they did not have PC; the other four (9.8%) did (M=1.10, 
SD=.30). Table 3 also shows how many participants had been told by their physician that 
they were at risk for PC (Q.29). Thirty-two (78%) did not have this risk, eight (19.5%) 
had been told that they did, and one participant was unsure (M=1.24, SD=.49). When 
asked (Q.30) if they had had a digital rectal exam, 14 (34.1%) responded negatively, 
while 27 (65.9%), responded positively (M=1.66, SD=.48). Question 31 asked 
participants if they had ever been told by a medical provider that they were going to have 
their PSA measured, to which 25 (61%) participants said no, 14 (34.1%) said yes, and 
2 (4.9%) were not sure (M=1.44, SD=.59). To Question 32, whether participants they had 
ever been told by a medical provider that they were being given a screening test for PC, 
27 (65.9%) said they had not, while 13 (31.7%) participants said yes (M=1.37, SD.54). 
The survey then asked about participants’ family history of PC (Q.33-40). In response to 
Question 33, 29 respondents (70.7%) said they did not know of a family member who 
was diagnosed with PC, while nine (22.0%) did know such a family member, and three 




Table 3. Prostate Cancer Scale (PCS-10) (N=41)     N       % 
(Q.28) Told by physician has PC  
(M=1.10, SD=.30) 
  
1. No 37 90.2 
2. Yes 
 
(Q.29) Told by physician at risk for PC 
 (M=1.24, SD=.49) 
      1. No 
      2. Yes 
      3. Unsure 
 
(Q.30) Had digital rectal exam  
(M=1.66, SD=.48) 
      1. No 
      2. Yes 
 
(Q.31) Going to have PSA measured  
(M=1.44, SD=.59) 
      1. No 
      2. Yes 
      3. Unsure 
 
(Q.32) Told being given a screening test for PC 
(M=1.37, SD=.54) 
     1. No 
     2. Yes 



















































(Q.33) Family member diagnosed with PC  
(M=1.37, Min 1, Max 3, SD=.62) 
  
1. No 29 70.7 
2. Yes 9 22.0 
3. Unsure 3 7.3 
 
The respondents who replied affirmatively to Question 33 were then asked 
Questions 34-40 (Table 4), which focused on the health status of their families in relation 
to PC. Of the participants whose family members did have PC (Q.34), three cases (7.3%) 
were participants’ fathers, followed by 4.9% (n=2) in uncles on the mother’s side, and 
2.4% each (n=1) from the maternal grandfather, paternal grandfather, and brother. Then 
asked (Q.35) whether they knew of a family member who had died of PC, 33 (80.5%) 
participants did not know anyone, while three (7.3%) did know someone and five 
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(12.2%) were unsure (M=1.32, SD=.69). Those who responded positively to Question 35 
(n=4) were then asked (Q.36) which family member had died from PC. One each of those 
four men replied paternal grandfather, uncle mother’s side, grandfather, and father. On 
the other hand, 16 (39%) participants did not know anyone diagnosed with PC (Q.37), 
while 61% (n=25) did know someone (M=1.61, SD=.49). Those who answered yes to 
Question 37 (n=25) were then asked whether they knew anyone who had died of PC, and 
if so, how many people (Q.38). Eight (19.5%) participants replied that they knew one 
person, seven (17.1%) said that they knew two men who had died of PC, and six (14.6%) 
participants replied that they knew four men who had died of PC. One participant knew 
three men who had died of prostate cancer, one knew five, and one knew six, and one 
knew seven or more (M=1.73, SD=1.95). Asked (Q.39) whether they knew anyone who 
had died of PC that had metastasized, 28 (68.3%) participants replied that they did not, 
while 11 (26.8%) did know someone; two participants (4.9%) were unsure (M=1.37, 
SD=.58). Those who answered yes to Question 39 (n=11), were then asked how many 
people they knew who had died from PC metastasis (Q.40). Ten (24.4%) participants 
indicated that they knew one person while one respondent said they knew who people 
who had died from PC (2.4%) (M=1.09, SD=.30). 
 
 
Table 4. Health Status of Participants’ Families (N=41)  N % 
(Q.34) If yes, family member diagnosed with PC (N=9)   
1. Maternal Grandfather 1 2.4 
2. Paternal Grandfather 1 2.4 
3. Father 3 7.3 
4. Uncle Mother’s side 2 4.9 
12. Brother  1 2.4 
14. Other (Father In-law) 1 2.4 
   
(Q.35) Know family member who died of PC 
(M=1.32, SD=.69)  
  
1. No 33 80.5 
2. Yes 3 7.3 
3. Unsure 5 12.2 
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Table 4 (continued) 
(Q.36) If yes, family member who died of PC (N=4) N % 
2. Paternal Grandfather 1 2.4 
4. Uncle Mother’s side 1 2.4 
13. Other - Grandfather 1 2.4 
13. Other - Father 1 2.4 
   
(Q.37) Know someone diagnosed with PC  
(M=1.61, SD=.49) 
  
1. No 16 39.0 
2. Yes 25 61.0 
   
(Q.38) If yes, number of people who died of PC (N=25) 
(M=1.73, SD=1.95) 
  
1 8 19.5 
2 7 17.1 
3 1 2.4 
4 6 14.6 
5 1 2.4 
6 1 2.4 
7 or more 
 



















   
(Q.40) If yes, how many people died from PC metastasis  











Part IV: Scale Measuring Health Literacy via Skills and Self-Efficacy  
(SM-HL-V-S-SE-16)  
Tables 5-9 show the data obtained from Part IV of the survey (Q.41-56). Table 5 
shows how participants rated their ability to perform certain behaviors and their 
confidence level in performing those behaviors (Q.41-44). Table 6 shows participants’ 




Table 5. Seeking Out Health Information/Services (N=41) N % 
(Q.41) For seeking out health information, I rate my ability as: 










3. Fair 4 9.8 
4. Good 8 19.5 
5. Very Good 17 41.5 
6. Excellent 11 26.8 
   
(Q.42) For seeking out health information, I rate my confidence as:  







40% 4 9.8 
60% 4 9.8 
80% 15 36.6 
100% Extremely Confident 16 39.0 
   
(Q.43) For seeking out health services, I rate my ability as: 
(M=4.85, SD=1.11) 
  






3. Fair 3 7.3 
4. Good 7 17.1 
5. Very Good 16 39.0 
6. Excellent 13 31.7 
    









40% 5 12.22 
60% 3 7.3  
80% 






health professional (Q.45-48). Table 7 indicates how well they believe that they really 
understand what they are told by a health professional, are able to communicate and 
make decisions about it, and ask questions that will help them to better understand 
(Q.49-56). For each behavior, participants were asked to rate (1) their ability, and 
(2) their confidence level.  
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Asked how they rated their ability to seek out health information (Q.41), 41.5% (n=17) of 
respondents rated their ability to do this as Very Good, followed by 26.8% (n=11) who 
rated their ability as Excellent, and 19.5% (n=8) who rated theirs as Good (M=4.8, 
SD=1.03). Then asked to rate their confidence level in performing this behavior (Q.42), 
39.0% (n=16) rated themselves as Extremely Confident, and 36.6% (n=15) replied that 
they were 80% Confident; of the remaining 10 respondents, four each chose the 60% and 
40% Confident categories (M=79%, SD=23.2). For seeking out health services (Q.43), 
39.0% (n=16) participants considered their ability as Very Good, and 31.7% (n=13) 
considered theirs Excellent (M=4.85, SD=1.11). Asked how confident they were in 
performing this behavior (Q.44), 46.3% (n=19) rated themselves 80% confident, and 
31.7% (n=13) responded that they were 100%, or Extremely Confident, and 12.22% 
(n=5) selected the 40% category (M=70%, SD=21.2).  
Table 6 (Q.45-48) indicates similar results to those seen in Table 5. In response to 
Question 45, 19 (46.3%) participants rated their ability to communicate and ask questions 
about their health as Very Good, followed by 11 (26.8%) who rated theirs as Excellent, 
and 7 (17.1%) who rated theirs as Good (M=4.83, SD=3.23) (Q.45). Similarly, in answer 
to Question 46, 17 (41.5%) rated their confidence in communicating and asking questions 
about their health at 80% and 14 (34.1%) rated theirs at 100% (Extremely Confident) 
(M=79%, SD=22.5). For thinking about and understanding what they were told by a 
doctor (Q.47), 43.9% (n=18) rated their ability as Very Good, followed by 24.4% (n=10) 
as Excellent and 22% (n=9) as Good (M=4.80, SD=3.10). Rating the level of their 
confidence in thinking about and understanding what they were told by a health provider 
(Q.48) yielded similar results: 41.5% (n=17) rated their confidence level as 80%, 29.3% 










(Q.45) For communicating and asking questions about my health, I 






1. Very Poor 1 2.4 
2. Poor 1 2.4 
3. Fair 2 4.9 
4. Good 7 17.1 







(Q.46) For communicating and asking questions about my health, I 









40% 1 2.4 
60% 6 14.6 
80% 17 41.5 
100% Extremely Confident 14 34.1 
   
(Q.47) For thinking about, understanding what I was told by a 
health provider, I rate my ability as:  
(M=4.80, SD=3.10) 
  






3. Fair 3 7.3 
4. Good 9 22.0 
5. Very Good 18 43.9 
6. Excellent 10 24.4 
   
 (Q.48) For thinking about, understanding what I was told by a 
health provider, I rate my confidence as:  











60% 9 22.0 
80% 17 41.5 




Table 7 (Q.49-50) indicates how well participants believed that they really 
understand what they are told by a health professional, are able to communicate and 
make decisions about it, and ask questions that will help them to better understand. 
Nearly half (43.9%, n=18) of the 41 men rated their ability to truly understand what they 
were told by a health professional (Q.49) as Very Good, while 31.7% (n=13) considered 
themselves Excellent at this, and 22.0% (n=9) rated their ability as Good (M=5.05, 
SD=.81). Similarly, 43.9% (n=18) rated their confidence in this (Q.50) as 80%, with 
36.6% (n=15) as 100% (Extremely Confident), followed by 17.1% (n=7) who rated their 
confidence level as 60% (M=83%, SD=15.8). 
 
Table 7. Really Understanding Healthcare Provider (N=41) N % 
(Q.49) For really understanding what I was told by a health 
provider, I rate my ability as:  
(M=5.05, SD=.81) 
  









4. Good 9 22.0 
5. Very Good 18 43.9 
6. Excellent 13 31.7 
   
(Q.50) For really understanding what I was told by a health 












60% 7 17.1 
80% 18 43.9 
100% Extremely Confident 15 36.6 
 
Table 8 shows how well participants thought they memorized and were able to 
repeat out loud what they had been told by a health provider, as well as how good they 
thought they were at asking questions about their health (Q.51-54). Nearly half (43.9%, 
n=18) rated their ability to memorize and repeat what they had been told (Q.51) as Very 
Good, while 29.3% (n=12) rated theirs as Good and 19.5% (n=8) rated theirs as Excellent 
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(M=4.76, SD=.86). Similarly, 48.8% (n=20) of participants rated their confidence level in 
this behavior (Q.52) at 80%, while 26.8% (n=11) rated theirs at 100% (Extremely 
Confident) (M=79%, SD=17.3). For their ability to ask questions that would help them to 
better or completely understand what a health professional explained to them (Q.53), 
46.3% (n=19) of participants rated their ability as Very Good, higher than the 26.8% 
(n=11) each for Good and Excellent (M=5.00, SD=.74); and for their confidence in doing 
this (Q.54), 46.3% (n=19) rated their confidence level at 80%, and 26.8% (n=11) rated 
theirs as 100% and, equally, at 40% (M=80%, SD=14.8).  
 






(Q.51) For being able to memorize and repeat out loud what I was 
told by a health provider, I rate my ability as: 
(M=4.76, SD=.86)  
  









4. Good 12 29.3 
5. Very Good 18 43.9 
6. Excellent 8 19.5 
   
 (Q.52) For being able to memorize and repeat out loud what I 
was told by a health provider, I rate my confidence as:  











60% 7 17.1 
80% 20 48.8 
100% Extremely Confident 
 
11 26.8 
(Q.53) For being able to ask questions that will help me 













4. Good 11 26.8 
5. Very Good 19 46.3 
6. Excellent 11 26.8 
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Table 8 (continued) 
 N % 
(Q.54) For being able to ask questions that will help me 
understand what a health provider explained to me, I rate my 










0   
0 
60% 11 26.8 
 80% 19 46.3 
100% Extremely Confident 11 26.8 
 
Table 9 shows participants’ self-reported ability to make the best health decisions 
for themselves, take the best health-related actions, and tell a health professional what 
they decided to do, needed to do, or preferred to do (Q.55-56). In response to 
Question 55, 19 (46.3%) of participants rated their ability as Very Good, 11 (26.8%) 
rated theirs as Excellent, nine (22%) considered their ability as Good, and two (4.9%) 
thought they were only Fair (M=4.95, SD=.84). Question 56 asked the men to evaluate 
their confidence in the answers they gave to Question 55. Eighteen (43.9%) rated 
themselves as 80% confident, and 13 (31.7%) considered themselves 100% confident 
(M=80%, SD=17.0).  
 
Table 9. Health Decisions and Actions (N=41) N % 
(Q.55) For making the best health decisions for myself, deciding 
what actions I should take, I would rate my ability as: 
(M=4.95, SD=.84) 
  









4. Good 9 22.0 
5. Very Good 19 46.3 
6. Excellent 11 26.8 
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Table 9 (continued) 
 N % 
(Q.56) For deciding what actions I should take, and telling a 
health professional what I have decided to do, need to do, or 












60% 8 19.5 
80% 18 43.9 
100% Extremely Confident 13 31.7 
Part V: Prostate Cancer Screening Empowerment Scale Measuring Stage of Change 
and Self-efficacy for Four Behaviors—Pre-video (PCS-ES-M-SOC-SE-PRE-V-4) 
Tables 10-12 present results from Questions 57-64 of the survey, which measured 
stages of change and self-efficacy in the men before watching the video. Table 10 shows 
the answers to Questions (Q.57-60). Question 57 asked participants about their behavior 
and their confidence in going to see a medical provider and getting a physical 
examination at least once a year. To this question, 23 men (56.1%) responded positively 
to the more-than-6-months option, followed by nine men (22.0%) who were thinking 
about it (M=3.93, SD=1.35). Question 58 followed up by asking participants to rate their 
confidence level in performing this behavior. Twenty-two (53.7%) men selected 100% 
(Extremely Confident), while 10 (24.4%) responded that they were 80% confident, and 
another 7 (17.1%) participants rated their confidence level at 60% (M=85%, SD=19.9). 
Question 59 asked participants about their behavior in discussing with their medical 
provider whether they should receive a digital rectal examination to screen for prostate 
cancer. In response, 13 (31.7%) participants selected the “more than 6 months” category, 
while seven (17.1%) responded that they were thinking about it, and six (14.6%) selected 
each of the following categories: Not thinking about it, Preparing to, and Less than 6 
months (M=3.59, SD=1.70). Question 60 rated participants’ confidence level in 
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performing the behavior described in Question 59. Thirteen (31.7%) participants 
responded that they were 100% confident, eight (19.5%) each selected the 80% and 60% 
confident categories, five (12.2%) chose the 20% confident category; and the others were 
split among the remaining categories (M=67%, SD=33.2). 
 
Table 10. Going to Medical Provider for Physical (N=41) N % 
(Q.57) When it comes to the behavior of going to see a medical 
provider and getting a physical exam at least once a year, check the 
following that most applies to you: 
(M=3.93, SD=1.35) 
  
1. Not thinking about doing this 1 2.4 
2. Thinking about doing this 9 22.0 
3. Preparing to do this 5 12.2 
4. Less than 6 months 3 7.3 
5. More than 6 months 23 56.1 
   
(Q.58) When it comes to the behavior of going to see a medical 
provider and getting a physical exam at least once a year, HOW 









3. 40% 1 2.4 
4. 60% 7 17.1 
5. 80% 10 24.4 
6. 100% Extremely Confident 22 53.7 
   
(Q.59) When it comes to the behavior of discussing with your medical 
provider whether you should receive a digital rectal exam to screen 
for PC, check the following that most applies to you: 
(M=3.34, SD=1.51) 
  
1.Not thinking about doing this 6 14.6 
2. Thinking about doing this 7 17.1 
3. Preparing to do this 6 14.6 
4. Less than 6 months 6 14.6 
5. More than 6 months 13 31.7 
6. N/A: I have PC and already know my status 1 2.4 
7. N/A: I have had PC previously 2 4.9 
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Table 10 (continued) 
(Q.60) When it comes to the behavior of discussing with your medical 
provider about whether you should receive a digital rectal 
examination to screen for prostate cancer, HOW CONFIDENT ARE 
YOU in performing this behavior: 
(M=67%, SD=33.2) 
N % 
1. 0% 3 7.3 
2. 20% 5 12.2 
3. 40% 2 4.9 
4. 60% 8 19.5 
5. 80% 8 19.5 
6. 100% Extremely Confident 13 31.7 
7. N/A: I have PC and already know my status 1 2.4 
8. N/A: I have had PC previously 1 2.4 
 
Table 11 covers participants’ responses to questions about PSA testing (Q.61-62). 
The responses to Question 61 were relatively spread out: eight (19.5%) men were not 
thinking about discussing PSAs with their doctor, nine (22.0%) were thinking about it, 
nine (22.0%) were preparing to, five (12.2%) selected “less than 6 months,” and nine 
(22.0%) selected “more than 6 months”; the remaining respondent had already had 
prostate cancer (M=3.05, SD=1.56). Question 62 rated the men’s confidence level in 
discussing with their medical provider whether they should receive a PSA test, to which 
the responses were more clustered: 14 (34.1%) characterized themselves 100% 




Table 11. Discussing PSA Testing with Medical Provider (N=41) N % 
(Q.61) When it comes to the behavior of discussing with your 
medical provider whether you should receive a PSA test to screen 
for PC, check the following that most applies to you: 
(M=2.95, SD=1.45) 
  
1. Not thinking about doing this 8 19.5 
2. Thinking about doing this 9 22.0 
3. Preparing to do this 9 22.0 
4. Have been doing this for less than 6 months 5 12.2 
5. Have been doing this for more than 6 months 9 22.0 
6. N/A: I have had PC previously 1 2.4 
   
(Q.62) When it comes to the behavior of discussing with your 
medical provider about whether you should receive a PSA test to 




0% 1 2.4 
20% 3 7.3 
40% 4 9.8 
60% 6 14.6 
80% 12 29.3 
100% Extremely Confident 14 34.1 
N/A: I have had PC previously 1 2.4 
 
Table 12 shows participants’ self-reported behavior and confidence in relation to 
spreading awareness among other African American men about the need for PC 
screening. In response to Question 63, nine (22.0%) participants said they were not 
thinking about it, 11 (26.8%) said they were thinking about it, 13 (31.7%) said they were 
preparing to, and seven (17.1%) selected the more-than-6-months category (M=2.66, 
SD=1.33). Question 64 rated participants’ confidence in performing the behavior 
described in Question 63. In response, 12 (29.3%) rated their confidence at 80%, while 
11 (26.8%) scored themselves as 100% confident. These were followed by nine (22.0%) 
who selected the 60% confident category and five (12.2%) who placed their confidence at 






Table 12. Behavior of Spreading Awareness (N=41) N % 
(Q. 63) When it comes to the behavior of spreading awareness 
among other African American men about the need for PC 
screening, check the following that most applies to you: 
(M=2.66, SD=1.33) 
  
1.Not thinking about doing this 9 22.0 
2.Thinking about doing this 11 26.8 
3.Preparing to do this 13 31.7 
4.Have been doing this for less than 6 months 1 2.4 
5.Have been doing this for more than 6 months 7 17.1 
   
(Q. 64) When it comes to the behavior of spreading awareness 
among other African American men about the need for prostate 




0% 3 7.3 
20% 1 2.4 
40% 5 12.2 
60% 9 22.0 
80% 12 29.3 
100% Extremely Confident 11 26.8 
Part VI: Dose of Exposure to Video (DOE-TV-1) 
Asked how much of the Avatar video they had watched (Q.65), the participants 
responded as shown in Table 13 below: 35 (85.4%) said they watched the entire video, 
while six (14.6%) said that they watched most of it. No one replied that they had watched 
less than that (M=3.85, SD=.36). 
 
Table 13. Amount of Exposure to Video (N=41) N % 
(Q.65) Watched how much of video: 
(M=3.85, SD=.36) 
  
1. None 0 0 
2. Some 0 0 
3. Most 6 14.6 
4. All 35 85.4 
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Part VII: Rate the Video (RTV-1) 
After watching the video, participants were asked to rate the information presented 
in it (Q.66). Table 14 below shows that 17 (41.5%) of the 41 men rated the information as 
Excellent, while 15 (36.6%) rated it as Very Good, and six (14.6%) rated it Good. Three 
(7.3%) others rated it as only Fair; no one rated it less than Fair (M=5.12, SD=.93). 
 
Table 14. Rate the Video (N=41) N % 
(Q.66) Rate information shared in the video 
(M=5.12, SD=.93) 
  
1. Very poor 0 0 
2. Poor 0 0 
3. Fair 3 7.3 
4. Good 6 14.6 
5. Very good 15 36.6 
6. Excellent 17 41.5 
Part VIII: Prostate Cancer Screening Empowerment Scale Measuring Stage of 
Change and Self-efficacy for Four Behaviors—Post-video 
(PCS-ES-M-SOC-SE-POST-V-4) 
Table 15 presents participants’ post-video responses to questions (Q.67-68), about 
their behaviors and confidence in relation to getting an annual physical exam. Twenty-
two (53.7%) expected to see a medical provider and get a physical examination at least 
once a year. Twenty-two men (53.7%) said they had been doing this behavior for more 
than six months; another eight (19.5%) said they were preparing to do this, and five 
(12.2%) said they were thinking about doing so (M=3.95, SD=1.30). When asked about 
their confidence in performing this behavior (Q.68), the majority (n=23; 56.1%) were 
100% confident that they could do so; another 11 (26.8%) were 80% confident that they 





Table 15. Behavior of Getting a Physical (N=41) N % 
(Q.67) When it comes to getting a physical exam at least once a 
year, check the following that most applies to you: 
(M=3.95, SD=1.30) 
  
1. Not thinking about doing it  2 4.9 
2. Thinking about doing it 5 12.2 
3. Preparing to do it 8 19.5 
4. Have been doing this for less than 6 months 4 9.8 
5. Have been doing this for more than 6 months 22 53.7 
   
(Q.68) When it comes to getting a physical exam at least once a 




0% 0 0 
20% 0 0 
40% 1 2.4 
60% 6 14.6 
80% 11 26.8 
100% Extremely Confident 23 56.1 
 
Table 16 shows participants’ responses to Questions 69-72, about their behavior 
and confidence in discussing with a medical provider whether to receive a digital rectal 
examination or a PSA test to screen for PC. Asked whether/how often they do this, 12 
(29.3%) replied that they are preparing to do this, and another 12 (29.3%) replied that 
they have been doing this for more than six months. Five (12.2%) participants said they 
were not thinking about it, and another five (12.2%) said they were thinking about it 
(M=3.32, SD=1.42). In response to Question 70—how confident they were in performing 
the behavior of discussing with their medical provider whether they should receive a 
digital rectal examination to screen for PC—14 (34.1%) selected 100% confident and 
another 14 selected the 80% confident category. The other responses were scattered 
throughout the other options (M=77%, SD=28.3). Then asked (Q.71) about their behavior 
in discussing with their medical provider whether they should receive a PSA test, 39.0% 
(n=16) said they were preparing to do this, and 22.0% (n=9) said they had been doing this 
for more than six months. Another five (12.2%) participants said they were thinking 
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about doing it (M=3.21, SD=1.27). The participants were then asked (Q.72) how 
confident they were in performing this behavior. Once again, most participants rated 
themselves highly in this regard: 17 (41.5%) chose the 100% confident category and 13 
(31.7%) selected 80% (M=81%, SD=24.1). 
 
Table 16. Behavior of Discussing with a Medical Provider (N=41) N % 
(Q.69) When it comes to the behavior of discussing with your medical 
provider whether you should receive a digital rectal examination to 
screen for PC, check the following that most applies to you: 
(M=3.32, SD=1.42) 
  
1. Not thinking about doing it 5 12.2 
2. Thinking about doing it 5 12.2 
3. Preparing to do it 12 29.3 
4. Have been doing this for less than 6 months 3 7.3 
5. Have been doing this for more than 6 months 12 29.3 
6. N/A: I have PC and already know my status 2 4.9 
7. N/A: I have had PC previously 2 4.9 
   
(Q.70) When it comes to the behavior of discussing with your medical 
provider whether you should receive a digital rectal examination to 



















100% Extremely Confident 





8. N/A: I have had PC previously  2 4.9 
 
(Q.71) When it comes to the behavior of discussing with your medical 
provider whether you should receive a PSA test to screen for PC, check 
the following that most applies to you: 
(M=3.21, SD=1.27) 
  
1. Not thinking about doing it 4 9.8 
2. Thinking about doing it 5 12.2 
3. Preparing to do it 16 39.0 
4. Have been doing this for less than 6 months 3 7.3 
5. Have been doing this for more than 6 months 9 22.0 
6. N/A: I have PC and already know my status 2 4.9 




Table 16 (continued)    
(Q.72) When it comes to discussing with your medical provider whether 
you should receive a PSA test to screen for PC, HOW CONFIDENT 
ARE YOU in performing this behavior: 
(M=81%, SD=24.1) 
  
0% 1 2.4 
20% 1 2.4 
40% 2 4.9 
60% 4 9.8 
80% 13 31.7 
100% Extremely Confident 17 41.5 
7. N/A: I have PC and already know my status 1 2.4 
8. N/A: I have had PC previously 2 4.9 
 
Table 17 shows participants’ self-reported behavior and confidence in relation to 
spreading awareness among other African American men about the need for PC 
screening (Q.73-74). Asked whether/how often they were thinking about spreading such 
awareness, 41.5% (n=17) said they were preparing to do so (Q.73), 29.3% (n=12) 
responded that they were thinking about doing it, and 17.1% (n=7) said they had been 
doing so for more than six months, while two others (4.9%) said that they had been 
spreading awareness for less than six months. Only three (4.3%) said that they were not 
thinking about doing so (M=2.95, SD=1.16). Asked how confident they were in 
performing this behavior (Q.74), 16 (39.0%) rated their confidence level as 100%, and 
another 13 (31.7%) rated their confidence at 80%, while six (14.6%) participants 
considered their confidence level to be 60% (M=78%, SD=24.6). 
 
Table 17. Spreading Awareness (N=41) N % 
(Q.73) When it comes to spreading awareness among other AA men 
about the need for PC screening: 
(M=2.95, SD=1.16) 
  
1. Not thinking about doing it 3 7.3% 
2. Thinking about doing it 12 29.3% 
3. Preparing to do it 17 41.5% 
4. Have been doing this for less than 6 months 2 4.9%  
5. Have been doing this for more than 6 months 7 17.1% 
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Table 17 (continued) N % 
(Q.74) When it comes to spreading awareness among other AA men 
about the need for PC screening, HOW CONFIDENT ARE YOU in 
performing this behavior: 
(M=78%, SD=24.6) 
  
0% 0 0% 
20% 3 7.3% 
40% 3 7.3% 
60% 6 14.6% 
80% 13 31.7% 
100% Extremely Confident 16 39.0% 
Part IX: Movements in Stages of Change to Perform the Four Target Behaviors 
Table 18 shows the paired t-test results based on Part V and Part VIII of this 
research that explores stage of change in the four target behaviors. To measure movement 
across the stages of change, paired t-tests were carried out for four pairs of questions that 
compared the change, or difference, between the pre- and post-scores for the target 
behaviors. The mean values and standard deviations were then compared for each 
question, and the t values, mean difference, and p values (Sig. 2 tailed) of each pair were 
obtained. While sample size N equals 41, some pairs were made with fewer observations 
because pairwise deletion was used. The use of pairwise deletion means that some of the 











































*Sig. (2-tailed)<0.05. All values above 0.05 are considered non-significant and only those below 
0.05 are considered statistically significant. 
Note the smaller n (<41) for some pairs is a result of a missing pre- or post-score since pairwise 
deletion was used. 
Each pair in table 18 is a change score, or a mean difference in an outcome that was measured both 
before (pre) and after (post) the intervention. Pair 1 refers to the change score of Q.67-Q.57 
(getting a physical exam at least once a year), pair 2 refers to the difference between Q.69 and Q.59 
(discussing with doctor about receiving a digital rectal exam), pair 3 refers to the difference 
between Q.71 and Q.61 (discussing with doctor about receiving a PSA test), and pair 4 refers to the 






means and SDs reported in table 18 are different that the means and standard deviations 
reported in earlier sections because if any respondent was missing a measurement, either 
pre- or post-, then that individual (and their scores on both pre- and post-measures) were 
dropped from the analysis. The significance level was set at 0.05 for the two-tailed 
hypothesis test (results shown in Table 18), statistically significant improvements are 
denoted with an asterisk (*) on each relevant p value. 
The test results reveal that participants showed significant improvement in their 
behavior for two of the four target behaviors. In particular, this study has found 
statistically significant improvements in the behavior of discussing receiving a PSA test 
with their doctor (t(37)=2.115, p-value=.041) and the behavior of spreading awareness of 
PC among other African American men (t(41)=2.221, p-value=.032). No significant 
results were found for the behavior of getting an annual physical exam (t(41)=.167, p-
value=.868) or the behavior of receiving a digital rectal examination (t(37)=.000, p-
value=1). Cohen’s d is used to measure the magnitude of these effects. As per Cohen’s 
(1988) guidelines, the estimated effect sizes for the behavior of getting a PSA year (d =  
.306) and spreading awareness of PC screening among African American men (d = .234) 
would be considered small effects. In sum, there is strong evidence that the e-health 
intervention created in this study significantly improved the stages of change for two of 
the four target behaviors.  
Part X: Movements in Self-Efficacy to Perform the Four Target Behaviors 
Table 19 shows the paired t-test results based on Part V and Part VIII of this 
research that explore changes in self-efficacy. To measure changes in self-efficacy, 
paired t-tests were carried out for four pairs of questions that compared the change, or 
difference, between the pre- and post-scores for confidence regarding the four target 
behaviors. The mean values and standard deviations were then compared for each 
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question, and the t values, mean difference, and p values (Sig. 2 tailed) of each pair were 
obtained. As in part IX, pairwise deletion means that some of the means and SDs 
reported in Table 19 are different that the means and standard deviations reported in 
earlier sections because if any respondent was missing a measurement, either pre- or 
post-, then that individual were dropped from the analysis.  
A significant and positive change was detected in self-efficacy for carrying out 
three of the four target behaviors. Specifically, participants reported more confidence in 
discussing the potential of screening for PC via either a digital rectal exam (t(36)=3.011, 
p-value=.005) or taking a PSA exam (t(38)=2.431, p-value=.020) as well as their ability 
to spread awareness among AA men (t(41)=2.959, p-value=.005). No significant change 
in confidence was detected for the behavior of going and receiving an annual physical 
examination (t(41)=.819, p-value=.418).  The three significant effects for changes in self-
efficacy in getting a digital rectal exam (d = .354), getting a PSA exam (d =.302), and 
spreading awareness among African American men (d = .327) all represent small effects. 
In summary, this study found that the avatar video instrument significantly improved 
participants self-efficacy for three of the four target behaviors. Importantly, these three 
behaviors were the ones associated with PC screening. 











































*Sig. (2-tailed)<0.05. All values above 0.05 are considered non-significant and only those below 0.05 are 
considered statistically significant. 
Note the smaller n (<41) for some pairs is a result of a missing pre- or post-score since pairwise deletion 
was used. 
Each pair in table 18 is a change score, or a mean difference in an outcome that was measured both before 
(pre) and after (post) the intervention. Pair 1 refers to the difference between Q.68 and Q.58 (confidence in 
getting a physical exam at least once a year), pair 2 refers to the difference between Q.70 and Q.60 
(confidence in discussing with doctor about receiving a digital rectal exam), pair 3 refers to the difference 
between Q.72 and Q.62 (confidence in discussing with doctor about receiving a PSA test), and pair 4 refers 




Part XI: Relationship between Demographic Variables and Other Study Scales with 
the Target Behavior of Going to Get a PSA Test to Screen for PC (Pre-measure) 
Part XI of this study considers the association between receiving a PSA exam 
(Q.61) to screen for PC and participant characteristics. Q.61 represents the pre-measure 
of this variable, so by considering the association of this variable before the intervention 
the findings are more generalizable to African American men in the population since the 
measurement of this variable would not be affected by the e-health intervention. Since 
Q.61 is measured on the ordinal scale level (as can be seen in part V of this dissertation), 
Spearman’s rank correlation coefficient was used to assess the association between Q.61 
and participant characteristics. Specifically, this section considers the relationship 
between Q.61 and participant characteristics, which include selected demographic 
characteristics, health status, and participant health literacy (ability and self-efficacy) 
measures. 
Table 20 shows the Spearman correlation between participant demographic 
characteristics and Q.61.2 Both age (ρ=.442) and educational level (ρ=.324) have positive 
and statistically significant relationships with Q.61. This shows that older study African 
American males were more likely to be in an action or maintenance stage concerning the 
behavior of receiving a PSA exam to screen for prostate cancer. Furthermore, participants 
with higher levels of education were more likely to get a PSA exam to screen for PC. 
Both significant effects make theoretical sense; as men become older PC becomes a 
larger threat and we would expect older men to be more proactive in preventative 
screening of PC. Achieving higher levels of education is also widely assumed to lead to 
more preventative health behaviors. Surprisingly, there was no significant relationship 
                                                 
2Other demographic variables were not considered for various reasons. For example, there 
was no variation in the race/ethnicity variable (Q.12) while the relationship status (Q.11) and 
employment (Q.19) variables were categorical (not measured on a numeric or ordinal scale) since 
they gave respondents the option to select multiple categories. 
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between income and Q.61, though the effect size (ρ=.260) was far from zero, suggesting 
that if the study sample had been larger this relationship would likely have been 
significant.  
 
Table 20. Spearman’s Correlation Coefficient between Being in Action or Maintenance 








(N=40, significance level=0.05, two-tailed hypothesis test) 
*Sig. (2-tailed)<0.05. All values above 0.05 are considered non-significant and only 
those below 0.05 are considered statistically significant. 
Each question represents a different variable in this study: Q.10 measures age, Q.17 
measures participant income, and Q.18 measures the highest educational attainment for 
each participant. 
There was no significant relationship between Q.61 and most health measures 
recorded in this study, as can be seen in Table 21. The lone exception was the positive 
relationship observed between Q.25 and Q.61 (ρ= .324)—as participants viewed their 
overall quality of healthcare as better, they were more likely to have had a PSA exam to 
screen for prostate cancer. Although not statistically significant, a positive relationship 
was found for overall self-rated quality of care received from primary care provider and 
the degree of perceived sensitivity and competence for treating African Americans by the 
healthcare providers, as compared to the care provided to whites. This study also found a 
negative relationship between BMI, weight-self rating and overall health status. These 
negative correlations are sensible: healthier participants were less likely to go in for a PC 
screening while participants who weighted themselves as more obese were also less 

























Table 21. Spearman’s Correlation Coefficient between Being in Action or Maintenance 










*Sig. (2-tailed)<0.05. All values above 0.05 are considered non-significant and only 
those below 0.05 are considered statistically significant. 
Each question represents a different variable in this study: Q.20 measures overall health 
status, Q.21/22 asked about height and weight and was used to make a measure of BIM, 
Q.23 measures weight self-rating, Q.25 measures a self-reported quality of care received 
for the participants’ health/medical condition, Q.26 measures the overall self-rated 
quality of care received from primary care provider, and Q.27 measures the degree of 
perceived sensitivity and competence for treating African Americans by the healthcare 
providers, as compared to the care provided to whites.  
 
This study also considered the participant’s ability to carry out a range of health-
related behaviors. As seen in Table 22, all variables that measured health-literacy 
behaviors had a positive relationship with the behavior of going to get a PSA exam, as 
expected, even though only a few areas of health-literacy ability had a significant 
relationship with Q.61. In particular, Q.41 (ability to seek out health information), Q.43 
(ability to seek out health services), and Q.47 (ability to understand what a health 
professional has told them) all had significant relationships. A few other variables (Q.49, 
Q.53, and Q.55) were close to significance but the small sample size resulted in 



































Table 22. Spearman’s Correlation Coefficient between Being in Action or Maintenance 













*Sig. (2-tailed)<0.05. All values above 0.05 are considered non-significant and only 
those below 0.05 are considered statistically significant. 
Each question represents a different variable in this study: Q.41 measures ability to seek 
out health information, Q.43 measures ability to seek out health services, Q.45 measures 
ability to communicate with a health professional, Q.47 measures ability to think about 
what a health professional has communicated to them, Q.49 measures ability to 
understand what a health professional has told them, Q.51 measures ability to memorized 
and repeat out loud what a health professional has told them, Q.53 measures ability to ask 
probing questions to a health professional, and Q.55 measures ability to make the best 
health decisions for oneself.  
 
Finally, Table 23 shows the association between receiving a PSA exam and 
participants’ confidence in carrying out a range of health-related behaviors. Similar to the 
findings of this study for health-literacy ability, all measures for confidence in health-
literacy behaviors were positively related to the behavior of getting a PSA exam. Four of 
the eight measures of confidence in health-literacy behaviors were significantly related to 
Q.61: confidence in seeking out health information (Q.42), confidence in seeking out 
health professionals (Q.44), confidence to think about what a health professional told 












































Table 23. Spearman’s Correlation Coefficient between Being in Action or Maintenance 














*Sig. (2-tailed)<0.05.  
Each question represents a different variable in this study: Q.42 measures confidence to 
seek out health information, Q.44 measures confidence to seek out health services, Q.46 
measures confidence to communicate with a health professional, Q.48 measures 
confidence to think about what a health professional has communicated to them, Q.50 
measures confidence to understand what a health professional has told them, Q.52 
measures confidence to memorized and repeat out loud what a health professional has 
told them, Q.54 measures confidence to ask probing questions to a health professional, 
and Q.56 measures confidence to make the best health decisions for oneself.  
Part XII: Predicting the Target Behavior of Going to Get a PSA Test 
to Screen for Prostate Cancer (Pre-measure) 
Table 24 shows the result for four multiple regression models. The dependent 
variable was the behavior of discussing with medical provider screening for prostate 
cancer via PSA test (Q.61) and was measured on a 5-point ordinal scale: (1) I am not 
thinking of doing this behavior at all, (2) I am thinking about doing this behavior, (3) I 
am preparing to do this behavior, (4) I have been doing this behavior less than six 
months, and (5) I have been doing this behavior for more than six months. Q.61 was a 
pre-intervention measure and thus was not contaminated by the intervention/study. Four 
models were created by regressing Q.61 on a subset of variables: Model 1 included 
demographic variables, model 2 included health status variables, model 3 included a set 











































stepwise regression analysis. No models violated the assumptions of normally distributed 
and constant variance of the errors. In all cases, listwise deletion was used; Table 24 
includes the number of cases that were include in each model, the R2, and the F-test.3  
Model 1 had an R2 of .359 and a significant F-test and used demographic variables 
as the covariates. Age (p-value = .011) and years of education (p-value = .015) were 
significant while income (p-value = .903) and married (p-value = .148) were not. The 
direction of all relationships was as anticipated, age, education and being married were 
positively related with the Q.61. The estimate for income (β=.000) was basically 0, which 
might be explained by low variability in this measure since this study oversampled high 
income individuals. In model 4, the backward stepwise regression, none of the 
demographic variables were retained in the final model. 
Model 2 explored the relationship between Q.61 and health status; it had a 
significant R2 of .391. Model 2 had a few significant predictors, including overall health 
status (p-value = .015), private insurance (p-value = .027), overall quality of health care 
for participants’ health/medical conditions (p-value = .002), and overall quality of health 
care from health care provider (p-value = .032). BMI (p-value = .521), weight self-rating 
(p-value = .891) and the sensitivity and competence of the health care provider for 
treating African Americans were not significant (p-value = .305). The direction of all 
relationships was as expected, except for the negative association between the DV and 
quality of overall health care for medical condition. The negative relationship of Q.26 is 
likely due to how the model is specified: even though its partial relationship appears 
                                                 
3 Not all of the variables shared in earlier parts of the findings section could used. For 
example, race could not be used in regressions because there was no variation in this measure (40 
participants indicated that they were black/African American while a single respondent indicated 
that they mixed race). For employment status and relationship status, most of the categories were 
omitted due to small groups in most categories. Uneven response distributions prevented the use 
of other variables in later models, such as the death of a father (n=1) or brother (n=0) from 
prostate cancer in the third model.   
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negative in the model, in part XI this study found its raw Spearman correlation with the 
DV to be positive (ρ= .266). 
Model 3 considered the relationship of a subset of health-history variables with the 
behavior of receiving a PSA exam; it had an R2 of .618 and had a significant F-test. Two 
of the four regressors showed a positive and significant relationship with the DV: having 
a digital rectal exam (p-value = .002) and being screened by doctor for prostate cancer 
(p-value = .002). The other two variables, being told by doctor that they are at risk of 
prostate cancer (p-value = .467) and having a family member that died of PC (p-value = 
.937), did not have a significant association with Q.61. The higher R2 in this model (as 
compared to models 1 and 2) suggests that the two significant variables, receiving a 
digital rectal exam and being screened for PC by a doctor, were the independent variables 
that had the strongest relationship with the DV in this study. This is supported by the 
backward stepwise regression analysis carried out by model 4, which converged on a 
solution where two of the four variables it kept were variables measuring health-history. 
Backward stepwise regression works by starting with a full model of all variables 
and then iteratively deleting one variable at a time based on some model fit statistic. 
Model 4 started with four demographic variables, seven health-status variables, and four 
health-history variables. In the end, the model converged on a solution with only four 
independent variables: BMI (p-value = .018), having private insurance (p-value = .001), 
receiving a digital rectal exam (p-value < .001), and being screened for PC by a doctor 
(p-value < .001). All four independent variables were significant at the .05 level, and 
these results are theoretically sound. The high R2 means the combination of the three 
covariates explains 76.9% of the variation in the behavior of getting a PSA exam to 




                                                 
4 This variable was scaled to the thousands of US dollars.  
Table 24: Regression Models between Receiving PSA Exam (Pre) and Selected Covariates 





   
Married (Q.11) .674 
(.455) 
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Sensitivity of Primary 





Risk of Prostate Cancer 
(Q.29) 
  .279 
(.378) 
 
Had a Digital Rectal 
Exam (Q.30) 




Screened by Doctor for 
PC (Q.32) 




Family Member that 
Died of PC (Q.35) 











N 40 38 35 33 
R2 .359 .391 .618 .769 




Part XIII: Intention to Engage in Diffusion of the Innovation 
of Watching the Avatar Video (DIWV-2) 
Table 25 displays participants’ intention to recommend or not recommend the 
educational Avatar video to other men (Q.75). The overwhelming majority (39, 95.1%) 
of participants said that they will recommend it; only two (4.9%) said that they will not. 
 
Table 25. Video Recommendation (N=41) N % 
(Q.75) Will you recommend the avatar video to other men? 
(M=1.05, SD=.22) 
  
1. Yes 39 95.1 
2. No   2   4.9 
 
Table 26 presents the qualitative data produced by this PC research and shows the 
opinions and feedback (Q.76) of all 41 participants on the Avatar video. The opinions 
were mostly positive and many of the participants indicated that they intended to share 
the knowledge gained, or even the video itself, with other African American men they 
knew. Some of the most common reasons for sharing the e-health video included how 
accessible it was, the clear and direct manner of how the content was communicated, and 
how informative it really was. As one respondent replied, the e-health video was 
“informative, culturally competent and forces one to analyze thoughts and behaviors.” On 
the negative side, there were a few respondents how thought the animation/acting could 
have been improved – but even so, the majority thought the e-health video production 
was good for what it aimed to achieved. A few respondents indicated that they were 
going to share the tool with others, with one saying they posted it to their Facebook wall, 
and also indicated that were part of a cancer support group. In summary, responses to the 
open-ended question (Q.76) suggests that the majority of participants that were involved 
in this study do intend to share the e-health video with other others. 




Table 26. Intention to Engage in Diffusion of the Innovation of Watching the Avatar 
Video (DIWV-2) 
(Q.76) Why would you recommend or not recommend the video cartoon to others? Please 
explain why or why not. What other comments do you have? 
 It is very clear and to the point. 
 It is direct with great facts about why we should get screened 
 YES 
 It made it all very easy to understand 
 I do not feel alot of the information it being shared or black male going to doctors 
where they could get the information. 
 It is a good educational tool. 
 video explained African American men are most vulnerable. very straight forward 
regarding our fears of getting an examination. 
 This video was tremendously informative, culturally competent and forces one to 
analyze thoughts and behaviors. 
 Video is highly informative and information is crucial and prudent to all African 
American men as they have the highest tendency to be stricken with prostate 
cancer 
 My age group is very young for this video. I also don’t believe this video was 
more able to communicate to me in a mature manner then others out there. 
 I would recommend the video because I feel its informative and relatable 
 I would recommend because it is simple and straight to the point. The graphics are 
also easy to internalize as opposed to reading dense material about it. 
 I think this is a good video as it speak to the younger men or younger men and 
this is a population that is most at risk 
 It provides awareness that is accessible to all types of black men, regardless of 
educational history. 
 Not many men i know have access or the ability to use the internet. 
 EVEN THOUGH ITS A CARTOON, IT’S VERY INFORMATIVE 
 This information is very helpful to community 
 It is highly informative and very good, great job!! 
 The animation was perfect. The voice talent could have been much better. 
 The facts in the video are true and to the point 
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Table 26 (continued) 
 Well the cartoon was kinda cute, but when it comes to educating our black 
brothers and sisters we need to go straight to the point, that’s why it should have 
been done with regular black men, real men discussing, and talking about rectal 
checking, and how they really feel about that procedure, but still giving the life or 
death situation, I think they will choose life, because in the real life video, we will 
identify ourselves as one of the guys in the video. 
 I love my brothers and want them to live long productive lives. 
 The video contains very good information. 
 I get the point you’re making. Yet the sadness and finality should be eliminated. 
As a survivor of prostate cancer, 1999 to present, all the doctors, white and black 
have helped me from the start. I found at the time of my diagnosis, it was not 
talked about. A athlete I think Jose Torre or Ed Koch got it and all of a sudden it 
was on the map. Until than black men were told you should get checked around 
the age of 50-55. Then I thought maybe that was what was killing all our older 
black men (unknown cause) in past years. I say stick to the obtaining information 
on Prostate cancer. Focus on the pride of having knowledge of the cure and not 
fear and the demeaning of having someone put their finger in your rear. I think 
someone said years ago, “You can choose between the Doctors finger or the 
Mortuary hose.” Early detection is the way to go without question. 
 I’d recommend seeing it because it has very useful information, it’s visually 
appealing and the dialogue is in everyday language. 
 I feel 100% confident in discussing the topic on my circle of friends and 
acquaintances. It is of paramount importance the information about this important 
test. 
 It shared good information that all Black males over the age of 40 should know. 
 The animation was choppy. The speech was not in sync. The representation of 
black men was the stereotypical skinny or muscular guy. And the one with cancer 
just so happened to be an overweight/obese black man. And the voices and gesters 
do no sound or look like a typical black man. Add some real dark skin brothers. 
Why are all the men shades of brown? 
 The video was informative, despite being poorly acted out. 
 I would recommend the video cartoon to others because everything they said in 
the video it’s true. This is a good example for African American men. 
 Good information 
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Table 26 (continued) 
 I would because of the information. I might not because of the quality of the 
actors’ rendering of the information. 
 I did not appreciate the part of the video that implies that African American men 
only care about “sex” when it comes to mitigating a prostate diagnosis. 
 more information, the better. 
 This video contains useful information about prostate cancer and the format used 
may be appealing to certain viewers. However, using the premise of an informal 
conversation as the only means to deliver this message undermines the 
information presented. The black doctor that appears for a few seconds at the end 
of the video could have been utilized to deliver some of the information presented 
by the men having the conversation. 
 I thought it was well presented and researched. As PROSCAN survivor, I could 
relate having had the same dialogue with friends and family. Furthermore, even 
though in the end, I managed to retain the best physicians and highest level of 
care, this was not the case in the beginning when I was experiencing difficulties 
with benign hyperplasia...or enlarged prostate, chronic prostatitis with apparent 
symptoms including urgency and rectal pain. some doctors mocked me as being a 
hypochondriac because they deemed me too young to be contending with these 
issues. I did not experience rejection because of race. Perhaps it could it have 
been because I am light skinned and highly educated? Alternatively it could have 
been because I am assertive and command answers as well as respect. In the 
questioning, I would include: have or ““had”“ prostate cancer. this is why I no 
longer get digital exams. My prostate gland was taken. I do go annually for the 
PSA test. 
 Just posted it on my Facebook Page. Although I have been diagnosed I am an avid 
supporter of Cancer Treatment. I am a member of a Cancer Support Group. I 
walk, I give, I serve, I support. 
 Sometimes its not enough to just tell someone to get there prostate exam. Every 
platform should be utilized. If a cartoon educates one person, its important. 
 It provided me with new information and may be helpful to others. 
 I would recommend the video to other men because it has valuable information in 
it. However the video does not sustain one’s attention, thereby reducing the 
amount of info each viewer receives. 
 the information is very good for all men, it may start them to take some action. 
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Anticipated Findings from Data Analysis 
This study also made a range of hypotheses about the relationship between the 
behavior of getting a PSA exam to screen for prostate cancer (Q.61) and various 
characteristics of the study participants. In particular, it was anticipated that the 
significant predictors of being in an action or maintenance stage for making sure they 
receive a PSA test to screen for prostate cancer (target behavior #3)—as measured before 
watching the video, will be the following independent variables: 
 Higher level of education 
 Higher socioeconomic status 
 Lower Body Mass Index (BMI) 
 Higher health literacy skills and self-efficacy 
 Higher pre-video viewing self-efficacy for (1) going to see a medical provider 
and getting a physical examination at least once a year, (2) making sure they 
receive a digital rectal examination to screen for prostate cancer, (3) making 
sure they receive a PSA test to screen for prostate cancer, and (4) spreading 
awareness among other African American men about the need for prostate 
cancer screening 
To test for a significant relationship between these covariates and the DV, a series 
of simple linear regression models were estimated. Additionally, a backward stepwise 
regression procedure was used where all of these independent variables were included in 
the analysis. All models were check for the assumptions of normally distributed errors as 
well as homoscedasticity, and there were no major violations. Table 27 has the regression 
models performed to test the above hypotheses; significance of each independent variable 
is marked by an asterisk and the R2 and F-statistics are included at the bottom of the 
table. Note that this analysis used income to proxy socioeconomic status and the variables 
  
125 
for health literacy skills and self-efficacy represent the average scores for two subscales, 
each of eight items, from the health literacy scale (SM-HL-V-S-SE-16). 
As seen in Table 27, most of these hypotheses were borne out by the data. 
Specifically, this study lends support that there is a significant positive relationship 
between health literacy skills (p-value = .008), health literacy self-efficacy (p-value = 
.008), seeing a medical provider and getting a physical exam annually (Q.58, p-value 
=.030), discussing with medical provider about receiving a digital rectal exam to screen 
for prostate cancer (Q.60, p-value < .001), discussing with medical provider about 
receiving a PSA test to screen for prostate cancer (Q.62, p-value <.001) and spreading 
awareness among other African American men (Q.64, p-value = .001). Thus, models 4-9 
support the anticipated hypotheses concerning health literacy skills and self-efficacy and 
the expected positive relationship between self-efficacy for the target behaviors (pre-
measures) and the behavior of going to get a PSA exam (Q.61). Regarding the first three 
hypotheses listed above, this study did not find significant results though the anticipated 
direction of the relationship was as expected: there was a positive relationship between 
education level (p-value = .050) and the proxy for socioeconomic status, income (p-value 
= .610) while there was a negative relationship between BMI and Q.61 (p-value = .390). 
In terms of effect sizes, R2 can be used since each of these models only contain a single 
independent variable. The bottom of Table 23 shows that Q.60 (self-efficacy of 
discussing getting a digital rectal exam with doctor) and Q.62 (self-efficacy of discussing 
getting annual PSA exams with doctor) had the strongest relationship with the DV, 
explaining 37.7% and 41.4% of the variance of Q.61 respectively.  
In summary, the hypotheses made at the start of this study were borne out by the 
data: in all cases the directionality was as expected, and many of the hypothesized 








                                                 
1 Health literacy is the average of eight items that assess health literacy: Q.41, Q.43, Q.45, Q.47, Q.49, Q.51, Q.53, Q.55.  
2 Health literacy self-efficacy is the average of eight items that assess health literacy: Q.42, Q.44, Q.46, Q.48, Q.50, Q.52, Q.54, Q.56. 




















Highest Education (Q.18) .329 
(.163) 
        
Income (Q.17)  .001 
(.002) 
       
BMI (Q.21/22)   -.044 
(.050) 
      
Health Literacy1    .813* 
(.289) 
     
Health Literacy SE2     .039* 
(.014) 
    
Seeing medical provider 
annually SE (Q.58) 
     .025* 
(.011) 
   
Discussing getting annual 
digital rectal exam SE (Q.60) 
      .025* 
(.006) 
  
Getting annual PSA exam SE 
(Q.62) 
       .034* 
(.006) 
 
Spreading awareness AA 
men SE (Q.64) 




















N 40 40 39 40 40 40 39 40 40 
R2 .097 .007 .020 .173 .171 .119 .337 .414 .243 




SUMMARY, DISCUSSION, IMPLICATIONS, 
 
RECOMMENDATIONS, AND CONCLUSION 
This chapter provides a summary of the dissertation research, as well as a 
discussion of the results, along with implications. This chapter also provides 
recommendations for future research and ends with a discussion of the limitations of this 
research and a final conclusion. 
Summary of Research Study 
The problem that this study addressed is the need to raise awareness in African 
American men about the fact that prostate cancer (PCa) disproportionately affects them 
as a group, both in incidence and in severity; and their attendant need to be 
knowledgeable and proactive about the disease and available healthcare options. The 
racial disparity they face is the largest for any major cancer, and so significant that the 
United States Senate passed a resolution in 2012 declaring PCa an epidemic among 
African American men (Prostate Health Education Network, 2013). 
E-based education is one approach to addressing the need of African American 
men for increased awareness and information about diagnostic and treatment 
possibilities. A number of studies using this innovative approach—specifically designing 
and using avatars (i.e., cartoonlike videos  that are culturally tailored to the target 
audience—have been conducted by fellows of the Research Group on Disparities in 
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Health (RDGH) at Teachers College, Columbia University, through the sponsorship of 
Professor Barbara Wallace, Director of the RGDH. These studies have all followed the 
work of Misra and Wallace (2012) in seeking to create e-health that is tailored to be 
culturally appropriate for the category of consumers of focus. 
The present study is aligned with those studies, which have found that culturally 
appropriate avatars can serve as a brief intervention (Aiyedun, 2014; Chung, 2013; 
Garcia, 2013; Renne, 2013), fostering significant movement across stages of change (e.g., 
precontemplation to contemplation stage) and producing increases in self-efficacy for the 
performing behaviors of focus in the video. 
One way to address disparities in health care service delivery is to empower 
African American men so they have a sufficiently high level of self-efficacy to be able to 
perform three target behaviors: (1) going to see a medical provider and getting a physical 
examination at least once a year; (2) making sure they receive a digital rectal examination 
to screen for prostate cancer; (3) making sure they receive a PSA test to screen for 
prostate cancer; and, (4) spreading awareness among other African American men about 
the need for prostate cancer screening –so they, too, can seek out prostate cancer 
screening.  Thus, there is a rationale for this study investigating men’s stage of change 
(i.e., theory of Prochaska & DiClemente, 1983) and self-efficacy (i.e., theory of Bandura, 
1977, 1997) for performing these three target behaviors—first, before watching an online 
e-health avatar (cartoon-like) video, and, second, after watching the video. The rationale 
for developing and evaluating the online e-health avatar video on prostate cancer follows 
from numerous previous studies conducted by fellows of the Research Group on 
Disparities in Health (RGDH) of Teachers College, Columbia University that have found 
that such a video can serve as a brief intervention (Aiyedun, 2014; Chung, 2013; Garcia, 
2013; Renne, 2013). Such studies have typically found evidence that an online avatar 
video can foster significant movement across stages of change (e.g. precontemplation to 
contemplation stage), as well as increases in self-efficacy for performing behaviors of 
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focus in the video. These studies have all followed the work of Misra and Wallace (2012) 
in seeking to create e-health that is tailored to be culturally appropriate for the category of 
consumers of focus. 
It also follows, logically, that there is value in determining dose of exposure to the 
video (i.e., watched none, some, most, or all of the video). Dose of exposure may be a 
factor related to how the participants evaluate and rate the videos. Further, of interest is 
the participants’ intent to recommend the video to others, or engage in diffusion of the 
innovation (Rogers, 1962, 1995) of e-health on prostate cancer. Reasons for either 
recommending or not recommending the e-health avatar video, as well as other 
comments offered, allowed the study men to express themselves freely, while qualitative 
data analysis identified emergent themes. 
At the same time, there is a rationale for investigating potential underlying causal 
mechanisms or varied factors potentially operating. More specifically, there is a rationale 
for investigating demographic and background characteristics, including age, 
socioeconomic status, level of education, Body Mass Index (BMI)—as well as health 
insurance and ratings of their health status and health care; and, ratings of their health 
care providers for their cultural sensitivity and cultural competence. 
Research has shown that potential factors are numerous. For example, they may be 
socioeconomic, biological, receipt of lower quality health care, a lack of cultural 
competency among physicians, deficiencies in nutritional intake—which can contribute 
to prostate carcinogenesis, as well as obesity and a lack of a healthy lifestyle (Wu & 
Modlin, 2012). 
There is also a rationale for investigating level of health literacy, while 
operationalizing this as per the definition provided by the CDC (2014). The CDC has 
defined health literacy, as follows: “The Patient Protection and Affordable Care Act of 
2010, Title V, defines health literacy as the degree to which an individual has the 
capacity to obtain, communicate, process, and understand basic health information and 
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services to make appropriate health decisions” (para. 1). Also, Mullins et al. (2010) 
identified a lack of health literacy as a potential factor in prostate cancer health 
disparities. 
Other studies have selected as the study outcome variable/dependent variable being 
in an action or maintenance stage for the target behavior of interest (e.g., Garcia, 2013). 
Thus, there is a rationale for this study selecting the study outcome variable/dependent 
variable of being in an action or maintenance stage for [# (3)] making sure they receive a 
PSA test to screen for prostate cancer—as measured before watching the video. This 
study outcome variable/dependent variable permits investigating whether selected 
demographic and other study scales are significantly related, and exploring independent 
variables that may significantly predict it. 
Summary of the Statement of the Problem 
The problem that this study addresses is the need to increase awareness among 
African American men regarding their potential risk of prostate cancer (Hoffman et al., 
2011) and the health disparities (Mullins et al., 2010; Wu & Modlin, 2012) characterizing 
their group, as well as foster discussion with doctors about their family history of prostate 
cancer and whether they should pursue prostate cancer screening—meaning involvement in 
the “prostate specific antigen (PSA) test and digital rectal examination (DRE)” which  
“enable the detection of early-stage and organ-confined disease among otherwise 
asymptomatic men” (Fowke et al., 2005, p. 333).  
There is also a need to increase awareness of treatment options to compensate for a 
lack of physician education on the topic (Mullins et al., 2010). Further, there is a need for 
innovative approaches to health education. For example, there is the need to evaluate the 
feasibility of positively impacting decisions to discuss prostate cancer screening with one’s 
physician through the use of e-health tailored to be culturally appropriate; and, also 
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positively impact knowledge of prostate cancer treatment options (Misra & Wallace, 
2012)—i.e., using avatar videos (cartoon-like). In addition, it is important to asses the 
extent to which those exposed to the avatar videos intend to recommend it to other African 
American men, as they may engage in the diffusion of the innovation (Rogers, 1962, 1995) 
of e-health on prostate cancer. African American men so informed via e-health may be able 
to share the video with any men in their social networks regarding prostate cancer. 
Summary of the Purpose and Objectives 
The purpose of this study is to develop and evaluate an innovative online e-health 
avatar video (cartoon-like) tailored to be culturally appropriate for African American 
men—as a potentially viable approach to fostering patient discussions with their 
physicians about prostate cancer screening. In addition, the main purpose of the study is 
to identify significant predictors of African American men recommending the e-health 
video to other men.  
While the present study followed that tradition of research, its purpose was to 
address the need to inform African American me about their disproportionate risk for 
PCa and healthcare options. Accordingly, an innovative online e-health avatar, tailored to 
be culturally appropriate for them, was developed, implemented, and evaluated to see if it 
would foster discussion about prostate screening between the men who were exposed to 
it, and their physicians. How likely were the men to follow up their exposure to the avatar 
by discussing their family’s history of prostate cancer with their physicians and deciding 
whether to pursue prostate cancer screening (i.e., the prostate specific antigen [PSA] test 
and digital rectal examination [DRE], which detect “early-stage and organ-confined 
disease among otherwise asymptomatic men” (Fowke et al., 2005, p. 333). 
In addition to learning if the African American men who watched the avatar would 
proactively address their risk for prostate cancer in this way, it was important to assess 
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the extent to which they intended to recommend the avatar to other African American 
men—thereby participating in the diffusion of this innovation (Rogers, 1962, 1995) to 
utilize e-health education as a way to inform this group as a larger whole about their risks 
for PCa. To ascertain if this objective was met, the study aimed to identify significant 
predictors of African American men recommending the e-health video to other men—
men, who, in turn, might share the video with other men in their social networks. 
Summary of the Research Questions and Survey 
In accordance with the data analysis plan, a sample (N=41) of African American 
men who responded to the social marketing campaign listed on social media and took the 
survey on surveymonkey (https://www.surveymonkey.com/r/AAProstateCancer) and 
who watched the e-health avatar video (cartoon-like). The questions they answered are 
available in Appendix D and are associated with each of the research questions covered 
in the quantitative part of this study. 
Quantitative Portion of Study 
1. What are their demographic and background characteristics (e.g., age, 
socioeconomic status, level of education)? 
PART I: BASIC DEMOGRAPHICS (BD-9) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
2. What is their health status (e.g., Body Mass Index) and how do they rate their 
healthcare? 
PART II: BRIEF HEALTH SURVEY (BHS-8) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
3. What is the prevalence of diagnoses of prostate cancer, history of screening 
for prostate cancer, as well as the prevalence of prostate cancer in their family 
and in their social network—including deaths from prostate cancer and the 
metastasis of cancer? 
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PART III: PROSTATE CANCER SCALE (PCS-10) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
4. What is their health literacy, as measured in terms of relevant skills and self-
efficacy to perform them? 
PART IV: SCALE MEASURING HEALTH LITERACY VIA SKILLS AND 
SELF-EFFICACY (SM-HL-V-S-SE-16) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
5. What is their stage of change and self-efficacy for (1) going to see a medical 
provider and getting a physical examination at least once a year, 
(2) discussing with their medical provider whether they should receive a 
digital rectal examination to screen for prostate cancer, and (3) discussing 
with their medical provider whether they should receive a PSA test to screen 
for prostate cancer? 
PART V: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—PRE-VIDEO (PCS-ES-M-SOC-SE-PRE-V-4) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
6. After watching an avatar (cartoon-like) video, what do they report as their 
dose of exposure to the video (i.e., watched none, some, most, or all of the 
video)? 
PART VI: DOSE OF EXPOSURE TO VIDEO (DOE-TV-1) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
7. How do they evaluate or rate the video in terms of the information shared? 
PART VII: RATE THE VIDEO (RTV-1) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
8. After watching the video, what is their stage of change and self-efficacy for 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
PART VIII: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 




Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages 
9. Did they move across stages of change from precontemplation or 
contemplation to preparation for any of the four target behaviors (i.e., 
(1) going to see a medical provider and getting a physical examination at least 
once a year, (2) discussing with their medical provider whether they should 
receive a digital rectal examination to screen for prostate cancer, 
(3) discussing with their medical provider whether they should receive a PSA 
test to screen for prostate cancer, and (4) spreading awareness among other 
African American men about the need for prostate cancer screening? 
PART IX: MOVEMENTS IN STAGES OF CHANGE TO PERFORM THE 
FOUR TARGET BEHAVIORS 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 
comparing their pre-video viewing (PART V) to post-video viewing scores 
(PART VIII) 
10. Did they experience an increase in self-efficacy or confidence to perform the 
four target behaviors from (i.e., (1) going to see a medical provider and 
getting a physical examination at least once a year, (2) discussing with their 
medical provider whether they should receive a digital rectal examination to 
screen for prostate cancer, (3) discussing with their medical provider whether 
they should receive a PSA test to screen for prostate cancer, and (4) spreading 
awareness among other African American men about the need for prostate 
cancer screening) from before to after watching the videos? 
PART X: MOVEMENT IN SELF-EFFICACY TO PERFORM THE FOUR 
TARGET EHAVIORS 
Data Analysis Plan: Inferential statistics, specifically paired t-tests, 
comparing their pre-video viewing (PART V) to post-video viewing scores 
(PART VIII) 
11. Is there a significant relationship between selected demographics and other 
study scales with the study outcome variable/dependent variable of being in 
an action or maintenance stage for [# (3)] making sure they receive a PSA test 
to screen for prostate cancer—as measured before watching the video? 
PART X1: RELATIONSHIP BETWEEN DEOMGRAPHIC VARIABLES AND 
OTHER STUDY SCALES WITH THE TARGET BEHAVIOR OF GOING TO 
GET A PSA TEST TO SCREEN FOR PROSTATE CANCER (PRE-
MEASURE) 
Data Analysis Plan: Inferential statistics, specifically Spearman correlations 
12. What are the significant predictors of being in an action or maintenance stage 
for [# (3)] making sure they receive a PSA test to screen for prostate cancer—
as measured before watching the video? 
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PART XI1: PREDICTING THE TARGET BEHAVIOR OF GOING TO GET A 
PSA TEST TO SCREEN FOR PROSTATE CANCER (PRE-MEASURE) 
Data Analysis Plan: Multiple regression and backward stepwise regression 
analyses. 
Mixed Methods Portion of Study 
13. To what extent do they intend to diffuse the innovation of providing health 
education on prostate cancer via e-health in the form of an avatar video by 
either recommending or not recommending the video? And, what are their 
reasons for recommending or not recommending the avatar video, including 
any other comments they might have? 
PART XIII: INTENTION TO ENGAGE IN DIFFUSION OF THE 
INNOVATION OF WATCHING THE AVATAR VIDEO (DIWV-2) 
Data Analysis Plan: Descriptive statistics, including means, standard 
deviations, frequencies, and percentages; and the identification of emergent 
themes for the qualitative data. 
Summary of the Literature Review 
This chapter presents a review of literature relevant to this study. More specifically 
this chapter covers literature on the following topics: (1) lack of awareness of treatment 
options (Mullins et al., 2010); (2) lack of patient education by physicians (Mullins et al., 
2010); (3) a need of increased awareness of prostate cancer (Mullins et al., 2010); (4) the 
world’s highest incidence of PC (Hoffman et al., 2001); (5) been found to possess a lack 
of awareness of treatment options and suffer from a lack of education by physicians, 
resulting in lack of access to health care, as well as lower likelihood of seeking 
aggressive treatment options for localized PC (Mullins et al., 2010); (6) investigating 
men’s stage of change (i.e., theory of Prochaska & DiClemente, 1983); (7) self-efficacy 
(i.e., theory of Bandura, 1977, 1997) for performing these three target behaviors—first, 
before watching an online e-health avatar (cartoon-like) video, and, second, after 
watching the video. 
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The rationale for developing and evaluating the online e-health avatar video on 
prostate cancer follows from numerous previous studies conducted by fellows of the 
Research Group on Disparities in Health (RGDH) of Teachers College, Columbia 
University that have found that such a video can serve as a brief intervention (Aiyedun, 
2014; Chung, 2013; Garcia, 2013; Renne, 2013). Such studies have typically found 
evidence that an online avatar video can foster significant movement across stages of 
change (e.g., precontemplation to contemplation stage), as well as increases in self-
efficacy for performing behaviors of focus in the video. These studies have all followed 
the work of Misra and Wallace (2012) in seeking to create e-health that is tailored to be 
culturally appropriate for the category of consumers of focus. 
Regarding prostate cancer, Mullins et al. (2010) identified a lack “of awareness of 
treatment options and lack of patient education by physicians” (p. 566). Thus, there is a 
rationale for increasing awareness around prostate cancer. 
Also, there is a rationale for investigating the prevalence of diagnoses of prostate 
cancer, history of screening for prostate cancer, as well as the prevalence of prostate 
cancer in their family and in their social network—including deaths from prostate cancer 
and the metastasis of cancer. Indeed, the rationale for this investigation is multifaceted, 
involving how African American/Black men have the following, with regard to prostate 
cancer (PC): 
 the world’s highest incidence of PC (Hoffman et al., 2001) 
 been reported to experience a PC incidence two-thirds higher than Whites 
(Wu & Modlin, 2012) 
 been found to possess a lack of awareness of treatment options and suffer 
from a lack of education by physicians, resulting in lack of access to 
health care, as well as lower likelihood of seeking aggressive treatment 
options for localized PC (Mullins et al., 2010) 
 higher incidence of PC, and a higher mortality from PC, and present with 
a more aggressive PC—relative to European American men (Mullins et 
al., 2010) 
 a lower likelihood of receiving more expensive or innovative treatment 
(Mullins et al., 2010) 
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 the lowest odds of receiving definitive therapy for prostate cancer—
including the risk of developing higher grade prostate cancers and greater 
cancer specific mortality (Underwood et al., 2004) 
 a pattern of being less likely to undergo radical prostatectomy compared to 
their White counterparts (Mullins et al., 2010) 
 a risk of increased metastasis as a result of inaccurate staging, or a 
tendency for the PC not to be staged, or suffer from physicians failing to 
provide education on the importance of staging PC (Mullins et al., 2010) 
 a pattern of presenting with more advanced prostate cancer disease with a 
poorer prognosis (Mullins et al., 2010) 
 a shorter disease-free survival period relative to other racial groups 
(Mullins et al., 2010) 
 suffer racial/ethnic disparities in prostate cancer mortality (Underwood 
et al., 2004)—specifically, a mortality rate twice as high as that of White 
men (Wu & Modlin, 2012) 
Also noteworthy is how equivalent survival outcomes have been realized when 
Black and Whites had treatment assigned “in a uniform manner without regard to race   
(Wu & Modlin, 2012, p. 315). This further underscores the likely role of disparities in 
health care service delivery.  
Finally, there is a rationale for the study’s theoretical framework, given prior 
similar research studies (e.g., Aiyedun, 2014; Garcia, 2013; Chung, 2013; Renne, 2013). 
This framework includes the following: the stages of change from the transtheoretical 
model brought forth by Prochaska and DiClemente (1983); the self-efficacy theory 
advanced by Bandura (1977, 1997); and, the diffusion of innovation theory as per the 
work of Rogers (1962, 1995). 
Summary of the Research Sample and Procedures 
The study design was cross-sectional, and an online survey was developed using 
Survey Monkey technology. The survey was then entered into the public domain on the 
Internet through Survey Monkey at www.surveymonkey.com. A link to the study survey 
was established, and disseminated on all selected social media sites to launch the social 
marketing campaign for the study. The survey was titled, “African American Men’s 
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Prostate Cancer Awareness Study.” On December 17, 2014, the study received approval 
from the Teachers College, Columbia University Institutional Review Board (IRB). It 
was given the IRB Protocol #15-125 (see Appendix for IRB Approval Letter). The social 
marketing campaign was launched on January 28, 2015 on social media sites. Data 
collection began in late March 2015. At the close of the survey, the computer randomly 
chose three email addresses (which were unknown to the researcher) to award incentive 
prizes of online Amazon gift cards. In addition, the data were downloaded into SPSS 22.0 
from Survey Monkey. The data were assessed for a series of research questions. 
Summary of Research Instrumentation 
The following measures were used for the research instrumentation: 
 PART I: BASIC DEMOGRAPHICS (BD-9) 
 PART II: BRIEF HEALTH SURVEY (BHS-8) 
 PART III: PROSTATE CANCER SCALE (PCS-10) 
 PART IV: SCALE MEASURING HEALTH LITERACY VIA SKILLS AND 
SELF-EFFICACY (SM-HL-V-S-SE-16) 
 PART V: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—PRE-VIDEO (PCS-ES-M-SOC-SE-PRE-V-4) 
 PART VI: DOSE OF EXPOSURE TO VIDEO (DOE-TV-1) 
 PART VII: RATE THE VIDEO (RTV-1) 
 PART VIII: PROSTATE CANCER SCREENING EMPOWERMENT 
SCALE MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR 
THREE BEHAVIORS—POST-VIDEO (PCS-ES-M-SOC-SE-POST-V-4) 
 PART XIII: INTENTION TO ENGAGE IN DIFFUSION OF THE 
INNOVATION OF WATCHING THE AVATAR VIDEO (DIWV-2)   
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Summary and Discussion of Results of Research Questions 
This section provides a summary and discussion of the findings of each research 
question. For each question, a summary of key research findings is presented first. This is 
followed by a discussion that places those findings in context.  
Summary and Discussion for Research Question #1: Basic Demographics (BD-9) 
Summary #1. Black/African American men, who are the research focus of this 
study, comprised 40 (97.6%) of its 41 African American participants. The remaining 
individual identified himself as mixed race. The average age of the study participants was 
44 years old, with ages ranging between 20 and 64 years of age. In terms of the 
participants’ relationship status, 31.7% (n=13) were married, 22.0% (n=9) had never 
married, 12.2% (n=5) were divorced, 9.8% (n=4) were in a committed relationship, 4.9% 
(n=2) of participants lived with a significant other, and 2.4% were dating. More than 
eighty percent (80.5%, n=33) of the participants were born in the U.S.  
In terms of education and income, this study oversampled from a high 
socioeconomic stratum. Regarding their education, 36.6% (n=15) of the 41 participants 
had a Bachelor’s degree, followed by 24.4% (n=10) with a Master’s degree, 14.6% (n=6) 
with a Doctoral degree, and the remaining five (12.5%) had earned a GED or Associate 
degree. The mean household income was reported as $118,000, with two (4.9%) 
participants falling in the $200,000-$299,000 category and participant reporting that his 
income was over $800,000. There were a total of 13 participants who reported an income 
below $50,000, which is roughly equal to the median income in the U.S. As to their 
employment status, over half (58.5%, n=24) of the participants were employed full-time, 
followed by 14.6% (n=6) who were unemployed, and 9.8% (n=4) who were full-time 
graduate students. None of the study participants were receiving welfare.  
Discussion #1. Forty-one study participants took the entire online survey, and 35 
watched the entire avatar video that was presented as the instrument of the study. The 
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survey link was advertised on Facebook and Twitter and at Teachers College, but 
obtaining the originally intended number of 200 participants was a challenge, and it is 
one with deep historic roots. As Corbie-Smith et al. (1999) discussed, barriers exist to the 
participation of African Americans in research: “Mistrust of doctors, scientists, and the 
government was reported consistently” (p. 537) by participants in their focus groups. This 
mistrust centers on the motives and ethical conduct of the researchers, as well as a lack of 
clear understanding about what “informed consent” means. “Many participants,” Corbie-
Smith et al. wrote, “described concerns about the ethical conduct of clinicians and 
investigators when poor or monitory patients are involved and cited examples of 
exploitation as supporting evidence for their mistrust of the medical establishment” 
(p. 537). As one participant stated, “They always use our race as guinea pigs” (p. 538). 
Throughout the focus group interviews, Corbie-Smith et al. (1999) stated that 
participants referred to the Tuskegee Syphilis Study (p.541). Many of them believed that 
the African American subjects of this widely known study had been injected with syphilis 
by the researchers as an experiment. And, while the Tuskegee study was the lynchpin of 
such suspicions, Corbie-Smith et al. further noted that “several participants believed other 
related ‘experiments’ and ‘conspiracies’ validated their concerns about the Tuskegee 
Syphilis Study,” (p. 541). Despite certain limitations of their study, which the authors 
describe, they conclude that it 
gives voice to African-American mistrust of the medical community in 
general and medical research in particular. The absence of trust has emerged 
as a stumbling block in efforts to include African Americans in clinical 
research. Although the Tuskegee Syphilis Study has come to symbolize 
exploitation of monitories, participants also believed HIV infection, Agent 
Orange exposure, and Central Intelligence Agency distribution of crack 
cocaine in black communities were contemporary evidence that the legacy of 
abuse continues in this population. (p. 546) 
This longstanding and profound mistrust of medical research and researchers on 
the part of African Americans—the belief that medical researchers do not have their best 
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interests at heart (which has origins in experimentation that took place during slavery)—
makes it more difficult to find African American individuals willing to participate in 
medical studies such as this one. In short, deep and ongoing suspicion within African 
American communities about the true purposes of medical research and initiatives impact 
the ability of researchers to find individuals willing to participate in studies. 
Unfortunately, the current study proved no exception to this difficulty. 
Summary and Discussion for Research Question #2: Brief Health Survey (BHS-8) 
Summary #2. Most respondents rather their overall health as either good (39%), 
very good (36.6%), or excellent (19.5%). About one-quarter of study participants had a 
BMI in the healthy range (26.8) which is defined by the CDC (2017) as the range of 
18-25, while 15 participants (36.6%) and 11 participants (26.8%) fell into the overweight 
and obese ranges of BMI. Interestingly, 24 (58.5%) of the participants rated their weight 
to be in the normal range, while only 15 (36.6%) and 2 (4.9%) rated their weight rating as 
overweight or obese, respectively.  
The majority of respondents had private insurance plan (73.2%), while 12.2% had 
Medicaid and only a single respondent had Medicare. When asked to rate their overall 
quality of health care, most responded positively: 24.4%, 48.8%, and 17.1% rated their 
overall quality of medical care as good, very good, and excellent respectively. Question 
eight on the Brief Health Survey asked how sensitive and competent their health care 
providers were for treating them as African American men, as compared to how their 
health care providers would treat White patients. Only one respondent indicated a 
negative response here, selecting poor, while 22% indicated good, 36.6% indicated very 
good, and 19.5% indicated excellent. 
Discussion #2. The majority of participants in this study self-reported their health 
status as good to excellent, and most of them stated that they had a good relationship with 
their primary care physician. They also demonstrated a clear understanding of their 
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medical conditions and the treatment options available to them, which indicate an 
effective level of communication with their health providers. However, it must be noted 
that many of these participants were more highly educated than the individuals originally 
targeted for the study; and may have been more familiar, comfortable, and conversant 
with medical practitioners than less formally educated participants would have been, 
given the historic suspicion of African Americans toward medical researchers and 
practitioners. 
The need for trust exists not only for medical researchers conducting studies, but in 
the practice of medicine, as well. According to the Institute of Medicine (2003), in 
Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, a lack of 
cultural sensitivity on the part of health providers contributes to a lack of patient 
engagement in effective communication regarding diagnostic results and treatment 
options. Moreover, as Eiser et al. wrote in their 2007 article, “The historical and cultural 
legacy of discrimination against African Americans influences their socioeconomic status 
and affects their health care interactions and clinical outcomes” (p. 177). On a national 
level, the U.S. Institute of Medicine’s (2003) Committee on Understanding and 
Eliminating Racial and Ethnic Disparities in Health Care, stated that “cross-cultural 
training should have a significant role in improving quality of care for minorities and 
eliminating racial and ethnic disparities” (p. 176). 
A number of researchers have addressed this need and what such training should 
involve. For example, Eiser et al. (2007) wrote that: 
Educational methods should include both information about relevant 
social group history as well as some experiential component to emotively 
communicate particular cultural needs. The authors describe particular 
techniques that help bridge the cross-cultural clinical communication gaps 
that are created by patients’ mistrust, lack of cultural understanding, 
differing paradigms for illness, and health illiteracy. (p. 176) 
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However, Eiser et al. also note that, despite “much [recent] interest in preparing 
physicians to care for patients from a variety of cultural and ethnic backgrounds … recent 
studies suggest that this area of medical education is the still most lacking” (p.176). 
The need for cross-cultural training and sensitivity, which directly impacts the 
delivery and acceptance of healthcare options among African American patients, must be 
of ongoing concern because, as Eiser et al. (2007) also wrote, “The majority of African 
Americans will see non-African American physicians. The ability to cross cultural and 
ethnic divides is [therefore] an essential component of the 21st-century physicians’ 
“toolkit” (p.179). 
While cultural sensitivity is of general benefit to the practice of medicine, it is 
particularly indicated when medical practitioners and researchers interact with African 
Americans, given the historic and ongoing suspicions toward the medical community that 
were noted in Discussion 1. As Corbie at al. (1999) wrote: 
The issue of trust was a recurrent theme throughout the entire discussion 
of participation in research. Although participants expressed concerns about 
the ethical conduct of researchers in general, they also noted that a trusting 
relationship was important for them to feel comfortable as participants in 
clinical studies. (p. 545) 
Moreover, Eiser et al. (2007) noted that “African American patients rated their 
encounters with physicians more rewarding and participatory when the physician was 
also African American” (p.179). Hopefully, advances in this area will continue to be 
made and will contribute to better outcomes in relation to PCa for African American 
men, and improve their willingness to participate in medical research studies and trials. 
Summary and Discussion for Research Question #3: Prostate Cancer Scale (PCS-10) 
Summary #3. The Prostate Cancer Scale asked respondents 10 questions about 
various behaviors regarding prostate cancer. The majority of study participants had never 
been told/diagnosed with prostate cancer (90.2%) or told that they were at risk (78%). 27 
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(65.9%) of the study sample had received a digital rectal exam, while 34.1% had not. 
Less than half (34.1%) had received a PSA exam to screen for prostate cancer.  
In terms of knowing other people or family members that were diagnosed with 
prostate cancer, only nine subjects (22%) had someone in their family diagnosed with PC 
while 61% of the study participants had known someone who had been diagnosed with 
PC. Regarding those who had a family member diagnosed with PC, three of them 
reported their fathers had been diagnosed with prostate cancer while two, one, and one 
indicated that a grandfather, uncle, and bother respectively had been diagnosed with PC. 
When asked more generally if they knew anyone who had died from PC, 11 (26.8%) 
replied that they had. Of these eleven, ten of them only knew of a single person how had 
died from PC while one person two knew people who had died. 
Discussion #3. While most of the participants in this study reported good health, 
access to healthcare, and only a minor amount of family history with PC, the U.S. Senate 
passed a resolution in 2012 that recognized PCa to be at epidemic proportions among 
African American men (Prostate Health Education Network, 2013). As noted earlier in 
this report, why this is the case among African American men specifically, continues to 
be a topic of discussion and research.  
For example, Mahal et al. (2014) noted that: 
Racial treatment disparity remains a highly problematic issue that has 
been persistent with time and alarmingly is worse among men with high-risk 
disease who need treatment the most. The underlying reasons for these 
disparities must be carefully studied so that interventions can be designed to 
address the problem in the immediate future. Differences in insurance status, 
mistrust in the health-care system, patient preference, comorbidities, and 
socioeconomic status are the frequently hypothesized reasons for health-care 
disparities. (p. 389) 
Mahal et al. also suggest some paths to changing such disparities in healthcare and PCa 
outcomes among African American men: 
To reduce disparate outcomes in aggressive cancers, it is clear that there 
will need to be equal access to cancer screening and interventions at the 
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community level to educate populations about the risks of aggressive 
cancers, clinical trials that include adequate numbers of minority 
participants, and prospective research of interventions that can help 
determine the most efficacious approach to alleviate cancer disparities.  
These interventions will take time before targets are achieved. Meanwhile, 
one method of achieving more immediate reductions in disparities in cancer 
outcomes may be done by setting race-neutral treatment of aggressive 
disease as a quality metric that an institution must achieve to reach a certain 
quality status. (p. 391) 
Other researchers, too, such as Gurudatta Naik and Tomi Akinyemiju (2017), have 
focused on the persistence of “racial disparities in cancer outcomes due to differential 
access to healthcare,” and have noted that “the elimination of barriers to access excellent 
healthcare decreases this disparity” (p. 73). According to Naik and Akinyemiju, “a higher 
proportion of African American patients presented with metastatic disease, [which] 
suggests that access to timely, high quality treatment is a major factor in racial disparities 
in prostate cancer mortality” (p. 78). In addition, Mahal et al. (2014) note that: 
Provider-level factors may also contribute to the observed race-risk 
interaction and disparity. For example, if providers overestimate the 
comorbidity burden of AA patients, this may lead them to recommend 
definitive treatment less frequently. Alternatively, providers may not be 
sufficiently communicating to AA men with high-risk disease that their 
disease is significantly more lethal and needs to be treated more urgently 
than if they had intermediate-risk disease. (p. 390) 
The findings of these and other medical researchers would seem to support this 
study’s showing of a correlation between the good overall health status of these men and 
their relatively high level of access to healthcare, possession of health insurance, and 
their participation and relatively good communication with healthcare providers. 
Summary and Discussion for Research Question #4: Scale Measuring Health 
Literacy Via Skills and Self-Efficacy (SM-HL-V-S-SE-16) 
Summary #4. Two aspects of health literacy were considered in research 
question 4: participant skills and self-efficacy related to a range of behaviors. Most 
respondents rated themselves as competent for seeking out health information: 26.8% 
(n=11) rated themselves their ability as excellent in this regard, while 41.5% (n=17) and 
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19.5% (n=8) rated their ability as very good and good respectively. Accordingly, over 
75% of study participants rated their confidence in seeking out health information as 
either 80% or 100% confident. In terms of seeing out actual health services, we again see 
a positive trend: more than 70% rated their ability as excellent or very good while more 
than 75% rated their confidence level at either 80% or 100%.  
For communicating and asking questions about their health, 7 respondents rated 
their ability in this area as good, while 19 and 11 rated their ability as very good and 
excellent in this area. Once again, over 75% of respondents indicated that they were 
about 80% or 100% confident in communicating and asking questions about their health. 
Regarding the behavior of understanding what a health care provider tells them, most 
self-ratings are again high in this area: 22%, 43.9%, and 31.7% rated their ability as good, 
very good, or excellent respectively. Over 80% of the respondents indicated a 80%+ 
confidence level in understanding what a health care provider tells them. All respondents 
indicated their skill level in being able to ask probing questions to a health care provider 
to understand what has been communicated to them was either good, very good, or 
excellent. In terms of their confidence of asking probing questions, 11 placed their 
confidence level at 60%, while 19 and 11 rated themselves as 80% and 100% confident 
respectively for this behavior.   
Discussion #4. With regard to how well participants believed they really 
understood what they were told by a health professional, Friedman et al. (2009) have 
noted the following about what they consider to be “adequate health literacy”:  
Numerous factors are associated with limited PrCA cancer screening 
behaviors among AA men including limited information, knowledge, and 
understanding about screening procedures; confusion between PrCA 
screening and diagnostic tests; fear of cancer itself; concern with sexual 
functioning if diagnosed with PrCA; lack of access to health care services; 
mistrust of the health care system; poor communication with health care 
providers; lack of health insurance; and inconvenient clinic hours. (p. 450) 
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In terms of understanding what a medical professional tells them, Friedman et al. 
(2009) discussed a number issues in this regard connected to health literacy: 
The majority of research on health literacy has focused on basic 
functional health literacy which is, according to the US Department of 
Health and Human Services and the American Medical Association, the 
ability to understand health care information.… Adequate health literacy 
does not only require skills needed to read and understand health-related 
information. It also involves being able to search proactively, access, and use 
the information in a manner that will positively influence health behaviors 
and health outcomes. While the concept of interactive literacy may actually 
be referring to skills related to information seeking and critical literacy may 
be individual empowerment and critical analysis of information as opposed 
to “literacy” per se. (p. 458) 
By this definition, it can be said of participants who watched the Avatar video in the 
current study and reported their intention to change lifestyle behaviors based on the 
information in the video and share with other men what they had learned, that the video 
succeeded in promoting their “critical literacy,” not just the skills associated with what 
Friedman et al. refer to as “functional literacy.” 
Friedman et al. (2009) further noted that even basic, functional health literacy is a 
serious issue in the U.S. for a huge portion of the population: 
In the US, over 75 million adults have basic or below basic literacy 
abilities and are unable to understand health materials such as prescription 
labels or hospital consent forms.… Furthermore, 67% of AAs have basic or 
below basic literacy skills compared to 32% of EAs, and men have slightly 
lower literacy skills than women…. (p.450) 
Researchers such as Ross at al. (2007) continue to study the barriers that contribute 
to the difficulty of getting African American men through the door of physician’s offices, 
and then to undertake appropriate PCa screening. As they put it, they hoped to offer 
“some insight to identify factors in addition to or outside of socioeconomic status-related 
factors that may be important in physician-patient discussions such as reported health 
status,” and added that “cultural, contextual, social-psychological, and/or personality 
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variables may help to explain the types of persons who are most likely to participate in 
physician-patient discussions or at least offer additional insight” (p. 160). 
More specifically, Ross et al. (2007) described the purpose and scope of their study 
as an examination of “the sociodemographic and other correlates of physician-patient 
discussions regarding the advantages and disadvantages of the prostate-specific antigen 
(PSA) test among African American men aged 40 or older”—and to this end, they 
“examined all African American men aged 40 and older who had undergone a PSA test 
in the NHIS 2000,” adding that “African Americans composed about 10% of the sample 
in the NHIS 2000” (p. 157). Their conclusion was clear: “African American men who 
were not having discussions with their physicians tended to be in fair or poor health, were 
not getting suggestions from their physicians to take the screening test, had not had a 
screening PSA text in the past 3 years, and had had health insurance coverage” (p. 162).  
Reynolds (2008) also discussed barriers to PCA screening among African 
American men, and stressed the need for awareness about the importance of such 
screening, among both patients and medical practitioners: “American men,” she wrote, 
“have less knowledge about the risk for developing prostate cancer and about prostate 
cancer in general.” She continued: “Not knowing that screening was needed was cited as 
the Number 1 barrier of being screened for prostate cancer, in a descriptive correlation 
study, conducted by Shelton et al. (2005)” (p. 174). Reynolds further noted that some 
medical practitioners are unaware of the increased risk that African American men have 
for PCa, and stressed the importance of that knowledge:  
There may also be inadequate knowledge on the part of the physician as 
well as the patient. In a 2005 survey conducted by Miles, only three quarters 
of physicians in high-rate cancer states identified African American men as a 
high-risk group. Where does that leave African American men, if 25% of 
their health care providers are unaware of the cancer risks facing this group? 
(p. 174) 
Such lack of information begs the problem that the current study was intended to 
address: how to get the needed information to African American men, who, as a group, 
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are at increased risk for PCa. In this regard, Reynolds (2008) cited a “2003 study 
conducted by Volk, Spann, Cass, and Hawley,” which “found that videotape as an 
education decision aid for promoting informed decision making about prostate cancer 
resulted in a higher rate of screening for African American men” (p. 175). 
In sum, barriers to PSA screening among African American men have been found 
not only to include their historic mistrust of the medical establishment, and lack of cross-
cultural training on the part of medical practitioners—they may also include a lack of 
awareness on the part of physicians about the increased risk of AA men for PCa and the 
failure to communicate this increased risk to their African American male patients and 
discuss screening options.  
These studies reaffirm and reinforce the crucial role of the patient-doctor 
relationship in preventing and screening for PCa. As Ross et al. (2007) wrote: 
Patient-provider communication is intimately linked with inadequate 
knowledge. If physicians and other health care providers are not getting the 
message out about the increased risk of African American men and prostate 
cancer, how is this group supposed to make an educated decision to get 
screened or not? (p. 174) 
Summary and Discussion for Research Question #5: Prostate Cancer Screening 
Empowerment Scale Measuring Stage of Change and Self-Efficacy for Four 
Behaviors—Pre-video (PCS-ES-M-SOC-SE-PRE-V-4) 
Summary #5. The fifth research question concerned stages of change and self-
efficacy of four target behaviors (getting an annual physical exam, discussing with 
medical professional about getting digital rectal exam to screen for PC, considering 
getting a PSA exam to screen for PC, and spreading awareness of PC among African 
American men) before watching the video. As it pertains to the first target behavior of 
getting a physical exam at least once a year, the majority (56.1%) of the study 
participants indicated that they have been performing that behavior for more than six 
months—which is considered the action and maintenance stage. 22% (n=9) of the 
respondents were in the contemplation stage of “thinking about doing this,” while another 
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12.2% (n=5) were “preparing to do this.” In terms of their self-efficacy for this behavior, 
17.1% (n=7), 24.4% (n=10), and 53.7% (n=22) rated their level of confidence as 60%, 
80%, and 100% respectively. The remaining three target behaviors were directly related 
to PC screening. 
The second behavior referred to seeing a medical provider to discuss receiving a 
digital rectal exam. The participants were generally lower in terms of their stage of 
change for this target behavior relative to the first behavior before the intervention: there 
was an even spread from 14.6% and 17.1% in the pre-contemplation stage (“Not thinking 
about doing this”) and contemplation stage respectively (“Thinking about doing this”), to 
14.6% in the preparation and action stages (“Preparing to do this” and “Less than 6 
months”). The action and maintenance stage received the highest number of respondents 
at 13 (31.7%) for the second target behavior. Confidence for the second behavior before 
the intervention was rated generally high—the average confidence level was 67% and 
over 50% of respondents indicated that they were at least 80% confident in carrying out 
this behavior. The third target behavior was talking with a medical professional about 
screening for PC with a PSA exam, and once again we see an even distribution across 
categories in terms of the stage of change—all categories received between 5 and 9 
responses, with the mean response being 2.95. In terms of confidence for the third target 
behavior, the respondents were generally confident that felt confident about 
communicating with a doctor about getting a PSA exam. The average confidence level 
was 74%, and only 4 respondents indicated that they were 20% or less confident on this 
behavior. 
The fourth target behavior concerned spreading awareness of PC screening among 
African American men. On this behavior, we see a lower stage of change than we do for 
the other behaviors: the mean was 2.66 and almost 50% of the study sample was only in 
the pre-contemplation or contemplation stage. In terms of their confidence to carry out 
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this behavior, the study participants were again confident: the average confidence level 
was 69% and less than 10 of them reported having a confidence level of 40% or lower. 
Discussion #5. Friedman et al. (2009) noted that health literacy skills exist “along a 
continuum progressing from basic functional health literacy (i.e., reading and 
comprehension skills), to interactive health literacy (i.e., personal skills involved in 
health information and help seeking), and finally to critical health literacy (i.e., individual 
and community capacity to use health information and be empowered to take control of 
one’s health)” (p. 450). Again, by this definition, participants in this study who watched 
the video and chose to use the information they received to take control of their own 
health and to use health information for the good of the community, achieved “critical 
health literacy,” the uppermost rung on the ladder of heath literacy, as per Friedman et al. 
By and large, the sample of men who participated in this study were more formally 
educated, and therefore more literate, than the targeted population. Therefore, the 
concerns that Friedman et al. (2009) expressed about the correlation between low literacy 
and poor disease prevention were not as pertinent as they probably would have been if 
the sample were more representative of the targeted group. Nevertheless, their concerns 
are relevant to studies of this kind, and are worth noting: 
Individuals who cannot read and understand disease prevention 
information because of its difficult reading levels could be less likely to 
perceive risk to cancer and to attend to cues to action about prevention. 
Further, limited health literacy may reduce the accessibility and effectiveness 
of medical care, resulting in worse health outcomes. Improving health 
literacy and providing individuals with clear, plain language information are 
effective mechanisms to reduce health disparities and help people feel 
comfortable in taking an active role in their medical decisions. (p. 450) 
Table 5c showed participants’ self-reported behavior and confidence in spreading 
awareness among other African American men about the need for PCa screening. In the 
study conducted by Friedman et al. (2009), the authors noted that: 
Several men said they would “spread the word” about PrCA to family 
members and close friends as long as messages were consistent. While they 
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requested information that was culturally specific and targeted to older AA 
men, having timely, accurate, and straightforward information was more of a 
priority. (p.456) 
This finding is of interest in relation to the current study and has potentially 
actionable  implications for future studies that seek effective ways to promote health 
literacy among African American men and reduce their incidence of and mortality rate 
from prostate cancer.  
Summary and Discussion for Research Question #6: Dose of Exposure to Video 
(DOE-TV-1) 
Summary #6. Asked how much of the Avatar video they had watched, 35 
respondents (85.4%) said they watched the entire video, while six (14.6%) said that they 
watched most of it. No one replied that they had watched less than that.  
Discussion #6. Thirty-five (85.4%) participants watched the entire video.  Six 
(14.6%) watched most of it, and no one replied that they had watched less than half. This 
suggests the e-health intervention is a realistic approach to education African American 
men about PC. 
Summary and Discussion for Research Question #7: Rate the Video (RTV-1) 
Summary #7. When asked to rate the level of information they felt that the video 
presented, responses were generally positive. The mean response was 5.12, and over 75% 
of study participants rated the information shared by the video as wither very good or 
excellent.  
Discussion #7. The positive response to the e-health intervention is meaningful. As 
Maibach and Parrot (1995) stated, “health messages that manage to establish new 
positive outcome expectations or to reinforce existing positive expectations, through 
demonstration or persuasion, are likely to increase people’s motivation for engaging in 
the relevant behavior” (p. 50). Furthermore, Rogers (1995) writes that “the easier it is for 
individuals to see the results of an innovation, the more likely they are to adopt it” 
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(Observability, para. 2). This suggests that the high rating of the avatar e-health 
intervention may mean that those who watch the video are likely to adopt the behaviors 
regarding PC screening. 
Summary and Discussion for Research Question #8: Prostate Cancer Screening 
Empowerment Scale Measuring Stage of Change and Self-Efficacy for Four 
Behaviors—Post-video (PCS-ES-M-SOC-SE-POST-V-4) 
Summary #8. The eighth research question concerned stages of change and self-
efficacy of four target behaviors (getting an annual physical exam, discussing with 
medical provider about screening for PC with a digital rectal exam, discussing with 
medical provider about screening for PC with a PSA test, and spreading awareness of PC 
among African American men) after watching the video. The average stage of change for 
the first target behavior of getting annual physical examinations was 3.95—over 50% of 
respondents (n=22) reported that they had been doing this behavior for more than 6 
months. Confidence levels were very high in terms of carrying out this behavior—the 
mean confidence level was 87%. The remaining three target behaviors were directly 
related to PC screening. 
Regarding the second target behavior of working with a medical professional to 
consider receiving a digital rectal exam to screen for PC, the mean response in terms of 
the stage of change was 3.32. Ten participants (24.4%) remained in the pre-
contemplation or contemplation stage, while twelve indicated they were preparing to 
discuss the possibility of receiving a digital rectal exam with a medical professional. 
Participants were fairly confidence they could carry out this target behavior: the mean 
confidence level was 77% and nearly 70% reported having a confidence level of at least 
80%. When asked about discussing whether or not to get a PSA exam to screen for PC 
post-intervention, about 20% (n=9) remained in the pre-contemplation or contemplation 
stage. The modal response post-intervention was the preparation stage (n=16; 39.0%). 
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The study participants were also confident they could communicate with a doctor about 
receiving a PSA exam: the mean response was 81%. 
In terms of the fourth target behavior, spreading awareness among AA men 
regarding PC screening, the mean stage of change was 2.95, with the majority of 
respondents falling in the contemplation stage (n=12; 29.3%) and preparation stage 
(n=17; 41.5%). Most respondents were confident they knew how to spread awareness of 
PC screening—the average confidence level was estimated at 78%.  
Discussion #8. Overall, the Avatar video had a positive effect on the behaviors and 
self-efficacy of many of the participants. In terms of ability, the third and fourth target 
behaviors were positively affected by the intervention, while confidence was increased 
for the second, third, and fourth target behaviors (the three behaviors specifically focused 
on PC screening). This suggests that a simple avatar video can motivate improvements in 
the stage of change and self-efficacy for health-related behaviors. In sum, the avatar e-
health intervention may have reinforced the target behaviors regarding screen for prostate 
cancer, something which Chan et al. (2011) have previously identified as 
underappreciated necessity among minority populations. 
Summary and Discussion for Research Questions #9 & #10: Movements in Stages of 
Change and Self-Efficacy to Perform the Four Target Behaviors 
Summary #9 and #10. Parts IX and X of this study compared responses both 
before and after the avatar video intervention to see the e-health intervention was 
associated with movements in the stage of change or self-efficacy for the four target 
behaviors. A change score was calculated as the difference between the post- and pre-
intervention score, a paired t-test was then conducted to check for statistical significance.  
The first target behavior (getting annual physical exam) was the lone behavior that 
was not explicitly related to PC screening, and this study found no significant differences 
in the stage of change (d =.015, p-value = .868) or in self-efficacy (d =.133, p-value = 
.418). The intervention did not lead to an improvement in the stage of change for second 
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behavior of discussing the merits of receiving a digital rectal exam (d =.000, p-value = 1), 
though self-efficacy significantly increased (d =.354, p-value = .005) for this target 
behavior. The stage of change (d =.306, p-value = .041) and self-efficacy (d =.302, 
p-value = .020) of the behavior discussing the possibility of receiving a PSA exam to 
screen for PC were both significantly affected by the intervention. Similarly, when it 
came to the behavior of spreading awareness among African American men, the 
intervention increased the stage of change (d =.234, p-value = .032) and self-efficacy 
(d =.327, p-value = .005 of this behavior. 
Discussion #9 and #10. Interestingly, getting an annual physical exam remained 
unchanged due to the intervention. This could be because receiving physical 
examinations is a rather routine procedure, and one that is hardly limited to those at risk 
of having PC. In the United States, receiving frequent physical examinations is almost 
universally acknowledged as an important tool to leading a healthy life style. Give this 
reality, it is not surprising that the participants in this study were found to be in the action 
stage of doing this behavior before the intervention occurred, thus explaining why a 
significant improvement in this behavior was not observed. This same logic applies to 
their confidence in getting a physical exam.  
The last three target behaviors were all directly tied to getting screened, or 
spreading awareness about getting screened, for prostate cancer. The e-health 
intervention created in this study significantly improved the stage of change in two of 
three target behaviors: getting a PSA exam and spreading awareness about the need for 
PC screening. Self-efficacy for all three target behaviors regarding PC screening was 
significantly improved by the e-health video. This is encouraging news, as other scholars 
like Chan et al. (2011) have specifically discussed the barriers to getting screened for PC 
among minority populations. Furthermore, it has been demonstrated that people who 
perceive a greater perceived benefit of PC screening are actually more likely to get 
screened (Tingen et al., 1998).  
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As per Friedman et al. (2009), numerous men said that they would use PrCA 
prevention information as a motivator to change their own behaviors. “Messages that 
motivate AA men to take action and communicate pertinent information to others will 
help decrease negative perceptions about cancer prevention in the AA community and 
encourage routine engagement in prevention, screening, and healthy lifestyle behaviors 
(pp. 457-458). 
Summary and Discussion for Research Question #11: Relationship Between 
Demographic Variables and other Study Scales with the Target Behavior of Going 
to Get a PSA Test to Screen for Prostate Cancer (Pre-measure) 
Summary #11. A number of study variables were correlated with the third target 
behavior of discussing whether one should receive a PSA exam to screen for PC with a 
medical professional. In terms of participants’ demographic characteristics, age (ρ=.442, 
p-value = .004) and education (ρ=.324, p-value = .041) were significantly related to the 
third target behavior, while income was not. Most of the health status variables were not 
significantly related with the behavior of discussing getting a PSA exam with a medical 
provider, including overall health status, BMI, weight self-rating, overall quality of 
medical care, and the perceived sensitivity of medical providers to treating African 
American males. Of the health status variables, only quality of care for the participants’ 
medical condition was significant (ρ=.324, p-value = .044). Finally, this study also 
considered associations between participant health literacy skills and self-efficacy. 
In terms of health literacy skills, the ability to seek out health information (ρ=.490, 
p-value = .001), seeking out health services (ρ=.439, p-value = .005), and thinking about 
what a health provider has communicated with them (ρ=.382, p-value = .015) were all 
significant. The remaining health literacy behaviors were not associated with the third 
target behavior in study. In terms of self-efficacy for the health literacy behaviors, 
seeking out health information (ρ=.560, p-value < .001), seeking out health services 
(ρ=.409, p-value = .009), thinking about what a health provider has communicated with 
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them (ρ=.377, p-value = .016) and understanding what a health professional has told 
them (ρ=.337, p-value = .033) were all significantly related to the third target behavior. 
Ability and self-efficacy of four health literacy behaviors did not correlate with the target 
behavior at all: communicating with a health care professional, memorizing and repeating 
out loud what a health professional told them, asking follow up questions to understand 
what they were told by a medical provider, and making the best health decision for 
oneself.  
Discussion #11. Schwartz et al. (2004) find that most adults in the U.S. believe 
regular prostate cancer is important, and that this preventative behavior can save lives. 
This study showed that among the African American community, age and education are 
both positively associated with the behavior of going to get screened for PC with a PSA 
test. The findings that health literacy skills and self-efficacy are significantly related 
getting screened for PC with a PSA exam support other literature that finds health literacy 
and  health outcomes are linked (Berkman et al., 2011). 
Summary and Discussion for Research Question #12: Predicting the Target 
Behavior of Going to Get a PSA Test to Screen for Prostate Cancer (Pre-Measure) 
Summary #12. A series of regression models were fit to explore how a subset of 
participant demographic, health status, and health history variables were related to the 
behavior of talking with a medical professional about receiving a PSA exam to screen for 
PC (Q.61).  
The first model that included a subset of demographic variables (age, married, 
income, education) had an R2 of .359 and turned up two demographic variables that were 
significantly related with Q.61: age (p-value = .011) and education (p-value = .015). 
Income and being married were not significantly related to Q.61, with the estimate effect 
of income being essentially 0 (β = 0.00). 
Model 2 included a set of health status variables: overall self-reported health, BMI, 
weight self-rating, private insurance, quality of health care for medical condition, quality 
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of medical care from provider, and sensitivity of primacy care provider for treating 
African American males. R2 for this model was .391, and four of the health status 
variables had significant relationships with the dependent variables: overall health status 
(p-value = .015), having private insurance (p-value = .027), overall quality of care for 
medical condition (p-value = .002), and overall quality from primary care provider (p-
value = .032). BMI, weight self-rating, and sensitivity of primary care provider were not 
found to be significantly related to Q.61.  
With an R2 of .618, model 3 had the strongest association with the behavior of 
discussing with a medical provider the prospects of getting screened via a PSA exam for 
PC. Two variables were significant in this model: previously getting a digital rectal exam 
(p-value = .002) and being screened for PC by a doctor (p-value = .002). Being at risk of 
getting PC and having a family member die from PC was not associated with Q.61. 
The fourth and final model estimated for Q.61 was a backward stepwise regression 
that included all of the independent variables included in the first three models. In the 
end, this procedure converged on a solution with four variables, all of which were 
significant: BMI, having private insurance, having a previous digital rectal exam, and 
getting screened for PC.  
Discussion #12. In the model with demographic variables, age and education both 
predicted the behavior of going to get screened for PC with a PSA test. This suggests that 
improving retention in educational settings is one long-way strategy of encouraging 
African American males to get screened for PC—something that Weinrich et al. (2009) 
previously found. In their study, they find that an educational intervention improved the 
chances that African American men, who actually have higher mortality rates from PC 
than Whites do, will get screened for PC. Unlike Tingen et al. (1998) found, being 
married was not significantly associated with getting screened for PC—which could be 
due to the small sample size used in this study.  
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In the model 2, there were a few variables that were significantly related to the 
behavior of getting a PSA test to screen for PC. As Potosky et al. (1998) found, having 
medical insurance, and particularly private insurance, was found to increase the odds of 
being screened for prostate cancer. As we would expect, higher ratings of medical care 
from the participants’ health care provider was associated with getting screened for PC 
via PSA exam. The negative association of overall health and getting screened for PC 
with a PSA test is difficult to explain, it could be that healthier individuals are less likely 
to go and get screened for any potential diseases.  
In terms of health history, pervious research has found that having a family history 
related to prostate cancer vulnerability was related to undergoing screening (Jacobsen 
et al., 2003). The third model, however, found that family history was not predictive of 
the getting a PSA exam to screen for PC, and nor was being at risk of PC a predictor of 
getting screened via PSA exam. As we would expect, there was a very strong association 
between getting screened by a doctor for PC and receiving a digital rectal exam to screen 
for PC. 
Summary and Discussion for Research Question #13: Intention to Engage in 
Diffusion of the Innovation of Watching the Avatar Video (DIWV-2) 
Summary #13. Part XIII of this study concerned the participants’ intention to 
spread awareness about the avatar video that was used as the study’s intervention. Of the 
41 study participants, 39 (95.1%) said they were going to recommend the avatar video to 
other men. The open-response questions largely agreed with this finding: most 
participants found the video informative and clear, and thought the video was well worth 
the time they spent watching it.  
Discussion #13. The majority of study participants said they would recommend the 
avatar e-video to other African American men, and that the video was informative and 
helpful. The respondents also suggested that the video was indeed culturally appropriate 
for the intended population. Misra and Wallace (2012) have noted that carefully crafted 
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e-health interventions on the web can not only be effective, but can allow for wider 
access to essential health-related information. The respondents clearly support that 
conclusion since the majority of them indicated that they intended to share the avatar e-
resource with other African American men.  
Implications 
This study has examined the potential of culturally appropriate e-health videos to 
reach and engage African American men vis-à-vis their heightened risk of developing 
prostate cancer, and the screening and treatment options available to them. The findings 
indicate that the culturally tailored avatar that was created for and presented to these 
African American men—a group that has been historically difficult to reach—positively 
impacted their behavior. It is incumbent upon health educators and researchers to 
continue to design, administer, and study the effects of such avatars. This will serve both 
the health needs of this at-risk population and may reduce the overall incidence and costs 
associated with prostate cancer. Given the epidemic proportion of PCa in the U.S. and its 
disproportionate incidence in African American males, and the promising results of this 
study, the innovative use of e-health avatar videos should be pursued. Culturally tailored 
avatars have not only been shown to be effective—they are low-tech, relatively 
inexpensive, readily accessible, and easily disseminated. Moreover, the men who 
responded positively to watching the avatar were also willing to recommend it to other 
men within their social networks. Such willingness and engagement should make the 
potential reach and positive effect of these avatars of serious interest to other health 
educators. Avatars have been shown, through this study and others conducted by fellows 
of the Research Group on Disparities in Health (RDGH) at Teachers College, Columbia 
University, sponsored by Professor Barbara Wallace, Director of the RGDH, to be 
effective tools in engaging at-risk and difficult-to-reach populations. In addition, they are 
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a viable and low-cost way to engage and positively affect vulnerable populations—in this 
case, African American men who face a disproportionate risk of developing PCa and its 
complications.  
This study therefore signifies the importance of having health educators use 
culturally appropriate videos to reach this at-risk population—African American men—
which has proven difficult to reach by other means, and to use innovative e-health in as 
wide a variety of community-based settings as possible, such as health clinics. I addition, 
such culturally appropriate materials could be highly effective in reaching this population 
through social networks and organizations for African American men.  
The implications of this study also include ramifications for the larger society. 
Because African American men comprise a disproportionate percentage of the men 
affected by the epidemic of PCa, and while tending to be less aware of this risk and less 
engaged in their healthcare, finding effective ways to address and disseminate 
information and ways contains the possibility of reducing the incidence of PCa in African 
American men and thereby reduce, too, the societal costs associated with it.  
Recommendations for Future Research 
Existing research on the disproportionate incidence and severity of PCa in black 
men indicates the need for future research in several areas. First, genetics has been 
identified as playing a definitive role in this racial disparity. Second, as Woods et al. 
(2004) found, in their longitudinal study of 277 Black men in the U.S., that the men did 
not participate in PCa screening. The reasons for this lack of participation raise a whole 
other avenue of needed research, especially in the light of the “epidemic” of PCa in 
American black men that the U.S. Congress declared in 2012. 
In relation to both the importance of genetics and the socio-cultural reasons why 
black men tend not to participate in PCa testing, Hoffman et al. (2001) recommended that 
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future research “be directed at the identification of biologic markers and genetic 
susceptibility factors, as well as additional socioeconomic factors, including use of 
health-care systems, distance from health care, diet, literacy, and health beliefs” (p. 394). 
Fowke et al. (2005) noted that assessing the “relationships between prostate cancer 
screening and social support structures, self-efficacy to make health care decisions, and 
individual perceptions of health and disease might help address these issues” (p. 339), 
while Woods et al. (2004) were more specific in reporting the conclusions and 
recommendations of their study: 
Five themes were identified as critical elements affecting men’s 
screening for prostate cancer: lack of knowledge, communication, social 
support, quality of care, and sexuality. These themes were associated with a 
sense of disconnectedness by black men from the healthcare system and 
contributed to nonparticipation in prostate cancer early detection activities. 
(p. 388) 
Based on these findings, Woods et al. (2004) concluded that “lack of discussion 
about the decision to screen for prostate cancer and general lack of culturally appropriate 
communication with healthcare providers has engendered distrust, created fear, fostered 
disconnect, and increased the likelihood of nonparticipation in prostate cancer screening 
among black men” (p.388). They recommended creating “a caring, trusting, social 
environment … a positive relationship with the physician/healthcare provider … and 
outreach using respected older men and family members” to address these issues, all of 
which are “consistent with other researchers who have identifies core black values and 
traits” (p. 395). “To more effectively reach black men,” they state, 
we recommend a combination of culturally attractive materials, cultural 
sensitivity (including an acknowledgment of past negative experiences of 
this group with healthcare), and competent, person-oriented quality service 
delivery. Most important is the need for a “personal touch”—a relationship 
between the provider and the men. (p. 388) 
In line with these recommendations, the current study provided “culturally 
attractive materials” as an attempt to engage a group of African American men in 
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thinking about their risk for PCa, their options for taking a proactive stance in diagnosing 
this risk, and their options for care. Future research needs to follow up on the findings of 
the present study and other studies, which have shed light not only on the genetic 
predisposition of Black men to develop PCa and the reasons why Black men have 
historically not participated in PCa discussion and screening—but have proposed ways to 
address the social reasons for this lack of participation. Studies can now be conducted 
that utilize the recommendations of this research to see whether their implementation 
produce positive results, and to what degree.  
In addition, studies that address the genetic predisposition of Black men to develop 
PCa can be conducted to determine whether, in the light of the known benefits of genetic 
testing and the lack of risk involved (unlike PSA testing), more routine genetic testing 
would serve Black men in this regard (as is now offered to women who have a family 
history of and genetic predisposition for breast cancer). 
Specifically, as Wu and Modlin (2012) stated, “Chromosome 8q24 variants have 
been shown in several studies to be associated with prostate cancer risk and are more 
common in African American men” (p. 314). Wu and Modlin also pointed to “a higher 
rate of variations in cell apoptosis genes such as BCL211 and tumor suppression genes 
such as EphB2 in African American men” (p. 314). 
Wu and Modlin (2012) discussed how evidence of a “genetic component to the 
high incidence and mortality rate in African American men comes from epidemiologic 
studies of men with similar genetic backgrounds” (p. 314). In their words, “Chromosome 
8q24 variants have been shown in several studies to be associated with prostate cancer 
risk and are more common in African American men” (p. 314). Wu and Modlin also 
pointed to “a higher rate of variations in cell apoptosis genes such as BCL211 and 
tumorsuppression genes such as EphB2 in African American men” (p. 314). Wu and 
Modlin discussed how these findings “suggest that genetic differences may contribute to 
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the higher prostate cancer incidence and mortality rate seen in African American men” 
(p. 314). 
Freedman et al. (2006) conducted a study to “explore how much of the increased 
incidence of prostate cancer in African-American men might be explained by African (as 
compared with European) ancestry at 8q24” (p. 14070). To determine this, they studied 
1,597 prostate cancer cases and 873 controls, and “evaluated the risk for individuals 
carrying zero, one, and two chromosomes with African ancestry” at the 8q24 locus 
(p. 14070). They concluded that “8q24 explains a large proportion of prostate cancer in 
younger African Americans” (p. 14071), and stated: 
If it were possible to develop a treatment that reduced prostate cancer 
risk in the African-American population to the level that is seen in men who 
carry two copies of 8q24 inherited from recent European ancestors, the rate 
of prostate cancer would decrease by 49%. (p. 14070) 
Mahal et al. (2014) examined trends in disparate treatment of African American 
(AA) men with localized prostate cancer (PCa) across National Comprehensive Center 
Network (NCCN) risk groups in the United States. According to Mahal et al., “African 
American (AA) men have a significantly higher risk of dying from PCa than white men” 
(p. 386). How much of this, they added, “is due to differences in biology vs disparities in 
treatment patterns and access to care,” is unknown (p. 386). 
Given the dangers known to be inherent in PSA testing, it would be important for 
future biomedical research to undertake the discovery of alternate forms of PCa screening 
that do not involve these (or other) risks. Such medical research might consider ways to 
use gene BCL2, chromosome 8q24, and/or gene EphB2 to develop new methods for 
diagnostic screening that do not carry the risks or uncertainties that are involved in 
current PSA testing. In addition, the development of a genetically based treatment that 
addresses the finding of Freedman et al. (2006) might result in the kids of reduction in a 




Disparities in the treatment and survival rates of African American men are another 
avenue in need of further research and change. Research has already acknowledged this 
disparity. Wu and Modlin (2012) also note that research has shown differences “in the 
treatments offered to patients, which in turn negatively affect survival” (p. 316). The 
treatments highlighted were “potentially curative local therapies (including radical 
surgery or radiation)” that “may be recommended less often to black men because of 
major comorbidities or socioeconomic considerations” (p. 316). One potential for future 
research is trying to expand the findings of this study to a lower socioeconomic sample 
since this study oversample individuals from higher socioeconomic backgrounds as 
measured by income and education.  
Given the well-established disparities in both the genetic disposition for and the 
treatment of PCa in African American men, our currently incomplete understanding of 
how variants in chromosome 8q24 affect the development of PCa, and more specifically 
how treatment disparities affect outcomes in African American men, it is incumbent upon 
future research to follow up on these topics and determine how best to develop and 
implement strategies designed to address them. 
Hoffman et al. (2001) recommended that future research “be directed at the 
identification of biologic markers and genetic susceptibility factors, as well as additional 
socioeconomic factors, including use of health-care systems, distance from health care, 
diet, literacy, and health beliefs” (p. 394). On the other hand, Fowke et al. (2005) 
suggested that the assessment “of relationships between prostate cancer screening and 
social support structures, self-efficacy to make health care decisions, and individual 
perceptions of health and disease might help address these issues” (p. 339). 
On a different level, utilizing the PCS-10 scale that was created for this study by 
the Principal Investigator and dissertation sponsor, Dr. Wallace, makes it possible to 
obtain the prevalence of diagnoses of prostate cancer, history of screening for prostate 
cancer (i.e., with yes, no, or unsure options), as well as the prevalence of prostate cancer 
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in men’s family and in their social network (i.e., check all that apply)—including deaths 
from prostate cancer and the metastasis of cancer in their network (i.e., number 
indicated). In future research, it would be optimal to use this new tool as the standard for 
obtaining and determining data on these specifics.  
Limitations 
The limitations to this study are as follows: (1) the use of self-reported data that is 
not validated, including the risk that participants provided potentially socially desirable 
responses (since no measure of social desirability is being used in this study); (2) the 
manner in which study subjects need to have access to computers and the internet to 
complete the study; (3) the potential time burden on study participants given the study 
task, even though the Principal Investigator attempted to limit the length of study 
participations; and (4) the difficulty of engaging a stigmatized, hard-to-reach population 
of African American men at risk for prostate cancer, which may have limited the sample 
size. Moreover, the fact that the study used a sample of convenience limits its 
generalizability, as does the fact that volunteers were used who may have certain 
characteristics (e.g., greater than usual interest in prostate cancer). Finally, the fact that all 
data were collected at a single point in time, and only through online sampling, makes it 
impossible to determine whether or what additional changes might occur over time in the 
subjects’ behavior.  
While these possible sources of bias exist, however, the findings of this study 
indicate that it culturally tailored and appropriate videos, such as avatars, have significant 
implications for following up with other such initiatives to communicate with and inform 
African American men about their risk for PCa, and their options for screening and 
treatment. Innovative e-health has been shown to be a viable tool in advancing the need 
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to reach this population and improve their chances of early detection and better care in 
relation to prostate cancer.  
Finally, a major limitation concerns the study sample. As has been stated, this 
study oversampled from an upper socioeconomic group of people. The median income 
was approximately 80,000, while the median years of schooling completed was 16—
meaning that half of the study participants at least had completed college. This impacts 
the generalizations that this study can claim—more research will be needed to show that 
the results of this study, and particularly the impact of the intervention, generalized to 
more underserved populations.  
Conclusion 
Chapter I introduced the study. The subsequent chapters provided a literature 
review (Chapter II), study methods employed (Chapter III), results of the data analysis 
(Chapter IV), and a discussion of the results, with implications and conclusions 
(Chapter V).  
Because African American men (1) face a disproportionately great risk of 
developing prostate cancer and developing/dying from comorbidities associated with 
PCa, (2) live with a significant disparity in their receipt of healthcare, and (3) are 
relatively uninformed and unaware about their risks and healthcare options, there is a 
pressing need to develop culturally appropriate tools that can engage this population of 
men in preventing and treating PCa, and to develop and prioritize strategies that integrate 
biomedical and behavioral approaches to PCa diagnostic screening and intervention 
strategies. Furthermore, society could benefit from additional NIH funding in the area of 
prostate cancer research regarding African American men. Additionally, increasing the 
number of African American scholars that focus on the prostate cancer dilemma in the 
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African American community would produce more strategies to decrease the incidence 
and mortality rate from PC among African American men.  
This study has identified important next steps that can be used to advance our 
knowledge of PCa in African American men; and the viability of innovative, culturally 
appropriate e-health products as valuable health education tools. These findings therefore 
serve to inform both public-health educators, and both biomedical and social researchers, 
moving forward.  
The following quote from Woods et al. (2004) sums up the medical and cultural 
need that must be addressed to produce a significantly positive impact on the current 
disparities faced by African American men in relation to PCa:  
Black men’s lack of engagement with the healthcare system in general 
and more specifically in prostate cancer screening occurs within a larger 
societal context. Black men have historically been dissuaded from active and 
meaningful participation as a partner in their own health care. 
Disconnectedness of black men from society has persisted for a long time, 
and healthcare is no exception. To improve the lagging health status of black 
men, health professionals must utilize strategies that reach, engage, and 
sustain relationships with this population.… Consideration of their ethnic 
origin will enhance our ability to reach disenfranchised black men more 
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Teachers College, Columbia University 
New York, New York 
INFORMED CONSENT 
 
DESCRIPTION OF RESEARCH:  
As a health professional (MPH) and pre-doctoral fellow with the Research Group 
on Disparities in Health within the Department of Health and Behavior Studies at 
Teachers College, Columbia University, in New York, New York, I am also working with 
my sponsor (Dr. Barbara Wallace) on this study. We are studying how African American 
men evaluate and rate a brief Avatar (cartoon-like) video on prostate cancer, while also 
obtaining important background information through a survey. Our goal is to use what 
we learn from this study to share information on the health education needs of African 
American men.  
Study Location: The research is being conducted online. Participants can only 
access the study by following the study link. This can be done wherever the participant 
has access to a computer and the Internet. 
RISKS AND BENEFITS:   
Potential Risks: There are no anticipated risks to participants in this study. 
When answering questions in this study, some participants might experience 
embarrassment, discomfort, emotional pain, sadness, or stress. This is a risk of 
answering some survey questions. Although, we would encourage study completion, a 
participant can discontinue participation in this study at any time. Simply exit the study, 
and delete the link to the study.  Any participant who becomes upset can pursue help, as 
follows, as an Internet user: conduct a search via Google.com by entering “free online 
counseling.” For example, go to http://www.myshrink.com/online-crisis-counseling-t.php 
and access support 24 hours a day/seven days a week from a trained professional 
volunteer; or, go to http://www.psychresources.net/ to access online counseling 
resources; or, go to http://www.mytherapycouch.com/free_online_therapy/ to receive 
free online therapy with a qualified professional. Again, we do not think that study 
participation will trigger so much discomfort that this is necessary. But, we offer these 
suggestions just in case you do experience discomfort.   
Remember, participation in this study is completely voluntary. Participants can 
end their involvement in the study at any time. Simply exit the study, and delete the link 
to the study. 
There is another risk for study participants. Participants may experience feelings 
of fatigue, frustration, or boredom while answering survey questions. We have taken 
steps to minimize this risk. We did this by selecting only the most important questions. 
And, we attempted to limit the amount of time it takes to answer questions. 
There is another potential risk. This involves feeling influenced by someone or 
pressured to participate in the study. No participant should feel forced or pressured to be 
in the study. The use of an online survey means that the researcher has no way of 
knowing who actually took the survey and who did not. This reduces/minimizes the risk 
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of your feeling coerced, pressured, or forced to participate in the study. Remember, you 
can discontinue study participation at any time. Simply exit the survey and delete the link 
to the survey.  
Potential Benefits: There are no direct benefits for study participants. No 
benefits from study participation are being promised or guaranteed. Some potential 
benefit is possible. 
For example, as a part of this study, a participant may experience a benefit from 
watching the video. A positive benefit is expected. However, no positive benefit is 
guaranteed. There is no way of knowing if any negative consequences follow from 
viewing the video. Again, no positive benefit is guaranteed. 
PAYMENTS:  
There are no payments for participating in this study.  However, a participant has 
a 3 in 200 chance of winning a $300, $200, or $100 gift certificate to www.Amazon.com. 
Once 200 participants complete the entire survey, a program will automatically send out 
bar-coded gift certificates to 3 randomly chosen e-mail accounts. This happens without 
linking participants to their survey answers.  
DATA STORAGE TO PROTECT CONFIDENTIALITY:  
Since this is an online survey, actual names, addresses and phone numbers are 
not needed. Only aggregate (group) data will be used by the researchers. The designers 
of the website have taken steps to ensure that all data will remain secure, private and 
confidential. 
TIME INVOLVEMENT:  
Study participation should take about 45 minutes. First, you will be asked to 
answer survey questions for about 30 minutes. Next, you will be asked to watch an 
Avatar (cartoon-like) video for about 5 minutes. Finally, you will be asked to answer 
additional questions, including rating the videos—taking about 10 minutes.  
HOW RESULTS WILL BE USED:   
The results of the study will be used in health education. This includes improving 
health education created to meet the needs of African American men, and improving our 
Avatar (cartoon-like) videos. The results will also be used as part of dissertation data for 
the researchers’ doctorate degree in health education. The data will be presented at 
health education meetings, published in health education journals, and used for other 
educational purposes. 
 





Teachers College, Columbia University 
New York, New York 
PARTICIPANTS’ RIGHTS 
 
Principal Investigator: WILLIAM HALL 
Research Title: AN INNOVATIVE APPROACH TO REDUCING PROSTATE CANCER 
HEALTHCARE DISPARITIES FOR AT-RISK AFRICAN AMERICAN  
MEN: DEVELOPMENT AND EVALUATION OF AN ONLINE E-HEALTH AVATAR 
VIDEO TAILORED TO BE CULTURALLY APPROPRIATE  
 
 I have read and discussed the Research Description. I have had the opportunity to ask 
questions about the purposes and procedures regarding this study.  
 My participation in research is voluntary. I may refuse to participate or withdraw from 
participation at any time without jeopardy to future medical care, employment, student 
status or other entitlements.  
 The researcher may withdraw me from the research at his/her professional discretion.  
 If, during the course of the study, significant new information that has been developed 
becomes available which may relate to my willingness to continue to participate, the 
investigator will provide this information to me.  
 Any information derived from the research project that personally identifies me will not 
be voluntarily released or disclosed without my separate consent, except as specifically 
required by law.  
 If at any time I have any questions regarding the research or my participation, I can 
contact the investigator, who will answer my questions. The investigator’s e-mail is 
wah47@tc.columbia.edu and his sponsor/ supervisor (Dr. Barbara Wallace) can be 
contacted at bcw3@columbia.edu or 267-269-7411. 
 If at any time I have comments, or concerns regarding the conduct of the research or 
questions about my rights as a research subject, I should contact the Teachers College, 
Columbia University Institutional Review Board /IRB. The phone number for the IRB is 
(212) 678-4105. Or, I can write to the IRB at Teachers College, Columbia University, 
525 W. 120th Street, New York, NY, 10027, Box 151.  
 I should receive a copy of the Research Description and this Participant’s Rights 
document.  
 NOT APPLICABLE: If video and/or audio taping is part of this research, I ( ) consent to 
be audio/video taped. I ( ) do NOT consent to being video/audio taped. The written, video 
and/or audio taped materials will be viewed only by the principal investigator and 
members of the research team.  
 NOT APPLICABLE: Written, video and/or audio taped materials ( ) may be viewed in an 
educational setting outside the research ( ) may NOT be viewed in an educational setting 
outside the research. 
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 My ELECTRONIC signature means that I agree to participate in this study.  
 
Participant’s ELECTRONIC assent: ___Yes I reviewed my Participants Rights__ 
Date:____/____/____ 
 




Screening for Study Participation 
SCREENING QUESTIONS FOR THE AFRICAN AMERICAN MEN’S 
PROSTATE CANCER AWARENESS 
AVATAR VIDEO STUDY 
 
Thank you for volunteering to participate in the African American Men’s Prostate 
Cancer Awareness Avatar Video Study. Before you begin, please answer the following 
questions: 
 
1) Are you an African American man who is age 18 or older? 
Yes ___ No___ 
 
2) Are you able to read and understand English on a high school level? 
Yes ___ No___ 
 
3) Are you able to devote about 25-35 minutes to this study at this time—for a 3 in 200 
chance to win a $300, $200, or $100 gift certificate for use on www.Amazon.com? 
Yes ___ No___ 
 
6) More specifically, are you willing to spend 10-15 minutes answering a survey?  
Yes ___ No___ 
 
7) Next, are you willing to watch an avatar video (cartoon) for about 5 minutes? 
Yes ___ No___ 
 
8) Are you willing to answer another set of questions for about 5-10 minutes, including 
rating the avatar videos and explaining why you would or would not recommend the 
video to others? 
Yes ___ No___ 
 
If you answered NO to any of the eight above questions, then please STOP HERE. 
This study opportunity is not for you. Please forward the study link to people you think 
are able to answer YES to the above questions. E-mail, text, or tweet for them to: 
Go to www.surveymonkey.com/s/AAProstateCancer/ to take a survey & rate a 
video for a chance to win a $300, $200, or $100 prize. 
Or, you can return to this survey when you have the time to devote to it.  
  If you answered YES to all of the above questions, then please proceed to the 





SURVEY FOR THE AFRICAN AMERICAN MEN’S PROSTATE 
CANCER AWARENESS AVATAR VIDEO STUDY 
 
Instructions:  Please answer the following questions in each section by clicking the box 
next to the item of your choice. 
————————————————————————————————————
———————————— 
PART I: BASIC DEMOGRAPHICS (BD-9) 
1)   I am:         A.  Female        B.   Male       
2)  My age is:  _________ (USE DROP DOWN MENU OF AGES 18-85) 
3)  I am currently:  A.  Married    B.   Divorced     C.   Separated    
 D.  Widowed         E.  Never Married   F.  In Domestic Partnership           
 G.  Living with Significant Other H.   In a Committed Relationship 
I.    Currently Dating  Other                                     k 
 
4) My race/ethnicity is as follows: (Please mark all that apply) 
__Black/African American  
__White / Caucasian / European American 
__Hispanic / Latino (including Puerto Rican, Mexican, Mexican American, Chicano, 
Cuban, other Spanish)  
    __Asian (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, or other Asian)  
__American Indian / Alaska Native 
__Native Hawaiian / Pacific Islander 
__Arab American / Middle Eastern 
__Other group(s) (specify)  
 
5)  Do you live in the United States?  Yes    No 
      If yes, what is your current zip code?                                                          k 
      If No, what country do you live in? ______________________________ 
 
6) Were you born in the United States? Yes    No 
 If answered “No, “Where was you place of birth or your country of origin? 
   Country of origin? ________________________________ 
   (USE DROP DOWN MENU OF COUNTRIES) 
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7) My yearly household income is: 
__Less than $10,000    
__$10,000 to $19,000     
__$20,000 to $39,000  
__$40,000 to $49,000   
__$50,000 to $99,999    
__$100,000 to $199,999 
__$200,000 to $299,000   
__$300,000 to $399,000    
__$400,000 to $499,000 
__$500,000 to $799,000   
__$800,000 or More 
__I do not know 
 
8) My highest education level is: 
                   Grade School (please indicate your grade completed) _____________ 
                   High School 
                   Associate Degree  
                   Bachelors Degree  
                   Masters Degree  
                   Doctoral Degree 
                   Other Degree (please explain) ______________________________ 
 
9) I am currently (check all that apply) 
__ part-time undergraduate student 
__ full-time undergraduate student 
__ part-time graduate student 
__ full-time graduate student 
__ unemployed  
__ on Welfare 
__ Employed Part-time                 
__ Employed Full-time 
__ Receiving SSI/SSD  
__ Other (please explain________________________) 
 
PART II: BRIEF HEALTH SURVEY (BHS-8) 
1. I rate my overall health status as 
a.___Excellent         b.___Very Good        c.__Good         d.__Fair          
e.__Poor        f.__Very Poor 
 
2)  My height is _________ feet _______ inches 
 
3) My weight is ____________ pounds 
 
4) I consider myself to be 
a). ___underweight b)___normal weight     c)___overweight         d)____obese     
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5) My type of medical insurance is (check all that apply) 
a) Private insurance plan (e.g. Blue Cross/Blue Shield, Aetna, Oxford, etc…) 
b) HMO    
c) Medicaid 
d) Medicare 
e) Not Applicable, I have no medical insurance 
 
6) I rate the overall quality of care I receive for my health (and any medical condition I 
have) as 
a.___Excellent         b.___Very Good        c.__Good         d.__Fair         
 e.__Poor        f.__Very Poor        g.___Not Applicable (don’ t receive health care) 
 
7). I rate the overall quality of care I receive from my primary care physician as 
a.___Excellent         b.___Very Good        c.__Good         d.__Fair          
e.__Poor        f.__Very Poor           g.___Not Applicable (I do not have one) 
 
8) For my health care providers showing sensitivity and competence for treating me as an 
African American, or providing me with the same care they provide to Whites, I rate 
them as 
a.___Excellent         b.___Very Good        c.__Good         d.__Fair         




PART III: PROSTATE CANCER SCALE (PCS-10) 
1-Have you ever been told by a doctor or medical professional that you have prostate 
cancer? 
__No     __Yes    __Unsure 
 
2-Have you ever been told by a doctor or medical professional that you are at risk for 
prostate cancer? 
__No     __Yes    __Unsure 
 
3-Have you ever had a doctor or medical professional perform a digital rectal 
examination (placing their finger in your anus/rectum)? 
__No     __Yes    __Unsure 
 
4-Have you ever been told by a doctor or medical professional that you were going to 
have your PSA measured? 
__No     __Yes    __Unsure 
 
5-Have you ever been told by a doctor or medical professional that you were being given 
a screening test for prostate cancer? 




6-Do you know someone in YOUR FAMILY who has been diagnosed with prostate 
cancer? 
__No     __Yes    __Unsure 
If you answered “Yes,” then please check off all those you know in YOUR FANILY who 
have been diagnosed with prostate cancer: 
____Maternal grandfather (grandfather on your mother’s side) 
____Paternal grandfather (grandfather on your father’s side) 
____Father  
____Uncle on your mother’s side ___More than one Uncle on mother’s side 
____Uncle on your father’s side ___More than one Uncle on father’s side 
____Cousin on your mother’s side ___More than one Cousin on mother’s side 
____Cousin on your father’s side ___More than one Cousin on father’s side 
____Brother ___More than one Brother? __Yes __No   If Yes, how many? 
____Other (please explain_____________) 
 
7-Do you know someone in YOUR FAMILY who DIED from prostate cancer? 
__No     __Yes    __Unsure 
If you answered “Yes,” then please check off all those you know in YOUR FANILY who 
DIED from prostate cancer: 
____Maternal grandfather (grandfather on your mother’s side) 
____Paternal grandfather (grandfather on your father’s side) 
____Uncle on your mother’s side ___More than one Uncle on mother’s side 
____Uncle on your father’s side ___More than one Uncle on father’s side 
____Cousin on your mother’s side ___More than one Cousin on mother’s side 
____Cousin on your father’s side ___More than one Cousin on father’s side 
____Brother  ___More than one Brother  
____Other (please explain____________) 
 
8-Do you know someone who has been diagnosed with prostate cancer? 
__No     __Yes    __Unsure 
If you answered “Yes,” then please indicate the number of people you know who have 
been diagnosed with prostate cancer: 
____0 ____1     ___2   ____3   ____4   ____5  ____6  ____7  ____8 ____9 ___10 
 
9—Do you know someone who DIED from prostate cancer? 
__No     __Yes    __Unsure 
If you answered “Yes,” then please indicate the number of people you know who have 
DIED from prostate cancer: 
____0 ____1     ___2   ____3   ____4   ____5  ____6  ____7  ____8 ____9 ___10 
 
10—Do you know someone who DIED from prostate cancer that had also spread 
(metastasis) to other parts of their body? 
__No     __Yes    __Unsure 
If you answered “Yes,” then please indicate the number of people you know who have 
DIED from prostate cancer that had also spread (metastasis) to other parts of their body? 




PART IV: SCALE MEASURING HEALTH LITERACY VIA SKILLS 
AND SELF-EFFICACY (SM-HL-V-S-SE-16) 
The CDC has defined health literacy, as follows: “The Patient Protection and 
Affordable Care Act of 2010, Title V, defines health literacy as the degree to which an 
individual has the capacity to obtain, communicate, process, and understand basic health 
information and services to make appropriate health decisions” (para. 1).  
 
Please answer the following questions: 
 
For seeking out health information,  
1-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
2-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
 
For seeking out health services, such as going to a clinic, hospital, or making an 
appointment to see a medical doctor in their office 
3-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
4-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
 
For communicating with a health professional and asking all the questions that I 
have about my health 
5-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
6-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
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For thinking about what I have been told by a health professional and turning it 
over in my mind so I begin to understand what is being told to me 
7-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
8-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
  
For really understanding what I have been told by a health professional 
9-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
10-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
 
For being able to memorize and repeat (state it aloud) what I have been told by a health 
professional 
11-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
12-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
 
For being able to ask questions that will help me to better understand, or completely 
understand what a health professional has explained to me 
13-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
14-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 




For making the best health decisions for myself, deciding what actions I should take, and 
telling a health professional what I have decided to do, need to do, or prefer to do 
15-I would rate my ability as 
Very Poor Poor Fair Good Very 
Good 
Excellent 
1 2 3 4 5 6 
 
16-And, I would rate my level of confidence for doing this as 
Not confident     Extremely 
confident 
0% 20% 40% 60% 80% 100% 
 
———————————————————————————————————— 
PART V: PROSTATE CANCER SCREENING EMPOWERMENT SCALE 
MEASURING STAGE OF CHANGE AND SELF-EFFICACY FOR FOUR 
BEHAVIORS—PRE-VIDEO (PCS-ES-M-SOC-SE-PRE-V-4) 
Please answer the following questions: 
 
Subscale 1: Receiving an Annual Physical Examination 
1.) When it comes to the behavior of going to see a medical provider and getting a 
physical examination at least once a year, check the following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
 
2.) When it comes to the behavior of going to see a medical provider and getting a 
physical examination at least once a year, how confident are you in performing this 
behavior: 
____0% confident                ____20% confident                ____40% confident  




Subscale 2: Discussing with Medical Provider Screening for Prostate Cancer Via a 
Digital Rectal Exam 
1.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a digital rectal examination (i.e. the physician inserts his 
finger into your anus to check your prostate) to screen for prostate cancer, check the 
following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a digital rectal examination (i.e. the physician inserts his 
finger into your anus to check your prostate) to screen for prostate cancer, how 
confident are you in performing this behavior: 
____0% confident                ____20% confident                ____40% confident  
____60% confident              ____80% confident                ____100% confident  
____Not applicable. I do not have sex like this. 
____NA, I have prostate cancer—already know my status 
———————————————————————————————————— 
Subscale 3: Discussing with Medical Provider Screening for Prostate Cancer Via a 
PSA Test 
1.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a PSA test to screen for prostate cancer, check the 
following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a PSA test to screen for prostate cancer, how confident are 
you in performing this behavior: 
____0% confident               ____20% confident                ____40% confident  
____60% confident             ____80% confident                ____100% confident  
____NA, I was born HIV positive—already know my status 




Subscale 4: Spreading Awareness among other African American Men about the 
Need for Prostate Cancer Screening 
1.) When it comes to the behavior of spreading awareness among other African 
American men about the need for prostate cancer screening, check the following that 
most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of spreading awareness among other African 
American men about the need for prostate cancer screening, how confident are you in 
performing this behavior: 
____0% confident               ____20% confident                ____40% confident  
____60% confident             ____80% confident                ____100% confident  
____NA, I was born HIV positive—already know my status 
____NA, I have prostate cancer—already know my status 
 
PLEASE CLICK THIS LINK AND WATCH THE AVATAR VIDEO –
TAKING ABOUT 5 MINUTES. 
 
———————————————————————————————————— 
NOW, PLEASE ANSWER THE QUESTIONS THAT FOLLOW 
 
PART VI: DOSE OF EXPOSURE TO VIDEO (DOE-TV-1) 
1) Please select one of the following: 
□ _____I watched none of the video 
□ _____I watched some of the video 
□ _____I watched most of the video 
□ _____I watched all of the video 
———————————————————————————————————— 
 
PART VII: RATE THE VIDEO (RTV-1) 
1. In terms of the information shared in the video, how do you rate the video: 
 
Very Poor Poor Fair Good Very 
Good 
Excellent 






PART VIII: PROSTATE CANCER SCREENING EMPOWERMENT 
SCALE MEASURING STAGE OF CHANGE AND SELF-EFFICACY 
FOR FOUR BEHAVIORS—POST-VIDEO (PCS-ES-M-SOC-SE-POST-V-
4) 
Please answer the following questions: 
 
Subscale 1: Receiving an Annual Physical Examination 
1.) When it comes to the behavior of going to see a medical provider and getting a 
physical examination at least once a year, check the following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
 
2.) When it comes to the behavior of going to see a medical provider and getting a 
physical examination at least once a year, how confident are you in performing this 
behavior: 
____0% confident               ____20% confident                 ____40% confident  
____60% confident             ____80% confident                 ____100% confident  
 
———————————————————————————————————— 
Subscale 2: Discussing with Medical Provider Screening for Prostate Cancer Via a 
Digital Rectal Exam 
1.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a digital rectal examination (i.e. the physician inserts his 
finger into your anus to check your prostate) to screen for prostate cancer, check the 
following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a digital rectal examination (i.e. the physician inserts his 
finger into your anus to check your prostate) to screen for prostate cancer, how 
confident are you in performing this behavior: 
____0% confident                ____20% confident                ____40% confident  
____60% confident              ____80% confident                ____100% confident  
____Not applicable. I do not have sex like this. 




Subscale 3: Discussing with Medical Provider Screening for Prostate Cancer Via a 
PSA Test 
1.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a PSA test to screen for prostate cancer, check the 
following that most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of discussing with your medical provider about 
whether you should receive a PSA test to screen for prostate cancer, how confident are 
you in performing this behavior: 
____0% confident               ____20% confident                 ____40% confident  
____60% confident             ____80% confident                 ____100% confident  
____NA, I was born HIV positive—already know my status 
____NA, I have prostate cancer—already know my status 
———————————————————————————————————— 
Subscale 4: Spreading Awareness among other African American Men about the 
Need for Prostate Cancer Screening 
1.) When it comes to the behavior of spreading awareness among other African 
American men about the need for prostate cancer screening, check the following that 
most applies to you: 
_____I am not thinking of doing this behavior at all. 
_____I am thinking about doing this behavior. 
_____I am preparing to do this behavior. 
_____I have been doing this behavior for less than six (6) months. 
_____I have been doing this behavior for more than six (6) months. 
_____NA, I have prostate cancer—already know my status 
 
2.) When it comes to the behavior of spreading awareness among other African 
American men about the need for prostate cancer screening, how confident are you in 
performing this behavior: 
____0% confident               ____20% confident                ____40% confident  
____60% confident             ____80% confident                ____100% confident  
_____NA, I was born HIV positive—already know my status 




PART IX: INTENTION TO ENGAGE IN DIFFUSION OF THE 
INNOVATION OF WATCHING THE AVATAR VIDEO (DIWV-2) 
1-Will you recommend the avatar video to other men? 
□ Yes 
□ No 
2- Why would you recommend or not recommend the video  
cartoon to others? Please explain why or why not. What other comments do you have? 
 
———————————————————————————————————— 
END OF SURVEY: THANK YOU AND SHARE WITH OTHERS!  
We invite you to text message, e-mail, and tweet other men to  
Go to www.surveymonkey.com/s/AAProstateCancer/ to take a survey & rate a video 
for a chance to win a $300, $200, or $100 prize 
 
TO HAVE A CHANCE TO WIN A PRIZE! 
Click the link below: 
______________________________ 
Thanks for completing the survey and clicking the FINAL link. You now have a 3 in 200 
chance of winning a prize in our random drawing for a bar-coded gift certificate to 






IF YOU ARE AN AFRICAN AMERICAN MAN AGE 18 OR 
ABOVE YOU ARE INVITED TO TAKE A SURVEY 
THIS STUDY’S IRB PROTOCOL NUMBER 
 
The Research Group on Disparities in Health within the Department of 
Health and Behavior Studies at Teachers College, Columbia University, in New York, 
New York is studying how African American men evaluate and rate a brief Avatar 
(cartoon-like) video on prostate cancer, while also obtaining important background 
information through a survey.  
 First, we ask you to spend about 30 minutes answering an online survey  
 Then we want you to spend 5 minutes watching an avatar/cartoon video 
 Finally, we ask you to spend about 10 minutes rating the video and answering 
final questions 
 Participation in this survey is limited to the first 200 men  
 After 200 men complete the survey, the computer program will automatically 
close the survey and send out bar–coded gift certificates for use at 
www.Amazon.com to three randomly chosen e-mail accounts ($300, $200 or 
$100) without in any way linking your identity to the survey results 
 Please go to the link below  
(“Go towww.surveymonkey.com/s/AAProstateCancer/) to view the 
informed consent, learn about your rights as a participant and proceed to 
the survey. 
 We invite you to e-mail, text, and tweet other men you know: 
     “Go to www.surveymonkey.com/s/AAProstateCancer/ to take a 
survey & rate a video for a chance to win a $300, $200, or $100 
prize.”  
NOTE: Participants have a 3 in 200 chance of winning a $300, $200, or $100 
bar-coded gift certificate for use on www.Amazon.com.  
 
THANK YOU FOR YOUR PARTICIPATION! 
 
WILLIAM HALL, M.P.H., and Doctoral Candidate, Department of Health and Behavior 
Studies, Pre-Doctoral Fellow, Research Group on Disparities in Health, Teachers College, 
Columbia University, Box 114, 525 W. 120th Street, New York, NY 10027; 
wah47@tc.columbia.edu 
 
BARBARA C. WALLACE, Ph.D., Director, Research Group on Disparities in Health, 
Professor of Health Education, Clinical Psychologist, Department of Health and Behavior 
Studies, Teachers College, Columbia University, Box 114, 525 W. 120th Street, New York, 
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The Study Text Message/Tweet 
 
“Go to www.surveymonkey.com/s/AAProstateCancer/ to take a survey & 










Prostate Cancer Script 
 
SCENE/ SETTING: A park with greenery, etc… 
 
CHARACTERS: Three Black men are walking around, sitting down, standing up, 
gesturing with their arms and hands, showing emotion as they talk. The Three 
Black men are: Dave (BROWN-SKINNED); Kwame (DARK-SKINNED); and, 
Steve (LIGHT-SKINNED): 
 
Dave: How are you? 
 
Kwame: Good, man. 
 
Steve: Good. How you doing, Dave? 
 
Dave: My brother was diagnosed with prostate cancer. 
 
Steve: I keep hearing the same story: Black men getting prostate cancer—like 
my best friend. 
 
Dave: Yeah, my brother went for his annual physical, had a Digital Rectal 
Examination, and his PSA test. His PSA was high, so he was called back for a 
biopsy. The biopsy was positive for prostate cancer. 
 
Kwame: How old is he? 
 
Dave: 48.  
 
Dave: Our father died from prostate cancer, so we are considered at high risk. 
We have been getting physical examinations every year—since age 40. That 
includes having a Digital Rectal Examination and PSA test. This time my 
brother’s PSA test was high. So, he had the biopsy that found the cancer. 
 
Steve: My best friend died from prostate cancer at age 54. 
 
Kwame: My uncle and my cousin died from prostate cancer. Still, I have not had 




Kwame: I’m afraid. Plus, I don’t want a doctor putting their finger inside my anus, 
or talking down to me, or explaining things by talking way above my head—like 
they are doing it on purpose. Plus, the last doctor made me wait longer than all 
  
197 
the other patients—seeing people who came in AFTER me. So, I walked out. 
And, I have not been back in 7 years.  
 
Steve: You have to get over that, man. Every Black man needs to have an 
annual physical.   
 
Dave: All African American men are at risk for prostate cancer—compared to all 
the other racial and ethnic groups in the United States. Black men get prostate 
cancer at the highest rates, and die from prostate cancer at the highest rates. 
 
Steve: The rate for Black men dying from prostate cancer is between double to 
triple the risk—compared to all the other racial and ethnic groups in this country.  
 
Kwame: And, we receive the worse medical care—if you ask me.   
 
Dave: Yes! For example, when my brother was diagnosed with prostate cancer, 
his doctor recommended watchful waiting—which really means doing nothing, or 
just waiting and watching the condition.  
 
Kwame: A lot of brothers are just not properly educated on all the treatment 
options available—because of racism, talking down to Black men, and, 
physicians not taking the time to explain all the treatment options in ways that 
can be easily understood. 
 
Steve: Disrespect. Sometimes doctors assume a Black man does not have the 
kind of insurance coverage to pay for treatment options.  
 
Dave: I was there when my brother received education on treatment options for 
his prostate cancer. When the doctor recommended watching waiting—or just 




Dave: I Googled TOP DOCTORS, searched on the Internet, and I asked around. 
I found a really good urologist who takes time to explain things, and treats Black 
men with respect.  
 
Steve: Like night and day—finally being treated with respect! 
 
Dave: Yes! Then, I found a really good oncologist—a prostate cancer specialist. 
The urologist and oncologist consulted about my brother’s case. We felt really 
respected. Now, my brother is thinking about surgery to remove his prostate. 
Watchful waiting is too dangerous, given his being African American, plus his 




Kwame: My cousin who died from prostate cancer had been advised to do 
watchful waiting. That was some bad advice, man! The prostate cancer spread to 
his bones. His leg bone was so thin it was in danger of snapping. He had to start 
using a wheelchair. Plus, he could barely walk anyway. 
 
Steve: They don’t want to tell you that watchful waiting can mean prostate 
cancer spreading—metastasizing—throughout your entire skeletal and lymphatic 
system. 
 
Dave: Exactly! I found a year 2002 article by Dr. Ramsis Benjamin. I memorized 
some facts: Lower back pain or headache can be a sign of prostate cancer 
spreading from the bone to the central nervous system—or what they call 
metastatic prostate cancer. Once you have metastatic prostate cancer, for 90% 
of patients it spreads to the spine, for 50% it spreads to the lungs, and for 25% it 
spreads to the liver. 
 
Kwame: That is what I saw in my cousin! 
 
Dave: When it spreads to the spine, the back pain can be so bad that reclining or 
lying down does not relieve it; and, after the pain starts, there can be muscle 
weakness, and difficulty walking. In other words, unless you get early treatment 
you can end up in a wheel chair, unable to walk.  
 
Kwame: You are describing my cousin! Nobody tells you how all that can 
happen. “Just do watchful waiting” is all they say. Yeah, and watch yourself end 
up in a lot of pain, or a wheelchair, then dead. 
 
Steve: They say that prostate cancer spreading to the brain is rare, but it 
happened to my best friend.  
Dave: Dr. Benjamin cites research going back to before they did regular PSA 
testing. The average time from the diagnosis of prostate cancer to a metastasis 
or spreading to the bone was 19 months; 35 months for it spreading to the lungs; 
and 60 months for it spreading to the brain. 
Steve: Then, when you have brain cancer you can start having seizures. And, 
once prostate cancer has spread to the brain, you usually have just 7-8 months 
left before you die. It was hard watching my best friend die. He was 54.  
Kwame: Wow! You are describing the last 5 years of my cousin’s life before we 
buried him at age 52! 
Dave: I think some doctors cannot imagine a Black man wanting to live more 
than wanting to have sex. Sometimes they put so much emphasis on the 
possibility of not being able to have an erection after surgery or some of the other 




Steve: Like all a Black man cares about is having sex! 
 
Kwame: I think my dead cousin would have preferred not being able to have an 
erection, or even having some urine leak out his penis—to being dead! 
 
Steve: The same goes for my best friend. But, Kwame, you have to know that 
there are some great medical doctors out there.  
 
Dave: Yeah, I have become expert at finding them. And, if they cannot treat a 
Black man with respect, and explain things in a way I can understand, then I am 
out of there.  
 
Kwame: Well, I guess I have to go back and starting getting my annual physical 
examination.  
 
Dave: Definitely, man. I have a referral for you. Every Black man MUST have an 
annual physical examination. And, that annual physical examination MUST 
include bending over and having the Digital Rectal Examination; plus your blood 
must be taken for the PSA test. Then, you have to make sure you get the results 
of your PSA test. 
 
Steve: Yes. Every African American man is supposed to begin having an annual 
PSA test starting at age 40—just because the risk is so high for our racial group. 
Then, if you have a family history of prostate cancer, or you were exposed to 
Agent Orange in Vietnam, then you are at the HIGHEST RISK for prostate 
cancer. 
 
Dave: So, even if a Black man is at the highest risk for experiencing racism and 
discrimination in the healthcare system, you have to know to shop around until 
you find a doctor who can give some real respect to you.  
 
Kwame: That is where I am now. I walked out of that doctor’s office 7 years ago. 
Now, it is time to go back and work with a professional who can truly respect me. 
 
Steve and Dave: YES! 
